From: ‘Sena Adon

To: Cmwtos. CaoY. (GOC/OD/OADC:eps.Jay 4.GOCIODIOADE)

ce rey
Subject OCapprovalroquestd: AQ Content
Dae: Tuesday,
Moy4 202192102A
Attachments: Gayol£40Coton 4.30COCake
HiCarol - Hope the week is of to a great start. Our content specialist, recently made copyedits to.
two CDC questions for our new FAQ modules appearing in the COVID-19 Information Center.
Theseare fairly minor edits to what you've already provided, but if you have additional edits, could
You please let us know by COB if possible?
A quick note that our new launch date is 5/17. We are not planning any proactive comms at the
moment, butifwe do, we will let you know and coordinate accordingly.
Thanks and let me knowifyou have questions!
Best,
Genelle
| BE
 From: ‘Stan cd 0/00/0400)
Tor ‘Ste
Oointar a Atos
Subject: COC acne contort
one: Wainy,Decor23, 020102000A.
Just FY. Rosie had this ready for discussion yesterday so sending it long if helpful. Have
agreat
holiday!

NewPages
‘ModernaCOVID-19Vaccine Information |CDC:
‘ModernaCOVID-10VaccineQuestions|CDC
COVID-19 Data Tracker: CDC
COVID DataTracker
NewPrioritizationRecommendations
ohm
goulvaccines/covid-19/mplementation:sicategies
toss.cdc im!

‘PagesUpdateswithPrioritization Recommendations
‘WhattoExpectatYourAppointment10GetVaccinatedforCOVID-19|COC
PagesUpdated
‘COVID-19Vaccinesand SevereAllergicReactions|COC
VaccinationConsiderationsforPeoplewhoarePregnantorBreastfeeding|CDC
Vaccines |COC
‘8 Things toKnowabouttheU.S.COVID-19VaccinationProgram|CDC
HowCOCisMakingCOVID-19VacrineRecommendations |CDC
OVIDClinicalLandingPage:
ProductnfobyUSVaccinePage:
Piizer-pioNTech
COVID-19Vaccine Information |COC
‘COVID-19Vaccine FAQSforHealthcareProfessionals|CDC
‘https. cdc govicoronavirus/2019-ncovlvaccines/odfs/321466:A_ES_What_Expect COVID:
12VaxFinal
12.1320.pdf
actsaboutCOVID-19Vaccines(cdegov)
DifferentCOVID-19Vaccines|COC
Informationaboutthe
Pizer-BioNTech COVID-19Vaccine |COC
‘£OVID-19Vaccination ProviderRequirementsandSupport|COC
Trainingandfducation|COVID-19Vaccination|CDC

CarolY. Crawford
I
Division of Public Affairs
 From:
Tor Contr advGOODIE)
Tat Toe:StesOrit:J rons:xnhn:CisAd: Sa Hay: hissThomas
Subject: SeConan)
GOV 10 BLO etn
Shan:
na: FranMay
rnay 14,2021
14,021 20040 PU
1230.00PU
Location: Zoom wotrs
ead hc teloetmenthcOnToLike
ranme Er SB in 0COND, L820 300on sm
el

Tanto
Cont comtot
tp Ns Bh
Jt——
contact
gov mitted
p>

Jontno ing

Dotty
yourbsion
us soe
oe [ST
ussito)
Mesiog
pascose ENE ]
aR
 From: ‘Cuts. Cae¥.COCIODIONE)
To! EatonIps;Ganehsv
Subject OVID BOLD Wifarmatn mestings
outer Mond,May10,2021124400 PM
We would like to establish COVID BOLO meetings on misinformation and invite al platforms to jin
the meetings. We are aiming for our frst one on Friday at noon. | know you were considering.
possible process on your end, but we wanted start here just as interim frst step. Are there direct
POCs on your end 1 should include on the invite? Happy to chat if better.
THANKS!
Lr el
ee

ee]
ToFrom: Cato,CattCD00)
ToiCo:tkeCrm:aAton: Eaton han:Gc dosSa Hae:ies
subjoct: naoinsta con Sowa GoesCOUINIRIR
COD19CECBOLOVert
Sr Fry a, 2081 120008 Pt.
era Fry. st 129000
Location: Zoom
Ae eS eg OT kn can COV. Ln un oe

To Blin
Tie 5,021 1200 xr Tne05 ndCans
ioon
esi
©6
Msg
psc
TEVE1]
Oneopmote
©) pa

ism
ssa
s
vo Yo
om)
paseo (INET]

nts
©16
int 2s
oe |
oe) UsEas)
Sew CE)
rootCET]
go cat
cocoons
ca
oy liechonCID,Gi
EE IED
fa Ket ac
brs
22 Eo
a nt
Sn
TmAewi
ER RT he

Mecung
10: TRMEY
ren CER]
re

teen

(0X6) Jus (Sandose)

bs
[woo]
passcode[TRVEY]
OY er |
wi

rain
pra
© JusEs
Mecung 0_ToE
cn
 wv EEE
DS
i
1"Cur eS Re
as
SRA
Sn
oe

einen
Mecing 10: CIDE]

or
_
©)6) US (New York)

Fatt,
yp
:
© 1S(SamJose)

wT
res[8]
ri .
sa
(XE)

_
[ooJs
Mecting
0 _BY6)]
-
 From: Cmts, CanY. COC/ODIONE)
To! Batonthane:CateAdans
Subject Ghion&Toonsvcsna no
Dae: Wednesda,
My12,2021 83800
Just FYI, we have a great deal of new content posted. Also, some new info on mythsyour misinfo
folks might be interested in.

«New web page:COVID-19VaccinesforChildrenandTeens provides information about the

benefits of COVID-1 vaccines for adolescents aged 12 and older, how to find
vaccination provider for adolescents, and what to expectduring and after vaccination.
«New fact sheet: COVID-19Vaccinesfor PreteensandTeens. is a printable fact sheet for
parents that explains the benefits ofa COVID-19 vaccine for their children, safety information,
and what to expect during and after vaccination. New frequently asked
‘questions: Twonew FAQ: address questions about the safety and benefits of COVID-19.
Vaccination for adolescents aged 12 and older.
«New myth-buster about menstrual cycles: Your menstrual cycle cannotbeaffected by being.
near someone who received a COVID-19 vaccine. This question andanswer explains why.
«Mythbuster about infertility: I is safe for people who would like to have a baby one day to
get a COVID-19vaccine. Thisquestion andanswerexplains why.
«Key things to know: The webpagesKeyThingstoKnowaboutCOVID-19Vaccines and About
COVID-19Vaccines have been updated to include the recommendation that adolescents aged 12
and older get vaccinated.

Information for Healthcare and Vaccine Providers

«Newpediatrictoolkit: ThePediatricHealthcareProfessionals COVID-19Vaccination
‘Toolkit provides materials to help healthcare providers give parents clear and accurate
information about COVID-19 vaccines. The toolkit includes answers to common questions, an
‘explanation of how mRNA vaccines work, and printable materials to give to parents
«New FAQs about consent for minors: £AQs have been posted on the Pfizer-
BioNTech product page for providers with information about consent, prescreening questions,
and other issues related to the vaccination of minors,
«New sample patient letter: Healthcare providers can customize and send thissamoleletter.
to encourage their patients to get a COVID-19 vaccine. It includes the new recommendation that
everyone aged 12 and up get a COVID-19 vaccination.
Information for Community Groups and Health Departments
‘Toolkit for community-based organizations: TheCommunity-fasedOrganizationsCOVID-19
VaccineToolkit has been updated to include information and resources on COVID-19 vaccination for
adolescents aged 12 and older.
Carol Crawford
Chief, Digital Media Branch
Division of Public Affairs
oApC
ccrawford@cdc gov
404-498-2840
 facebook ae

Na
TR,iia
Ear:
i

Feed promotions and COVID-19

from their state health website

or local provider.
 [El -y CO
EEE
 From: Stet Cal 000A)
Tor Gaia
Ei bans
Subject EarlGu Question rm HS
Dut: Fy dm25.2081 75300 0
Thiswas the idea but I think we'd probably change up the question if we were taking about a OP.
Do vaccines contain the COVID virus? (User selects answer, choosing true or false]
True
False
[Correct answer displays upon click - [Include 1 plain-language sentence with explanation, followed
by link]
False. A COVID-19 vaccine cannot make you sick with COVID-19 because it doesn't contain the ive
virus.LearnmorelinkleadstorelatedcdcgovcontentorQR videol
 From: ‘Cuts.Cae¥.COCIODIONE)
To! [rey
Subject: Exam qu |mentioned
Oster Moda, na25,2021 1:41:00
A

110) COCon Toit er: “IF voul coup: q

“ETL

httos://wuwfacebook
com/76625396025/p0sts/10159266620161026/2d=n
 From: ‘Sand. Cad.0000/0400)
Tor Eatonbana:CasaAdama
Subject FW OC pprors este: FAQContent
Outer Tusa, ay11.20315:00
Atachments: Fob COVID-19 vax ruber usr Kans srsoment cx
“carrie
From: Crawford, Carol Y. (CDC/OD/OADC)
Sent: Tuesday, May 11, 2021 1:51PM
‘To: Genelle Adrien <genelleadrien@fb.com>; Dempsey, Jay H. (CDC/OD/OADC) <ifbS@cdc.gov>
Ce: Payton Iheme <payton@fb.com>; McDaniel, Rebecca (CDC/OD/OADC) <Idy8@cdc.gov>
‘Subject: RE: CDC approval requested: FAQ Content
Ifyou call can sign this we can move forward with the logo add. Thanks!

From: Genelle Adrien <geneleadrien@fh

com>
Sent: Tuesday, May 4, 2021 8:45 PM
‘To: Crawford, Carol
Y. (CDC/OD/OADC) <ciyl@cdc.gov>; Dempsey, Jay H. (CDC/OD/OADC)
<ifbs@cdc.gov>
Ce: Payton Iheme <payton@(hcom>; MeDaniel, Rebecca (CDC/0D/OADC) <idyB@cdcgov>
Subject: Re: COC approval requested: FAQ Content
Thanks, Caroll This i great feedback. The proactive comms was in reference to this new FAQ
mode
Speaking of the logo approval, the action page is live here:
hitos//aboutfacebook
com/actions/responding:1o-covid-19. And, we wil add the CDC logo once we:
have your go ahead.
Thank you—
Genelle
From: Crawford, Carol Y. (CDC/OD/OADC) <ciy1@cdc.gov>
Date: Tuesday, May 4, 2021 at 7:53 PM
To: Genelle Adrien <genslleadrien@fh.com>, Dempsey, Jay H. (CDC/OD/OADC)
<ifbS@cdcgov
Ce: Payton heme <payton@fhcom>, McDaniel, Rebecca (CDC/0D/OADC)<IdvE@cdc gov>
‘Subject: RE: CDC approval requested: FAQ Content

Hi Genelle ~ one Q was ine but our SMES said the below on the other question. Also, just to check
‘was the proactive comms note about the item I'm getting the logo approved for?
 Centers for Disease Control and Prevention/CDC
Trademark License Agreement—Non-Exclusive

Trademark License Number:

Licensee: Facebook Technologies, LLC
This Agreement (“Agreement”) is dated as of +20__ (“Effective Date”),
between the Centers for Discase Control andPrevention/ ATSDR, an agencyof the Public Health
Service, located at 1600 Clifton Road, Atlanta, GA 30329 (“Licensor; PHS”) and Facebook
Technologies, LLC (“Licensee”; collectively, the Parties) located at 1601 Willow Road, Menlo
Park, CA 94025.
Recitals
PHS is the owner oftrademarks (“Trademarks”) as identified in Attachment “A,” and the
‘goodwill associated therewith
The Trademarks are used in association with public health/safety messages, training, or
communication initiatives that support the mission of Licensor, which is “Collaborating to create
the expertise, information, and tools that people and communities need to protect their health —
through health promotion, preventionof disease, injury and disability, and preparedness for new
health threats.”
Licensee desires to use the Trademarks on and in connection with jointly developed public
health/safety messages, training modules, or other communication initiatives, as identified in
Attachment B, as a co-brand with Licensee’ brand.
‘The Parties are entering into this Agreement to confirm the basis upon which Licensee is
permitted to use the Trademarks.
NOW, THEREFORE, for good and valuable consideration, including the mutual promises and
covenants contained herein, the receipt and adequacy of which is hereby acknowledged, the
Parties agree as follows
1. Grant
1. PHS hereby grants to Licensee a non-exclusive, non-transferable, royalty free,
license (“License”) to use, reproduce and display the Trademarks on and within
Internet pages, visual presentations, or written materials solely in connection with
thejointly developed public health/safety messages. The License is for non-
commercial useofthe Trademarks only. The Trademarks may not be used in
connection with any other goods or services without the written consent of PHS.
2. Licensee shall only use the Trademarks on or in additional products or services
other than those identified in Attachment B after such use has been approved by
PHS, in writing, in response to a writen request by Licensee.
2. Term of the Agreement: This Agreement will begin on the Effective Date and will continue
fora periodofthirty-six (36) months or upon expirationofthe use described in Attachment B
or any subsequent approval under paragraph 1.2, whichever occurs first (“Tem”), unless
terminated earlier in accordance with this Agreement.
3. Termination: Licensee shall have a unilateral right to terminate this Agreement by giving
PHS seven (7) days written notice to that effect. PHS or Licensee may (without prejudice to
any other right or remedy) terminate this Agreement (a) at any time upon notice in writing to
the other partyifthe other party is in material breach of any obligation hereunder and does
not cure such breach within seven (7) days of being requested in writing to do so; or (b) upon
notice, where the Licensee's useof the Trademarks is the subject ofa legal claim. The license
to use PHS's Trademarks will cease within three (3) business days upon the termination or
expirationofthis Agreement. Licensee agrees to remove any Intemet page contentifin
PHS's sole discretion such removal is warranted, and to destroy all material bearing the
Licensed Trademarks. Licensee shall provide PHS written confirmationof such destruction.
Notwithstanding, Licensee may, at PHS’s discretion, distribute stocksof co-branded
materials existing at the timeoflicense termination unless Licensee has materially breached
this Agreement and failed to cure such breach within thirty (30) days written notice by PHS.
In the event there is a significant change in the scientific research or data reflected in any
product using the Trademarks, which PHS reasonably concludes renders the content
substantially inaccurate, PHS may notify the Licensee in writing. Upon receiptof such
notice, Licensee shall, prior to producing any further such products update the content of
those products. Failure to provide such update will result in PHS's terminationofthe license.
‘granted with respect to such products determined by PHS to contain scientifically outdated,
incorrect, or harmful content.
4. Permitted Use; Standardsof Quality; and Approval: The Licensee will only use the
‘Trademarks in conformance with the policies, specifications, regulations and standards
authorized or stipulated by PHS and whose character and quality is not altered by the
Licensee without the authorizationof PHS. License is strictly prohibited from using any
materials including the licensed product to promote any political party or affiliation or for
lobbying purposes. Licensee may not use the Trademarks together with any content that is
unlawful, defamatory, infringing, obscene, fraudulent, hateful,o racially, ethnically or
otherwise objectionable in the sole discretion of PHS. Licensee may not use the Trademarks
for any commercial purpose or to endorse or imply endorsement of any entity, product or
service, including Licensee. Licensee agrees to adhere to the trademark usage guidelines
illustrated in Attachment A. Licensee shall submit for PHS's approval at least one sample of
ach product using the Trademarks, including any product to be made available through the
Internet, packaged and labeled in the form proposed to be marketed, at least twenty (20)
business days before actually marketed. Licensee shall use the Trademarks only as specified
in Attachment B or as otherwise approved in accordance with paragraph 1.2.
5. Trademark Control: Upon request by PHS, the Licensee wil provide PHS with
representative use(s)of Trademarks. Useofthe Trademarks on goods or services other than
as covered under this Agreement or in a manner inconsistent with Licensor's Trademark
‘Guidelines or paragraph 4 shall constitute material breach of this Agreement.
Notwithstanding paragraph 3,if such material breach has not been cured within five (5)
business days following receipt ofnotice from PHS, this Agreement will be terminated.
6. Ownership: Licensee agrees to use the Trademarks only as stated in this Agreement.
Licensee agrees not 10 use the Trademarks in combination with any other trade name,
trademark or service mark without the prior written approval of PHS. License acquires no
right, title or interest in Licensor Trademarks or the goodwill associated with them, other
than the right to use Licensor's Trademarks according to this Agreement. In accepting this
Agreement, Licensee acknowledges that as between Licensee and PHS, PHS is the owner of
the Licensor's Trademarks and Licensee agrees not to use or applyto register any trademarks
which include a Licensor Trademark or any trademark, service mark, trade name or
derivation confusingly similar to a Licensor Trademark, in any country or territory during or
after the termofthis Agreement. Licensee will not take any action in derogationofany of the
rights of PHS in any Licensor Trademarks.
7. Copyright: Contributions by US govemment employees in products bearing the Trademarks
are not subject to copyright in the United States.
8. Indemnification: PHS offers no warranties other than that it owns the Trademarks. No
indemnification of any loss, claim, damage or liability is intended or provided by any party
under this Agreement. Each party shall be responsible for any loss, claim, damage or
liability it incurs.
9. Assignment: The License granted herein is personalto Licensee and Licensee shall not
assign, sub-license, transfer,orotherwise convey Licensee's rights or obligations under this
Agreement without PHS's prior written consent, such consent of PHS not to be withheld
unreasonably.
10. Survival. The parties’ rights and obligations, which by their nature would continue beyond
the terminationof this Agreement, including, but not limited to, indemnification and actions
affecting the enforceability of the mark, shall survive such termination.
11. Partial Invalidity: The provisionsofthis Agreement are severable, and in the event that any
provision of this Agreement shall be determined to be invalid or unenforceable under any
controlling bodyoflaw, such determination shall not in any way affect the validity or
enforceabilityof the remaining provisionsofthis Agreement.
12. Entire Agreement: This Agreement supersedes all previous agreements, understandings, and
arrangements between the partis, whetheroral orwritten, and constitutes the entire.
agreement between the partis regarding the subject matter herein.
13. Notice: All notices required or permitted by this Agreement shall be given by confirmed
receipt email or prepaid, first class, registered or certified mail properly addressed to the
following:

1. For CDC:
Rick Hull
Health Communications Specialist
Centers for Disease Control and Prevention
4770 Buford Highway K80
Atlanta, GA 30341
770-488-5055
 fh @ede.gov

2. For Licensee:
Julian Nagler
inagler@fb.com
Witha copy to:
Email: Legal-Notices@fb.com
Attention: FB Legal Notices

14, Trademark Notice; Non-Endorsement Statement: Licensee agrees to place the following
trademark notice on any product, communication, item, or Internet page that includes a
Licensed Trademark: “The mark ‘CDC” is owned by the US Dept. of Health and Human
Services and is used with permission. Useof this logo is not an endorsement by HHS or
CDCofany particular product, service, or enterprise.” The notice must be placed in
proximity to Licensed Trademarks.
15. Waiver of Rights: Neither Party may waive or release anyofits rights or interests in this
Agreement except in writing. The failure of PHS to assert a right hereunder or to insist upon
‘compliance with any term or condition of this Agreement shall not constitute a waiver of that
right by PHS or excuse a similar subsequent failure to perform any such term or condition by
Licensee.
16. Non-endorsement: By entering into this Agreement, PHS does not directly or indirectly
endorse Licensee or any product or service provided,or to be provided, by Licensee whether
directly or indirectly related to this Agreement. Licensee shall not state or imply that this
Agreement is an endorsement by the U.S. Government, PHS, any other U.S. Government
organizational unit, or any U.S. Government employee. Additionally, other than the use:
specified in Attachment B, Licensee shall not use the names of CDC, PHS, or DHHS or the
U.S. Government or their employees in any commercial advertising, promotional, or sales
literature.
17. Dispute Settlement: The Parties agree to attempt to settle amicably any controversy or claim
arising under this Agreement ora breachofthis Agreement. Licensee agrees first to appeal
any such unsettled claims or controversies to the designated PHS official, or designee, whose
decision shall be considered the final agency decision. Thereafter, Licensee may exercise
any administrative orjudicial remedies that may be available.
18. Modifications: Ifeither Party desires a modification to this Agreement, the Parties shall,
upon reasonable notice of the proposed modification by the Party desiring the change, confer
in good faith to determine the desirabilityof such modification. No modification will be
effective until a written amendment is signed by the signatories to this Agreement or their
designees.
IN WITNESS WHEREOF, the parties have caused this License to be executed by their duly
authorized representatives.

For PHS:

Signatureof Authorized PHS Official Date

Juliana Cyril, Ph.D.
Director, OfficeofTechnology and Innovation
Centers for Disease Control and Prevention

For Licensee:

Signature of Authorized Licensee Official Date

Michael Abrash
VP, Facebook Research
Authorized Representative, Facebook Technologies, LLC
 Attachment A ~ Trademarks
Color
The oficial COC logo colori Pantone 286 blue (CMYK: 100, 6,0, 2 RGB: 0,3, 170) or blac.
Substitution of COC blu or blacks prohibited. The blue i acceptable for use on color material and the
black is only acceptable for black and white or spot color use or when the partner logo is also presented
in black and whi.
Alignment and spacing
Separate the CDC logo from the partner logo by a minimum of 1/2 the vertical measurement of the COC
logo excluding the COC logo tag ine).
nx

Fe
3 Re
minimum nr]
TT Em
SIRE ae Sabin wr

buffer area of “1/2 around the CDC logo should be maintain freoftexto graphics.
Partner use of the CDC logo on a Web site or Web page:
& The logo should be placed near the bottom of the partner's Web page.
~Thefollowing trademark notice should be placedproximatetothe logo “The mark ‘CDC is
‘ownedby the US Dept. of Health and Human Services and is used with permission. Use of
‘this logo is not an endorsement by HHS or CDC of any particular product, service, or
antarpie”
- The logo should be used at a minimum of 35 pixels in height and a maximumof45 pixels in
height, with proportional scaling of its horizontal dimension.

Appropriate relative sizing

Ona vertically-oriented document the logo may occupy approximately 1/15 of the vertical grid. On a
horizontally-oriented document the logo may occupy approximately 1/12 of the vertical grid.

|
I
Ld ]
Legibility over a background color or image

The same is true for the black version. Do not use a drop shadow, halo effect, or add
acolor frame to

Ivr Al, Whsstostn

Examples of inappropriate
logo use

em
mpm i
upc ol CDC
Wr RH
 Attachment B — Covered Use
(sample covered use, showing where partner and PHS trademarks will go, per trademark
usage guidance in Attachment A, and with “Trademark Notice; Non-Endorsement
Statement” provided in paragraph 14. of the agreement.)

oe 1 Helping 50 million people

3 JA find the vaccine
4 ' information they need.
CL AI TN vcr os poi sy toue
. Facebook and Instagram tafind when and
of KS FAO crc they can makeavaccineappointment.
° Ng 2
NATED, ©) FinaCOVID-19vaccinesitsmoa you »

= 142,692,987
From task force:
I would suggest] 16) plus correcting the lst as
shown in red). For that bottom text, the first sentence is duplicative of the bulleted list

©)6)

From: Genele Adrien <genelieadrien®fh com>

Sent: Tuesday, May 4, 2021 9:19 AM
To: Crawford, CarolY. (CDC/OD/OADC) <ciyl@cdc.gor>; Dempsey, Jay H. (CDC/OD/OADC)
<ifbs@cdc gor
Ce: Payton Iheme <payton@fh.com>
Subject: CDCapproval requested: FAQ Content
Hi Carol ~ Hope the week is off to a great start. Our content specialist, recently made copyedits to
two CDC questions for our new FAQ modules appearing in the COVID-19 Information Center.
Theseare fairy minor edits to what youve already provided, but if you have additional edits, could
You please let us knowbyCOB f possible?
Aquick note that our new launch date is 5/17. We are notplanning any proactive comms at the
moment, butifwe do, we will let you know and coordinate accordingly.
“Thanks and let me knowifyou have questions!
Best,
Genelle
 From: ‘Cuts. Ca¥. COC/ODIOME)
To: ‘Couto
Y_(COCIODIOAE)
Co
Bee: Legiona ba:a si stat hid DomsosCoO
nh Soke.
@hcon: (C0C/OD/OADE):Gls.Hat
Toad0B an (COC/OD/OADE):Crane
Antares’fscinwal,roe
(COC/DODNGIIO0) Fuhcscis,3:
Subject: Followup fofomBOLOmeetingon528
oat: Fda, ay28,2021 1:13.00
Attachments: COChcsicn2 cdl
‘Thank you for those that were abletoattend today. Here are the sides. Please do not share
outside your trust and safety teams.
Let us knowifyou have any questions. Thank you.

Carol Crawford
Chie, Digital Media Branch
Division of Public Affairs
oApC
coc
‘ccrawford@cdc gov
404-498-2840
 ha

i
iS)
121

5
S
> ¢
o

te £4
=}
=)
i BN
c <
= N
5 ~ S,
2[= a
@ | &
= 8 @
Q(= ®
Ei5 I ©
EE [3

2g ]
| SS
EN i iia
 z
£
2

gs
:
2
2
£3
53
2 8% si
E85 § 258
© FE 2 BEE
EE 2 $ £5¢
83
:
£
= ge £ 35% i
2. § | £

5 :
E §
2 H
z £

: 3 f
HS
I £
$B, 5H
sid
fis
BES
§ 4ai3
Lope
©
S
3 Bigg
e322
£ pes 4%
< HE
© i
i od @
gS
<
UWIl 8
-
8
A
 i
iis i HH

hi
%3ng
©5i

@® L
H

$ily,
la8 cg 141
H 30
3 =
S33i3 y
n©
l l i f
isl Hil ail
aa t ni:
nin
i
i o l hl ig
CB11V3ii d ljlill W4 1Y z
l p o
pil 1 §
j il i i ia
a [Ei
id
Hi idly
7| i ahs

if 1,85. 4
: g8% 3 EH
Lt if i]
il
t
‘ii !
oi
aE 2 HIE
§i2
Poth
ATT tes:
1% fail i I
3
25t: i H
b
3
<5 yg 11 Ba:
8
%f 2i1f:f 22 aw
P3oa i n g d EH
Iz 2:
.
3
h I B iE

1
2

Bila
ES
r
%s8
F y
 i ES
2
= &
5s
a Ys
= £3
° gg
i a 5%
FI: ©
oF
os
3 3: 2 Ek
i : E °t 0
3
g3
2 2sz BHMH]
25
i 5 EL:
3 Huai E
5 8 wp Lu)
08928
< Hdd BH
H
gin NEES adi RB
Ta iti ugi 4333:
co... BHH
3 LYE
TE ie=|
:H
4
ih BS :
a ’ $2523 §
$83 Eg
3 Eye,
£558
83574
§£882
L
2 Es} 283% §35838
Ig 533 IH TEiie]
>2¢ 5&3 s8EF |, Esg¥as
xcs 5: §298 f $3ig::
Off f2:,
NES (»E%
fir
,=: $3:% ©f sili:
gilszi
SEE 538% : 3:3: 0% gti: ib
Lz: 5
S:8E8 gfif PF dEgsis ig
$8 gite
EZ SES: 3 2 x
8: 338258 :z i1 i S
 HEH E=H
deel E Els]|
HE oll
Gia
HyB
fii: EE z
ii 2s zg
Hae Hf 2
Eins = Hi =
” i
S10 tu i 3
sii
g3k5s HH
$354
i=5
feiit i320
shit]
0 sin
518i} 32 3
iy
Egil
Hep
28282 S8 al
Pics 115 2 4
5 22183 a
Hee pH < Jd449
fe iy g
Hi, nin
Hit
ilies in
EE
fa 2kEHl

a3 253 gif SEs

gBE 3:23 iif

xr ii:
2:
I 3
332% 3
ii;
#3}
OL,
QF: £22 4 Hie Ith
SE §Es Pi cifil BzEs
Bi ff: IM 2B
L,
gt 2f
p
=gaf
l 1:
<3: S85 GB:
gs thE G3 fibre 8.8IL
3d sis 5 Jiiz§ #1 1H
FIRES) z 8
Eis i: 3 EE: BY
 i

2.
£9 :
<9 |
oe :
Se
23
SE
[4
|
|
cde
" gain
S
S
—
22g
858
35§
3 $92

ES3%
£2
2ER

$E poi
5
iis
58
§5223
g Ee 8
£258 i
a 232%4
ii 33|
i
= E3538 g
=8
8
S 18%5%
§ 0 OJ
US
S p
-
» 4
-~
 From: ‘Cod
CaraY.(CDC/00
ord /0ADG)
To: ‘Caav
Carol (CDC/00/0ADG)
dord
ce: DEEN TI CTESeyTAT
er TTR
E
Subject: Foliow vpinfo from BOLOmeeting.
Date: Friday
May14,2021, 12:34:00 PM
Attachments: COGWorkon Grou Meslon 20210514SEoat
‘Thank you for attending. Here are the slides. Also, as mentioned on the call, any contextual
information that can be added to posts about VAERS could be very effective in education the public
about what VAERS is. CDC.gov includes authoritative information about VAERS, such as the following
taken fromthisnage: “VAERS acceptsreportsfrom anyone, including patients, family members,
‘healthcare providers and vaccine manufacturers. VAERS is not designed to determine ifa vaccine
‘cau or contributed
sed to an adverse event. A report to VAERS does not mean thevaccinecaused the
event.”

Carol Crawford
Chief, Digital Media Branch
Division of Public Affairs
0ADC
cerawford@cde gov
404-498-2840
 12]
BS)
[="
= ¢
o

=
==} Ld
[=]
= D
c <

E NN Q
= ; N

fem o

@ | 3
=) @
© ©
‘G ar Oo
Sc

RY
> 8~N

a
AE i iia
|
 Zz5
£
3
gs
2i
82s
25
§8
wv of 88.
2=S2Ef 4§ &:.2
13%
©» PP: § 53
oi: {23 ,i
® Ec mT .

g ge Eg 358
2.08 ]

3 5
£5 2

2st
283
“cg
:E
8.583 :
5828 5
gee
c 38:85
25233
2
©
ge3s323
2 ESESE
3 253:58%
3E £5fss
grads .i
= xT i

=3 fi
ii
g 4 @ u %
=< 7
oY
 of
22%
ORzdg i
Shzbs
EH 5$
IE i z
LwEgS &
Week
PATH z
£:
2
3*
:

EEE i: i
He 3g
Ee
HE . E012 FE
enh] 3 £99: H
EEE | 2 i
EEE
Se
[2
°
iTigi:Hl H
Ea iE

3 is prof
~% Ii tes 3 ni
: set Ll: 3:3
2.8 gg fpsad
3% $3823
2%
a2 zi 132 2
ff HERHI
2:
8;
af
oy
18:1
3%3
bon
$f id
sie be
1
£1 fpeec 1:
25s: HH

TEL Ri 8
iI £188 Ba i
desi 0
$i 32 Z
22502
£8
18
288 s3
3
:Eg
3}
if:
3
! K
RY
N
 nisl | :
FH i

Ey iol
i
Li
fil i :
3
nif
LEi
ailil
iii il]
3£3 ail | 3

i?
I

RC 13p :3
Hi wi =
ia wut 5
i oh dl i 3
3 Z
E
sigs ML i}
ppd)
ie rd |B
1)
Haein
181: a HE
RH are

Er
£5 ge 23

E BE gz
23 83
i i
i
. gf
i gt
i 5&3
AE i:f
i, °E BE:

gh
ais
oi
si:
28: it :
Bo|
ge
HE Hi
i
21 Bi. oi
ali 3tiil 5 i holiEi
i i
sf i ail
i Fimsnt
fErii di
gy 8iz°° ha 1 &
$38
532
32732
iiss 3B3 1iEZi JEB\
A
 3 |
ul,
ml s m F | 32
si [Fon |
al le a (lid
|e
gpl lle HEE
pial lls a | |e E
H E
F528
H E ||
3s
| EZ
PE||i i |) 3
The [|£2
EI
5d g .
IEHIRIEE: if]|2t ¥ 3 2
Feline | 2%| £13 2 :
Brille ii] 3444s

fo
HEEf Hr
EN Eo f t
or i
ye l
t
>3 if
t 5f 1 J OS EF HE
of EE;faid
if , iF
Off if I.sf
co: r
i: fPoois
ssi 0:,l
23ile
azf fr of ilefci;:
SZ: 855 gf fEp
Bi 8% FP Lide §ogi ngnsii
f H
<IH BI Sis
Zar RER 3 le s in
LI EN iH
gg

Euiit i bf:
 ia
ii
ih 5
d -
iti 4 i
b[i 1t4if11
[ 5 z
o

hpit it ob
|.
g
z 5
z g
FI :2
=2
s28i581k2, z i
3583

2g g
tH i
94£%
H i g i
i228, s
frieats SE
p fzis
si

g2:i5g5 R5.I8E% 31 :
575%
2«= if: Sig
|; £58 Hid $2s8i5si2:
i
1 5
g8;
:
£E2s5s £§ f§el: £31:41320
>
o i
gfSoG: i: i i
l | H E1H2
f g i g f 1 11
f; fi: fii
aSg; i Pian e
ig e di §Poinbi c ib1
i53t8:3 3f
g 5g at gf ceg i
o f
3 nd
< e 3 gR i T o g 33
55 fir f i
=
T y f a
$2
n
]-
HI
i :§sE
ifB e R
s s £ Ii
i
2: E
H
 S583

fl 3
aif z
aire
H2piizd z
iE
3g
£3155

BHiLeiE hbi 2
£z
i} il
ill y
gi 2
Hi i
h ii =
ii l ; g
3
Hi lle
i ie i
h
ii
1 o
Hsiliiis Hil
gis gul' FB
3 m o Bgsils i8s:
i igs sd g io
2
4
fis Satins ta
zi
i
f a
IEri, _B%EE1E2C5EkE l g ii:
gaiE 3 1
£15
i i
S Ti e d
R E da]n i e l | i
3QE4:: g )
ag nn PE 3it it
2%i Teh
isles
§ 3IN
fi 1i1l:
fiziss Ni
 13

£
E= :
<9
ee :
os H
] 2%
ti
<5
|H|
° 2

g £22
5 52%
TS 332
2ER |
E282
£
=
: 58
L588
iF Hg A

58: Bi
ifs]
ji:
E2eis
31:
ii
li
=g
i]
Ss E2843
3 0 OT
v
S p
-
» 4
-~
 From: ‘Cuts. Can¥(COCIODIOMOE)
To: ‘Couto
Y_(CDCIODIOAE)
Ca
co Di TS rr
Sk
oncom e (CDC/OD
Ly 0400)
Toda0B: an Galata.
Kato(COC/CDOADG):
Antonis Carpe
Fao@cans,co:
Subject: luof2800mostngtomorrow.
oat: Thursday.un 17,20216:18.00PU
Attachments: COCWorkin GroupMost 20210818200i
Given the new federal holiday, Il be cancelling our BOLO call tomorrow. However, | am sending the
slides outforyour reference. Let us know ifyou have any questions.

Thank you!
Carol Crawford
Chie, Digital Media Branch
Division of Public Affairs, OADC
coc
‘ccrawford@cde gov
404-498-2840
 ==

-—
v
.

3
*

wv
1
[=}
o
|<
Ed

=
Z gd
i=Ss |
£ l =
=
S ER
O
:= ,
o
a

5 - @
Q
2 -. ®
o®
i] ee” ®
5 = 0
>][3Y

E> BE
3
|) Es
Nini
d
 sgl
ty
Sg

gee
£25
23%
SEE
Sis
w 233
© gs
SE
5 pig
REE
0 $223 rn
QEiEs i
2523 f
H

s :

S F

<5

c
£E
gE
8 w £3
§ fit
eae
gT
EE 4
< i
os i
ao iH
gS
Io]
& dg ® m}
is IN a
is
HH
N\ k
i \il. |
HH Ail
i A z
ii y g E
ul 2 2
— lg 32
sl 3 53
£ 2
LB 2 I z ,
Eo ol |g E £
8 {| fl 2 3 i
fi ] z 5 F
i
i: i : & 3
ii!ty : a3 £{
i:
E i
eo
¢ :
iH i
EE | € H
gil . ii
iil HY

zz :
2 EED
BL < a.
22% 1
FEE 1,4
£33
81
8:
fs 3.
88s?
i
B5 gz 2
s Ey £i5i SE
EERE HH iH
> 838s fired iii:
g f e § L h
£:3:8
H h
pid
Ocilst
NEE HH HL
TBREE nf ioral. f ogiizic J
BiRgis Bo fpfize i fic ul
<gefgr Lgl o¢osafnif gb
§E83% i
fF 2adgiie poss
Bi 3 3 8
$883 8 g8 Ei Of o
7
H H $f i: if :
 I Sr =
a AS z
LL gr i 2
Fang| ei 3B
ll gf EBS

iE
23 4 { = E
SC Negi 3 ]
Sg Re SR || 3IgE H
22 f 3 I]
gf : i
iN ¢ < 3
a | :

oF 358s, ;
EL
Ls 2 32 3 i: H
gEgis f55, © Egifi
| f1:f 3 2
2st 385: @ 3gefs
>Esiif 2:8 fT gdsd
S333 $320 8 iff
QES EE; I iii. TrEIZE
i:S
Edi
=$%:233 §§ £528 §
Cf i i, fH i
gh
QIfect 2: fle: ci oii
gsfif Is gE5o: I
gBEfEE fr3 2lis
<L335f8;
s It ined
£382 F _s Y =
HEE
$38
fis 83:
§ff 5; 22 I
FE SE é:
PW7);
Ea3iff 23 3
 ; A
et BS

aIL i= z¥
! L1] a
i | g
| = § 8

id A 3 £
Iiok§ i H
S
HH ve 2 H
:
ii
tl
= 2 :
¢
iid 2 :
LE {
EH. £

x iL.
EF I s2385
Iogst i
|; g2f Lp og mad
fo5i: i §:F 3 peal
54583
> 38453 df5r
: 343 1 Sofi
cfd
Zg8iss otf fiqad
£53 :oOEir eff
effiff : hh igi
HIER HE
FHIEE IEE TR
E2s53f
£3322 IF
58: $33;
£3FF :& gi iii
8§afEE UW
358
HI 3 2 g
HEFT I TT I
i332 = 2 if:
 $8
2
2w
S =
©3
£28
£2
So

<R
ge EH]
52
so H1]
52
cS Fi
S93 y
2a %
23 52
o

$°
rg i
:
28 ;
gL £
o 8% H
=© it
Se

=
E E&
5 2%
za

Ea
= 3%, 3
jii
i

+= £8 i
©
§ 59
8VS IH
Hi
= Sg T
= 589 rt
2
oO
525
oad
5
A)
Ze
a

volll RGa
4 :
 From: ‘Cuts, Ca¥. COC/0DIONE)
To: anAnions;StareQyinta
Subject: adcoment
outer Wednesda,
Apr 14,2021 10:05:00
A
FY1..the contentthatwe thought would post last night, has not. Will be posted after the ACIP this
afternoon.
 From: ante cutsC0000KD)
To: Ent nn:Gatesi
I
Subject: ‘Siarto
hae:Cota
ontuses LewittSchen GENSUSIAOCOMFED):Ste,unGOSO0OMDE)
Baer rs oy8, 21 855507
Payton/Genele-
As mentioned, here are twoissuesweare seeing agreat deal of misinfo on thatwewantedtoflagforyou all~
vaccine shedding and microchips. Thesearejust some example posts. We do plan to post something shortly to
address vaccine shedding and | can send that lnk s00n. Ou census team copied here, has much more nfo on
tif needed,
Thanks!

Facebookand Instagram
[Potted Tuk
Screenshot thatreads: Foa year, | ilps.avs insagramcon/p/COTIZMISUN.
we were told that we need to
social distance and wear masks.
to avoid asymptomatic spreaders,
NOW, the vaccinated ARE the
‘asymptomatic spreaders through
vial shedding of their vaccine.
SWIPE: For weeks, t has been |Bip insagramcon pICOTQUOMIT
rumored that vial shedding from
Covid-19 vaccinated to Covid-19
unvaccinated people was the
cause of problems with women
and their menstrual cyces. Some
ofthese problems include
miscarriage.
Screenshot that reads: We now |Blps/avsninsagram
con/p/COUASNOAON
Know the COVID jab sheds. The
first distribution of this nightmare
went to healthcare providers who.
are now shedding on their
patients and then to teachers who,
are now shedding on our children.
Fitis being used for ips Tacchookcon (00 ASIST posi 262TSTIRAY
depopulation, then why are they
giingit to the key people ike
NHSworkers, carers, the miltary,
ec?
Fal these people end up dying
from the poison, then what?
Do the poisons have a strilty
agent that won't il the person,
but wil make the sterile thus
 reducing the population nthe
future?
Any thoughts?
Former VP OF Pizer Drops Tieacebookcom 72S RO HG po ARTTR 022562
Terrifying Bombshell On Vaccine
Scheme: “Entirely Possible This
Will Be Used For Massve-Scale
Depopulation”
hitosi/fw teapartyorglformer:
spotpfgerdrops.|
"Only ones really pushing these |Dips es.Tcehouk con22587 28 0S post TSS TLT1E
unapproved jabs are those in with
Gates Foundation that are behind
depopulation of the planet
Wo medica degree yet controls | Bsn magma con COSTOUSPL
the field of medicine? No
agricultural degree yet has
purchased LARGE quantities of
land? Father worked with planned
parenthood and was indeed a
EUGENICIST? So whats the goal
ofthese s Mr. Gates? The same.
a5 your fathers = Depopulation...
Or. Sherri Tenpenny Explains How_|Bp ses islagra con COVPScuDARL
the Depopulation COVID Vaccines
Will tart Working in 3-6 Months
Vacdne Shedding Causing TeTacshonkcon 109622TOSSpo ORTR SRO55
Miscarrages and Blood Clots in
Unvaccinated Females
Tors out Phe 01 tests and |Dipsoe.TcehookcomOTST5520posts[01SO T00000267102
found that the spiked protein can
“shed” (their word) and affect
unvaccinated peopl.
Are you concerned about being
around people who may be
unknowingly emitting the fithy
vaccine?
Seeing more andmore signs Tke |Hips ansTacehookcon[14 6306R02 post[TSTT6003007
this stores because of shedding.
Be aware that for up to four
monthsateryou getyourvaccine
You can really get others
extremely il Note: Fact checked
but not removed)
as anyone else heard of people_|Bp es.[chook com [0 005K [03 2ponNO[O00TSG6
that have gotten the Vaccine,
malig people tha didnt get
vaccine sicklaer being in close
contact with them)? Symptoms
suchas itching, migraines, bad
 tomas pls
ri
pr A
veea
Cn p—a oh
‘Stay tuned and follow “hutps:/wwwinstagram.conVp/COMIAVInHbE/

Furi, Terpeny, somony

a
reorient
weaver ete
tanga cnmrpgageta
remaducive rams Tre sO
Toot art cong

iHind
In a disturbing twist of the “hutps:/www
instagram.conVp/CNISSoDAAWO!

KA,
ei a aes
veri doe amon
pe
ES, AC ARTETA
‘SPIKE PROTEIN CONFUSION - V/ “hups://www.instagram.com/tv/COPDR
1aAEgm/

This aclp trom Amanda

Vobmeryra—
Doctor Yury ht pins
a —t
proms re medang eet
 From: ‘tot CotyO000OA)
Tor i cs:ike Oot
4 abot aie CO0DOIDNIRDD: strMstrFsgmaryCOCTDNDACIECDYKal Kista
Subject: Caan
NeeAo
VaceFnder COGwee
Date Trade,
Feb 25,202122900
Stanley/Jan — Just saw this after our 1:00 with HHS. We wanted to point out this new webpage we
just posted -AboutVaccineFinder. It would be great f this would come up higher in results
instead of our provider page(Vaccinefinder:COVID-19InformationforJurisdictionsandHealthcare
Providers). But also, | wanted you to see our resource on it if helpful in anyway.

Happy to answer any other questions and have copied Kathleen and Rosie, our vaccine experts here
too.
 From: Cao. CoralY.(00/00/00)
To: Toki ote
Subject RE: COG COVID19 80L0 ting
Date: Trade, dre 10,2021 71200A
Thanks for letting us know.
From: Todd O'Boyle <toboyle@twitter.com>
‘Sent: Wednesday, June 9, 2021 7:54 PM
To: Crawford, Carol Y. (CDC/OD/OADC) <ciyl@cdc gov
Subject: Re: CDC COVID-19 BOLO Meeting
will be on BX6) ext week, but 1 will see if another colleague from Twitter can join.
Best
0
On Wed, Jun 9, 2021 at 4:23 PM Crawford, Carol Y. (COC/OD/OADC) <ciy1@cdc.gav> wrote:
‘We would like to invite digital platforms to attend our 3rd short “Be On The Lookout” meeting on
COVID. Let us know if you have questions and feel free to forward this message to anyone in
Your organization that should attend.

Join ZoomGov Meeting.

(046)

Meeting ID: (0X6)

passcode THUR J
One tap mobile
US (san Jose)
Jus (New York)

Dial by your location

(san Jose)
©16) (New York)
(san Jose)
vera
(b)6)

passcode: (BY)

Join by SIP

(b)6)

Join by H323

(US West)
(b)X8)
(US East)

Meeting ID ®GI6)
passcode: EXE]
 From: ‘tot Coty.CO0ODOA)
Tor [rrr
‘Eton hava; boa! Becca(0/00/00)
Subject HeCOGspr eo: £0Cntort
Dut: Tut, ay11. 203 15000
Aachments: ExoCOD.12acmansssoKoso ssa cos
If you call can sign this we can move forward with the logo add. Thanks!

From: Genelle Adrien <geneleadrien@fb

com>
Sent: Tuesday, May 4, 2021 8:45 PM
‘To: Crawford,Carol Y. (CDC/OD/OADC) <cjyl@cdc.gov>; Dempsey, Jay H. (CDC/OD/OADC)
<ifbS@cdc.gov>
Cc: Payton Iheme <payton@fb.com>; McDaniel, Rebecca (CDC/OD/OADC) <Idy8@cdc.gov>
Subject: Re: CDC approval requested: FAQ Content
‘Thanks, Carol! This is great feedback. The proactive comms was in reference to this new FAQ
module
Speaking of the logo approval, the action page is live here:
httpsi//aboutfacebook
com/actions/responding:10-covid-19. And, we wil add the COC logo once we.
have your go ahead.
Thank you—
Genelle
From: Crawford, Carol Y. (CDC/OD/OADC)<cil@cdcgov
Date: Tuesday, May 4, 2021 at 7:53 PM
‘To: Genelle Adrien<genelleadrien@fb com>, Dempsey, Jay H. (CDC/OD/OADC)
<ifbS@cdcgor>
Ce: Payton Iheme <pavion@fbcom>, McDaniel, Rebecca (CDC/OD/OADC)<ldyA@cdcgov
‘Subject: RE: CDC approval requested: FAQ Content
Hi Genelle- one Qwas fine but our SMEs said the below on the other question. Also, just to check ~
was the proactive comms note about the item I'm getting the logo approved for?
From task force:
1 would sugges ©E plus correcting the lst as
shown in red). For that bottom text, the first sentence is duplicative of the bulleted list

©)
 Centers for Disease Control and Prevention/CDC
Trademark License Agreement—Non-Exclusive

Trademark License Number:

Licensee: Facebook Technologies, LLC
This Agreement (“Agreement”) is dated as of +20__ (“Effective Date”),
between the Centers for Discase Control andPrevention/ ATSDR, an agencyof the Public Health
Service, located at 1600 Clifton Road, Atlanta, GA 30329 (“Licensor; PHS”) and Facebook
Technologies, LLC (“Licensee”; collectively, the Parties) located at 1601 Willow Road, Menlo
Park, CA 94025.
Recitals
PHS is the owner oftrademarks (“Trademarks”) as identified in Attachment “A,” and the
‘goodwill associated therewith
The Trademarks are used in association with public health/safety messages, training, or
communication initiatives that support the mission of Licensor, which is “Collaborating to create
the expertise, information, and tools that people and communities need to protect their health —
through health promotion, preventionof disease, injury and disability, and preparedness for new
health threats.”
Licensee desires to use the Trademarks on and in connection with jointly developed public
health/safety messages, training modules, or other communication initiatives, as identified in
Attachment B, as a co-brand with Licensee’ brand.
‘The Parties are entering into this Agreement to confirm the basis upon which Licensee is
permitted to use the Trademarks.
NOW, THEREFORE, for good and valuable consideration, including the mutual promises and
covenants contained herein, the receipt and adequacy of which is hereby acknowledged, the
Parties agree as follows
1. Grant
1. PHS hereby grants to Licensee a non-exclusive, non-transferable, royalty free,
license (“License”) to use, reproduce and display the Trademarks on and within
Internet pages, visual presentations, or written materials solely in connection with
thejointly developed public health/safety messages. The License is for non-
commercial useofthe Trademarks only. The Trademarks may not be used in
connection with any other goods or services without the written consent of PHS.
2. Licensee shall only use the Trademarks on or in additional products or services
other than those identified in Attachment B after such use has been approved by
PHS, in writing, in response to a writen request by Licensee.
2. Term of the Agreement: This Agreement will begin on the Effective Date and will continue
fora periodofthirty-six (36) months or upon expirationofthe use described in Attachment B
or any subsequent approval under paragraph 1.2, whichever occurs first (“Tem”), unless
terminated earlier in accordance with this Agreement.
3. Termination: Licensee shall have a unilateral right to terminate this Agreement by giving
PHS seven (7) days written notice to that effect. PHS or Licensee may (without prejudice to
any other right or remedy) terminate this Agreement (a) at any time upon notice in writing to
the other partyifthe other party is in material breach of any obligation hereunder and does
not cure such breach within seven (7) days of being requested in writing to do so; or (b) upon
notice, where the Licensee's useof the Trademarks is the subject ofa legal claim. The license
to use PHS's Trademarks will cease within three (3) business days upon the termination or
expirationofthis Agreement. Licensee agrees to remove any Intemet page contentifin
PHS's sole discretion such removal is warranted, and to destroy all material bearing the
Licensed Trademarks. Licensee shall provide PHS written confirmationof such destruction.
Notwithstanding, Licensee may, at PHS’s discretion, distribute stocksof co-branded
materials existing at the timeoflicense termination unless Licensee has materially breached
this Agreement and failed to cure such breach within thirty (30) days written notice by PHS.
In the event there is a significant change in the scientific research or data reflected in any
product using the Trademarks, which PHS reasonably concludes renders the content
substantially inaccurate, PHS may notify the Licensee in writing. Upon receiptof such
notice, Licensee shall, prior to producing any further such products update the content of
those products. Failure to provide such update will result in PHS's terminationofthe license.
‘granted with respect to such products determined by PHS to contain scientifically outdated,
incorrect, or harmful content.
4. Permitted Use; Standardsof Quality; and Approval: The Licensee will only use the
‘Trademarks in conformance with the policies, specifications, regulations and standards
authorized or stipulated by PHS and whose character and quality is not altered by the
Licensee without the authorizationof PHS. License is strictly prohibited from using any
materials including the licensed product to promote any political party or affiliation or for
lobbying purposes. Licensee may not use the Trademarks together with any content that is
unlawful, defamatory, infringing, obscene, fraudulent, hateful,o racially, ethnically or
otherwise objectionable in the sole discretion of PHS. Licensee may not use the Trademarks
for any commercial purpose or to endorse or imply endorsement of any entity, product or
service, including Licensee. Licensee agrees to adhere to the trademark usage guidelines
illustrated in Attachment A. Licensee shall submit for PHS's approval at least one sample of
ach product using the Trademarks, including any product to be made available through the
Internet, packaged and labeled in the form proposed to be marketed, at least twenty (20)
business days before actually marketed. Licensee shall use the Trademarks only as specified
in Attachment B or as otherwise approved in accordance with paragraph 1.2.
5. Trademark Control: Upon request by PHS, the Licensee wil provide PHS with
representative use(s)of Trademarks. Useofthe Trademarks on goods or services other than
as covered under this Agreement or in a manner inconsistent with Licensor's Trademark
‘Guidelines or paragraph 4 shall constitute material breach of this Agreement.
Notwithstanding paragraph 3,if such material breach has not been cured within five (5)
business days following receipt ofnotice from PHS, this Agreement will be terminated.
6. Ownership: Licensee agrees to use the Trademarks only as stated in this Agreement.
Licensee agrees not 10 use the Trademarks in combination with any other trade name,
trademark or service mark without the prior written approval of PHS. License acquires no
right, title or interest in Licensor Trademarks or the goodwill associated with them, other
than the right to use Licensor's Trademarks according to this Agreement. In accepting this
Agreement, Licensee acknowledges that as between Licensee and PHS, PHS is the owner of
the Licensor's Trademarks and Licensee agrees not to use or applyto register any trademarks
which include a Licensor Trademark or any trademark, service mark, trade name or
derivation confusingly similar to a Licensor Trademark, in any country or territory during or
after the termofthis Agreement. Licensee will not take any action in derogationofany of the
rights of PHS in any Licensor Trademarks.
7. Copyright: Contributions by US govemment employees in products bearing the Trademarks
are not subject to copyright in the United States.
8. Indemnification: PHS offers no warranties other than that it owns the Trademarks. No
indemnification of any loss, claim, damage or liability is intended or provided by any party
under this Agreement. Each party shall be responsible for any loss, claim, damage or
liability it incurs.
9. Assignment: The License granted herein is personalto Licensee and Licensee shall not
assign, sub-license, transfer,orotherwise convey Licensee's rights or obligations under this
Agreement without PHS's prior written consent, such consent of PHS not to be withheld
unreasonably.
10. Survival. The parties’ rights and obligations, which by their nature would continue beyond
the terminationof this Agreement, including, but not limited to, indemnification and actions
affecting the enforceability of the mark, shall survive such termination.
11. Partial Invalidity: The provisionsofthis Agreement are severable, and in the event that any
provision of this Agreement shall be determined to be invalid or unenforceable under any
controlling bodyoflaw, such determination shall not in any way affect the validity or
enforceabilityof the remaining provisionsofthis Agreement.
12. Entire Agreement: This Agreement supersedes all previous agreements, understandings, and
arrangements between the partis, whetheroral orwritten, and constitutes the entire.
agreement between the partis regarding the subject matter herein.
13. Notice: All notices required or permitted by this Agreement shall be given by confirmed
receipt email or prepaid, first class, registered or certified mail properly addressed to the
following:

1. For CDC:
Rick Hull
Health Communications Specialist
Centers for Disease Control and Prevention
4770 Buford Highway K80
Atlanta, GA 30341
770-488-5055
 fh @ede.gov

2. For Licensee:
Julian Nagler
inagler@fb.com
Witha copy to:
Email: Legal-Notices@fb.com
Attention: FB Legal Notices

14, Trademark Notice; Non-Endorsement Statement: Licensee agrees to place the following
trademark notice on any product, communication, item, or Internet page that includes a
Licensed Trademark: “The mark ‘CDC” is owned by the US Dept. of Health and Human
Services and is used with permission. Useof this logo is not an endorsement by HHS or
CDCofany particular product, service, or enterprise.” The notice must be placed in
proximity to Licensed Trademarks.
15. Waiver of Rights: Neither Party may waive or release anyofits rights or interests in this
Agreement except in writing. The failure of PHS to assert a right hereunder or to insist upon
‘compliance with any term or condition of this Agreement shall not constitute a waiver of that
right by PHS or excuse a similar subsequent failure to perform any such term or condition by
Licensee.
16. Non-endorsement: By entering into this Agreement, PHS does not directly or indirectly
endorse Licensee or any product or service provided,or to be provided, by Licensee whether
directly or indirectly related to this Agreement. Licensee shall not state or imply that this
Agreement is an endorsement by the U.S. Government, PHS, any other U.S. Government
organizational unit, or any U.S. Government employee. Additionally, other than the use:
specified in Attachment B, Licensee shall not use the names of CDC, PHS, or DHHS or the
U.S. Government or their employees in any commercial advertising, promotional, or sales
literature.
17. Dispute Settlement: The Parties agree to attempt to settle amicably any controversy or claim
arising under this Agreement ora breachofthis Agreement. Licensee agrees first to appeal
any such unsettled claims or controversies to the designated PHS official, or designee, whose
decision shall be considered the final agency decision. Thereafter, Licensee may exercise
any administrative orjudicial remedies that may be available.
18. Modifications: Ifeither Party desires a modification to this Agreement, the Parties shall,
upon reasonable notice of the proposed modification by the Party desiring the change, confer
in good faith to determine the desirabilityof such modification. No modification will be
effective until a written amendment is signed by the signatories to this Agreement or their
designees.
IN WITNESS WHEREOF, the parties have caused this License to be executed by their duly
authorized representatives.

For PHS:

Signatureof Authorized PHS Official Date

Juliana Cyril, Ph.D.
Director, OfficeofTechnology and Innovation
Centers for Disease Control and Prevention

For Licensee:

Signature of Authorized Licensee Official Date

Michael Abrash
VP, Facebook Research
Authorized Representative, Facebook Technologies, LLC
 Attachment A ~ Trademarks
Color
The oficial COC logo colori Pantone 286 blue (CMYK: 100, 6,0, 2 RGB: 0,3, 170) or blac.
Substitution of COC blu or blacks prohibited. The blue i acceptable for use on color material and the
black is only acceptable for black and white or spot color use or when the partner logo is also presented
in black and whi.
Alignment and spacing
Separate the CDC logo from the partner logo by a minimum of 1/2 the vertical measurement of the COC
logo excluding the COC logo tag ine).
nx

Fe
3 Re
minimum nr]
TT Em
SIRE ae Sabin wr

buffer area of “1/2 around the CDC logo should be maintain freoftexto graphics.
Partner use of the CDC logo on a Web site or Web page:
& The logo should be placed near the bottom of the partner's Web page.
~Thefollowing trademark notice should be placedproximatetothe logo “The mark ‘CDC is
‘ownedby the US Dept. of Health and Human Services and is used with permission. Use of
‘this logo is not an endorsement by HHS or CDC of any particular product, service, or
antarpie”
- The logo should be used at a minimum of 35 pixels in height and a maximumof45 pixels in
height, with proportional scaling of its horizontal dimension.

Appropriate relative sizing

Ona vertically-oriented document the logo may occupy approximately 1/15 of the vertical grid. On a
horizontally-oriented document the logo may occupy approximately 1/12 of the vertical grid.

|
I
Ld ]
Legibility over a background color or image

The same is true for the black version. Do not use a drop shadow, halo effect, or add
acolor frame to

Ivr Al, Whsstostn

Examples of inappropriate
logo use

em
mpm i
upc ol CDC
Wr RH
 Attachment B — Covered Use
(sample covered use, showing where partner and PHS trademarks will go, per trademark
usage guidance in Attachment A, and with “Trademark Notice; Non-Endorsement
Statement” provided in paragraph 14. of the agreement.)

oe 1 Helping 50 million people

3 JA find the vaccine
4 ' information they need.
CL AI TN vcr os poi sy toue
. Facebook and Instagram tafind when and
of KS FAO crc they can makeavaccineappointment.
° Ng 2
NATED, ©) FinaCOVID-19vaccinesitsmoa you »

= 142,692,987
 ©)

From: Genelle Adrien <genelleadrien@fb

com>
Sent: Tuesday, May 4, 2021 9:19 AM
To: Crawford, Carol . (CDC/OD/OADC)<ciy1@cdc.gov; Dempsey,
ay H. (COC/0D/0ADC)
<ibs@cdcgor
Ce: Payton Iheme <pavton®@fbcom>
Subject: COC approval requested: FAQ Content

Hi Carol — Hope the week is off to a great start. Our content specialist, recently made copyedits to
two CDC questions for our new FAQ modules appearing in the COVID-19 Information Center.

Theseare fairly minor edits to what you've already provided, but if you have additional edits, could
you please let us know by COB if possible?

‘Aquick not that our new launch date s 5/17. We are not planning any proactive comms at the
moment, but if we do, we will let you know and coordinate accordingly.

Thanks and et me know if you have questions!

Best,
Genelle
From: ‘CavtordCaraY.(CD0/0D/0ADG)
To: ‘aontbama
Subject: RE:Heath ulyStategymentioned onthe call
Date: Thursday, Apr 15, 2021 3:48:00PM
CDC COVID-19ResponseHealthEquityStrategy|CDC
From: Payton Iheme <payton@fb.com>
Sent: Thursday, April 15, 2021 3:15 PM
“To: Crawford, Carol. (CDC/OD/OADC) <cjyl@cdc.gov>
‘Subject: Health Equity Strategy mentioned on the call
Can you send (resend) just in case | don't have this?
Best,
Payton

FACEBOOK
Payton Iheme.
USS. Public Policy
‘Eacebook
 from: Sant Ga.0000/0800)
Tor Sui,Gea
= rym
Subject: Redcar
one: Wes, Aor 14,2021 1230900
We ended up posting some new info, have some FAQs going up (likely before ACIP or during) and
then updates from there.

butosi/u
soulcoronavirus/2019:ncouvaccines/safety/iadate
cc ham

From: Staniey Onyimba <sonyimba@google com>

Sent: Wednesday, Apri 14, 2021 10:32 AM
Tos Crawford, Carol Y. (COC/0D/0ADC) <ciyl@cde.gov>
et Jan Antonaros<jantonaros@google com>
Subject: Re: J8 content
Thanks for letting us know, Carol.
On Wed, Apr 14, 2021, 7:03 AM Crawford, Carol Y. (CDC/OD/OADC) <giyl@cdc.goy> wrote:

FYL..the content that we thought would post last night, has not. Will be posted after the ACIP this
afternoon.
 From: ‘Sand.Cd. 000/000)
Tor Eaton hana
co Comey
ego:
Subject Eoof owGane ported tan: Dancy, ny (OSO0A00)
Outer Wain, Ae14,2021 123300
Sorry ~ theAdvisoryCommitteeon
Immunization Practices that will meet to make
recommendations on next steps related to this pause.

From: Payton Iheme <payton@fb.com>

Sent: Wednesday, April 14, 2021 12:31 PM
To: Crawford, Carol Y. (CDC/OD/OADC) <cjyl@cdc.gov>
Ce: Chelsey Lepage <chelseylepage@fb.coms; Genelle Adrien <genelleadrien @fb.com>; Dempsey,
Jay H. (CDC/OD/OADC) <ifbS@cdc.gov>
Subject: Re: 18 info now posted
Thank you.
Whats ACIP?
From: Carol Crawford <cjyl@cdc.gov>
Date: Wednesday, April 14, 2021 at 12:29 PM
To: Payton heme <gavton@fh.com>
Cai Chelsey Lepage<chelseylznage@fhcom, Genelle Adrien <genelleadrien@fb.com>,
“Dempsey, Jay H. (CDC/OD/OADC)" <ifbs@cdcgov
‘Subject: J&) info now posted
First page is up, some FAQs are in process of being added. | expect more updates after ACIP.

httpsi//wenw
cdc.gov/coronavinus/2019-ncov/vaccines/safety/l)Update
html.
 From: ‘Canto,
Goa¥.(CO0O0/0A00)
To: 23aGant
I Eatonhans:Sct aba
Sublect Re etn toy
Date: dn,Decanter 18,2020TASOOP
Attachments: COW 19icin cusrcs.ToonEula
Not exactly the same thing but | was able to get my hands on this. | hope it helps!

From: Priva Gangoly <pgangolly@fb.com>

Sent: Wednesday, December 9, 2020 3:20 PM
To: Crawford, CarolY.(CDC/OD/0ADC) <ciyl@cdc gov>
Ce: Payton Iheme <payton@fb.com>; Rosalyn Mahashin <rmahashin@fb.com>
Subject: Re: Meeting today.
ve atached the study here! I think it was among the flu resources the immunization team had
shared with us this summer.

From: "Crawford, Carol Y. (CDC/OD/OADC)" <ciy1@cdc.gor>

Date: Wednesday, December 9, 2020 at 11:55 AM
To: Priya Gangolly <ngangollv@fhcom>
Subject: RE: Meeting today
Can you remind me which study you are referencing? Its not hitting me.

From: Priva Gangoly <agangallv@fhcom>

Sent: Wednesday, December 9, 2020 2:46 PM
To: Crawford, CarolY. (CDC/OD/OADC) <ciyl@cdc
gor
Cc: Payton theme <payton@fb com>
Subject: Re: Meeting today.
One question | forgot to add from the team ~ has the COC done a quant study for the COVID -19
vaccine (similarly to the one you shared with us for iu)?

From: Priya Gangolly <pgangollv@fhcom>

Date: Wednesday, December 9, 2020 at 11:40 AM
To: "Crawford, Carol Y. (CDC/OD/OADC)" <civ1@cdcgov>
Ce: Payton heme <pavton@fh com>
Subject: Meeting today
 a
o

Be i
- :i
< ::
£ i
3a ii
uo :
© {
eg
iE
9 g8 5

EZ S g
a ©

£9 8 8 i
8; Sa
SA «© zgE i
§ gs uw EO:
¥
a 2
EO «~ TI EE.
$ gs:
ENE
k=]
bl [
=
wn
S :5 £21
o 2
2}
ER
hE
“2
a5
@
=
2528
S=&8
fi = c= < €8ga
:
£ 5 S
58%:
ER ESRS!
z=
Pe
© 5
cm
= EESS
SEE :i
£5
a= w c Os2E&
Sie|
SES o =zalo
Sot EE
ES §
SE c SES T :
FA = £2588
52
ie) g
Oo gwST8
25558:
ge
bp = SEsg2
= Qo Zo
el E50 % |
Sc
8 & 52285
Sz g88
in
Fa 5S Ww .
fegeee
1 SEE
fo EERS

LE 38228!
 =
a
=
=
3
wv 25
Qa
2
=
5
Es
=T 3
gS &
3> ®co2
72a {3
[2

2vo 32
32
3z
£
2
£Sw
O 3 So
es S <
= 2 a 3
5% 92
28¢
® © 23s
3 £8
og
Ls g
Og5%
2
© E oc E
27 E28 8
32
E ®° 5£©» 4
ch
o ES] vs co
0 - 2 0 wu
c 2 SE
°
o
5w 88 £2E 38 982
= 3 2 ga 2 0
3 eee £82
3 2 0 — ©
es £8&= © © 8
< Bel c cB
e ege £82
© gE BEE
0¢
Q ©
OC>EQR
22T
0 TT 7
wn x0<0
cc g
Q al 11 22 4
oc . a = ow
 ©2
5 >
> c

g 3
< £
o o
3 o
zz
= <
E [7
3 £
ag =5 3
ez
Sg T
£ =

1:
S — 3 °

e£3 oo§a of
eZ
gS 2,58 53
2 IS
§ Ssc 8
52d §
LC 28%
Es 82%» 8<
ag gf
g 283 SES ES
23S Big
os a S33
5852 %gd
> 3 9s8Y geg2
£858
5 38% 8 £23
& Joss £8523
Sa5
a | 3%
<3 gsi 8g
oEEE
SAN 8st S 9s ENG: ESx
£
£8188

fips
5.888%
=
g3 2g
3 3
Sid
25% ov E
Sc
w3
gz ER
mg £5 ES
,£2 $58:%: SE:Eg
8s
Q SK a= c E¢ 3

33% S83 Eg
S S%t E£S3 Exess
825
3 Ss
E
= G55
883
ssf
£58, =
3 © 223 a 3
= oes oislgsiag
g S3sfsstzé
253
FR - 8% 8 &
g%5233433
"= = PE=
 @
je)
=
s>
z
> [7]
°
. 3
gI< £2
2© §
&> 3
ao |:
zg
: Z 8Qo
a gg
58 5%
£¢ i
5s =E ig
x 5
:
£9
:
: 3
— E $3 3
5 8
g 5i LR Poi £31
c
g Gera IEEE 22 E Ft
[7] oSEgS gd
ares
n
§2252 352353:
o SHERIEE
2
2
n 1H
THERE EE
ge8sg
£88525
gd

=£ > TER
225%
o .
seiihggits
- A .
 3 s
2-~-R-E- Flea

Nl
fA -
EgI S©
HE - ISl-0=
«- B= =
Fl
=
gH
s B
b5
£
El =
E
££
3 om ow omo
om om oF
=
3
g
7)
c

£ a4a FE
FE
EH$
& HEE
CE AEE
wv HERE]
o EEE
EEE 5 |£ [2
O EEE
c BHEHEEEEREEEREE
El1B |B B|5 (2 |&
0 EEE
5
T HFRERERHEREREE
HERE ERE
5 HREEREEREE
EA EE ERERE EE
< EIREEEEHEREEEE
2
o <
E :
o = 2 :
© s 3 i
> 8 : ii
Lo | 7 :
= g 8s
ii
a E 3 i
SOo
3 §2 3
Ez : %
FE
[EE
H
oO : :
> 3g 243
8 5 589

2 g <go£8
o : 5 c
on < : 11
: : 2 & 3E
[7} : ij
— =
=2 5i

"BRE i
2 £ ;
2 &
00 i:
£3

ss
e & g> i
i
= 8 ? cH
yi
oO Zz :

5
wv

c
iz¢ t
2t 2
58%
585:
£
5d
ie
55 :5i3 88
if
:

>
s
&
= £ sizes
iigiiit
213
Hel ¢
4 fEsi
E35 & ©
T8885
Ee
538
<
<
.
 2
Qo
5
3% 2
SE g
S| ® :
gg
sl
:
z
S| = : :
ol © : :
ov 2 §7)
££ i:©

S 3
: &
i
gt 8
rd o

3 Fs
a
Q qa Ti
| :
Bs
, 3Sea
FE y:
S 5
z
§
©
:
:
: : : :
©
oS =8
© 13=
c
si
®
§
IIS
E
if
fg
=$Y
¢
: 2
®
g3 & |§:
£ gif
53 : :
o 2

i: - zt : 5 £88
:
3
> 3 =
:
1s
5: 53 £8
:
8

= § 82
g=. sd
|
EE
£8 g 8
5 5:
co &

“3g s2 92
o ©2%
<
ge
1
EXT
cc
£3
P=
Sty
°1 iE
RIE)
g
ec
Ey3
Wo 2 2s E35
c no :
grist
ux §
2
£ ££ 5i
£2Ine 3
2 a £ geil £
c gt
Eile
2 8%7 3&t :
52
=
|
=
gz ifseis
[I
fglfiaisi:
=. o $233
28
eg woE
. u
F333
 .3 1g
. 3

3Po
1
i: 12
5s
SH
I
g
=
fz
5
©
5

© i
2 : H
£3 3
6 g 5
Se g i

© 5 - ;
££
=
QU
£5
2%
££
<
]:
z

£2 Ee
gg
& 2: :
> 5 £

o 5
3: & ::
eSo 2c
£2 0%8 5:
c e 2 5
g£
5
3 :
:
&
°
IEez
0 = c gL£
25
i
©
sc $
R=
83
c
= 5%
JSES 2S;
FgZ=8
So a
<
34
wv
>
 <
] 5
: 2

= 5 :
o
S
:
5
S n
2 5
a 3
: ; 4 ;
i 1 £ |
| 5 :
«53 i:
a 8 538
i
s oP :
Oo
:
£
3g
11
TO a

oO gvn 3 :

s sii
:£ 0 z

°c 8
§5 Sf
E32 (7)
g
i
:2
s fe
2 £2%%
s
g =
gf
2:
0 9 3
5
£258
Lad
LoSs s
3
a
gE i:25 :3E £558 3%:=
:
gg8s
1553
:
£ i:
5
ot ®

< it
GB {oo £82¢
1
558 i
g
2
< ES
£e8s §
i
if
o£ 5 £858

£250 3
5 SES2
: 5 5
£53 go ¢ :
Lo
© LE8 5/5 OL ® £3
of
- 3 £ 2 > :
gis2
2
9 as 25
5 5g Se
5
|
o Ex %®lS
z= | 2 s,8%
£538 558
—
a 23 55 i
(550% 35:
23 gis
838 ES
© v5

3 EERE
5 7=3 fr 8s
EE
figs
~ 2 jit
TTT
ag . 5
<
EE 522k
= g3%
.
 c |x
E «3%
S | ©
oc |§ =
> S =
on
§
|
3
7

2? |g §
a> |§f¢
8
“- Q g
£5
s £2
EE® 22gs|B
So
- |°
ec 2
o

[Ta
5£2
5 &
T°
wn Cc
5s
LoCT ww
Cc
sS 2
> E
cs ©
So
wn Q iE
5
BS 32 :
Ld a2 5

8
o
= -
53
go
=
g,p%
L£,¢%
= 2 g=<
° © 6 Sox =
T o 2u50
TcQ
oe =
3 S.,53:¢
2° 5 8 aE ES
2522
eC noc lER
= 8 2° E_-53
S
8 = 228E:2%
E og ae
S BOs Lul
=
 =2E
=22
23
g=

Fe
gEX
58

o £5 E 22
FE
2 5fk ] > s
2% }
2 1
g SEe 5
gi: : EQ :
Oo Si :
AE
i
® £gd : @g £2
> ge >2
2 sf558:
11118 i
g
i
gg
2888s
x S 5
il
wn
c 5521
© af
2:23
<=
3 2
z =
8c 58
get ? i 4 |

= 1 5
58 if
3
gogt
[7] 2gEst
2235s os 1
oT
«0 _81i¢}
a if 1]
id
giEil? 5:
geist
5%
f25=%}
5 Sele
gefiis 12131
Qo $3
> Baise
SicEds i
3écis
Q ro 3
disit
t | TT3i
x giepss
. - i
 g a
a
2
=1
2
© g 1
it
Oo : :
- 3i
2 £4 |
|
c 25%oo |
£ EA Is
“= F323
w
i
2© HiH
ER i
Bpt
i
a £32
i HE
i
8 H
2258
|
il
i
o fo ]
© 28%
[-3 i8:t
o
190% -
5Q iH
o
2 11
1nd) |
0 ml
:| SiH
ni
iisi
:
3 Ei
iid
Fi o oe
o
& ji
ii
(sist
S
S Biz its
3108
Eire& <
S - bist
ge
5&2.
 w
£3
& So
3
By £
8 So %

g
[=}
Es
SE
:
5
zwn
>
;
a=
- 3
o
=
® ci 33
£
© 98%
7 OCB g
s
z 2%;
32s o g3
£Sy gae 2::
I 3 5

C8
ga Loo Se
§2
2s
83
33%
3 } ge
c 3
5°
2 £83 : 8
z
22

80 seit :2
. Bix
= 8252
ge 6 E 3
° 2
5 Flas
353 zg ek
eg 373
38
:
S| & 3 £523
80
— EER £3 £3
@
3- giz Erg: 82
FER
5% cls
588%
& EEE 8 SE LE
g 5
3 8
S Jee §2zso gE
Oo 525 9:88S
Y= S23 88538 £3
yak
° Beldceed
0 BoiuTgaz fis

safari:
g5€s giegii=d:
Hts
x
5EERE
+=
589% g=z2
° IF
€

FQ
3

I all
2
£

=1
.
 s
s :
§5

t§a BL
1
ie

&
a 1
iH
Q :
:
Q
ec gis
I
g
H
i
:
2 2i
: i (fg
:
©
3 i
5 2 23
2 : Bs
3 2
!3g
2 ?c
S E
£$ S3
2
: 5 g i
LQ

® c :
s :

:
IE3
£
I
53
£ 38
iL
gE
¢
:$5
3
g £
2
I] §
cg ER
13 2 ER)
53
53
5 ‘
: 5 £
i:
52id 8§ zz 3
i
E 3
fe i: :
5 n

£9 gg 22 1
fi
2 £8 gg
= TT
2 28 fo 8 :3 E
I
58
S & 28 sig £8
: i
,53 6 3 i
2
£
frisaiid
2 £8 S $f 3
§ 853
foros 1
= Epi; Ey 1
ESE E tz I:
§ E38 m2 §
[7]
S ®cl iE
1: 1
ff
[4] S 55% igs
p82
o t5ai
=
5
5 $52
£33 2x
2§ 530 SEE
Bs:
85: 8
:025 TRIER
il
Bszgs FE
$i:
3st
3 a xa geo ‘ *
.
E2575
Iz Il 2442
 - Q
$s ©
2
8 &
8
g e
3 [9]
s 5
: 2
g 2
2
- 8

QL g i

£
= €
z
=
o£
:

3 £ ; :

s |: :
5
: 2 tai3t
a E : 3

2 g 15
o z8 gsd2
e
xX g Hn
w z i]
Se 5
niis
u
< 1.3855
fils
oO
gifs
: 2 :
:
o- iz
ffs1
Se
! Iziigl
EJ 83
>
:
ww fiir
1H
Til

« iii
fEilii :
S AEE: £12
Ss
a
SES
: 15:
8
iil, b+
:

|
= P5588
Hit
- a $
 =5S 2=
© °o 2

:
a
a 2Z
z
Z
:

g E 2
© S g

=
[9 2 :
| ]

. is g
&
<
§
53
<
§£
[7]
:

a £ ;
5 2 1 o
-
%
: 2
: :
fey 2 3ce
i

s 5 n
1: ¢
:
S, E :
he] >
© fgril:
2zgeiis °:
@
:
3Eefsis
Flags
:
©
HH
>
© ghee
2
§
sfEtcs
Festi

S 3
2
g
er :
:
Q figs;
SEiinis :
ic:
(C 1igc
£8 £3
~
i 2 :
Q Sang :
~ TEE
S32i51 :

3 iiilie
Hisg
£ Eile
“580353
ES E83
<8 &
< fi
- HEHEa
 o
N o

Fl.
nl
3:
$3
33
> Fl
o
a > §
i:
J © :®
5 9 52
D.g id
® 8 is
S
IT
XN
ii
ogBE i:
£5
> wi FE
cw Ea
rr
wn
52
Fa
£523
Qo is3
Eg
ph $1
S
= IE
i:
I
© O 1:
re i
EX
>
i
i:
& ii:
5 Es

§ £8
? B23
FE
Hi Carol,
It looks lie Payton has an urgent Policy meeting during our time today and | don't have any updates.
to share either (beyond the email sent you last night on Learning Units, whichwe can discuss at any
time over email or at our next meeting if you need more time).
Would you like the time back today and we can cover any questions you have async?
Thanks,
Priva
From: ‘Smuts. Ca¥.COCIODIONE)
To! pry
Subject RE: Rogues for paso accounts
Dae: FrayArk, 202121400PM.
Yes, we'll get that to you early next week. Thanks for checking in.

From: Todd O'Boyle <toboyle@twitter.com>

Sent: Thursday, April 8, 2021 8:28 PM
To: Crawford, Carol Y. (CDC/OD/OADC) <ciy1@cdc gov
‘Subject: Request for problem accounts
Hi Carol -
I'm looking forward to setting up regular chats; my team has asked for examples of problematic
content so we can examine trends. All examples of misinformation are helpful, but in particular, if
You have any examples offraud - such as fraudulent covid cures, fraudulent vaccine cards, etc, that
‘would be very helpful
Thanks in advance,
0
 From: Saas ar1 cOI0DIOMDK)
To: Lo acon) toaPte orp: noSans;Sale Cos
oo a Gata Jnrons
Subject: RE:Stang recordCOD ptefrom OO
out: Today,Decin 1,2020 81500A
Great, thanks!

From: Lee (Hadlow) Halloran <Ihadlow@google.com>

Sent: Monday, November 30, 2020 12:29 PM
To: Crawford, Carol Y. (CDC/OD/OADC) <ciyl@cdc.gov>; Peter Murphy
<petermurphy@google.com>; Jono Sadeghi <jsadeghi@google.com>; Stanley Onyimba
<sonyimba@googe.com>
Cc: Garth Graham<garthgraham @google.com>; Jan Antonaros <jantonaros@google.com>
Subject: Re: Sharing a recent COVID update from COC
+ Peter and Jono from theYT COVID Promo Support Team
carol,
Jono will take the lead in ensuring we have al the necessary assets to help promote the latest Expert
QA video.
Please keep us posted on any new videos from the COC and thank you!
Lee

On Fr, Nov 20, 2020 at 3:40 PM Crawford, Carol Y. (CDC/OD/OADC) <ciy1@cdcgov> wrote:
Lee/Garth - Just letting you know we jut posted ths new ideo if here is any interest in sharing it
further on YouTube's end. Trying to ge the scence out there!

Also, when we had the meeting with you and Garth, you al mentioned a 1 pager on expanding
‘our work on YouTube but | never received it - is there more to share? Just checking,
Lastly, thank you so much foral the assistance on the college influencers. Weappreciate the
special helpyou are providingus aswe navigate this new territory.
Thanks.
 From: Cuts. Can¥.COCIODIONOE)
To! [rey—
Subject RE:Thursday mostig Ask or phon an textingrtd 0 vaccines.gov
Dae: Tuesday,May18, 2121 81100At
Carrie~ just wanted to check to seeif there had been any reconsideration ofincluding this
information on the information panel, etc. | know you guys were not planning on it per our
conversation on Thursday but you mentioned you'd double check given the information|provided
on the call
Thanks,
From: Payton heme <payton@fb com>
‘Sent: Tuesday, May 11, 2021 11:45 AM
Tos Crawford, Carol Y. (CDC/OD/OADC) <ciy1@cdc.govs; Carrie Adams <carrieadams@fb.com>
Subject: Re: Thursday's meeting- Ask for phone and texting related to vaccines. gov
Apologies.
Just saw the heading...)
Thursday itis!
Best,
Payton

From: Payton lheme <payton@bcom>

Date: Tuesday, May 11, 2021 at 11:32 AM
To: Carol Crawford <giy1@cdc.gov>, Carrie Adams <carrieadams@fb com>
Subject: Re: Thursday's meeting - Ask for phone and texting related to vaccines.gov
Thanks Carol.
Helpful
D0 you want to discuss Thursday during our sync or set up a different call sooner?
Best,
Payton

From: Carol Crawford <ciyl@cdc.gov>

Date: Tuesday, May 11, 2021 at 11:30 AM
To: Payton heme <payton@fb.com>, Carrie Adams <carrieadams@fh.com>
‘Subject: Thursday's meeting - Askfor phone and texting related to vaccines.gov
Payton — | was hoping to discuss how Facebook/Instagramy/Etc. could help WH/HHS/CDC to promote:
the other ways to access the vaccinefinder (vaccines.gov) call and text numbers? WH/HHS asked me
to reach out on their behalf for
al of us.
Thanks!

Text your zip code to B16]

cl ©6)
 From: Sant Cd. 000/000)
To Marni
Lohr TodOo
ps MinDora Ooms.Ln.CO010010800 ee rime
Subject RE: Vacors Monat
Dut: Tuy,Maen23,202112:11:00.
Hi Todd & Reggie ~ wanted to check back i to see f this was possible?

From: Meredith Lightstone <mightstone@witter.com>

Sent: Friday, March 19, 2021 2:22 PM
To: Crawford, CarolY. (CDC/OD/OADC) <cjy1@cdc.gov>; Todd O'Boyle <toboyle@twitter.com>
Ce: Megan Dorward <mdorward@twitter.com>; Dempsey, Jay H. (CDC/OD/OADC) <ifbS@cdc.gov>;
Reggie McCrimmon <rmecrimmon @twitter.com>
Subject: Re: Vaccine Misinformation
Hi Carol | am adding in Todd and Reggie from our Public Policy eam who wil coordinate next steps.
Many thanks,
Meredith
On Thu, Mar 18, 2021 at 9:12 PM Meredith Lightstone <miightstone@twitter
com> wrote:
Hi Carol and Jay, this sounds great! | will chat with our internal teams about next steps and will
follow up.
On Thu, Mar 18, 2021 at 8:34 PM Crawford, Carol Y. (CDC/OD/OADC) <giyl@cdc.goy> wrote:

Megan/Merecith ~ We are working on project with Census to leverage their infrastructure to

identify and monitor social media for vaccine misinformation. We would like the opportunity
to work with your trust team on a regular basi to discuss what we are seeing. | understand
that you dd this with Census last year as well. Are you all interested in scheduling something
tokickt off and discuss next steps? I'm happy to discuss further as well
Thank you!

Carol Y. Crawford
Chief, Digital Media Branch
Division of Public Affairs
Office ofthe Associate Director for Communication
Centers for Disease Control and Prevention
404-498.2480
scrawford@cdegov
cele)!
 Meredith Lightstone
|Government&Causes
a Titer OCOffceAmbassador
sheer |@ereighis
a

Moredith Lightstone
|Goverment&Causes
a Tutor OGOffcaAmbassador
sheer |@erelotis
a
From: Gator.CoalY. 0C/00/OK0)
To: TokiOot
I chy ton:Mogan
Doct;Dense GOCODOA00)
ay. BieWenn
Subject: RE: Vac Mimormation
Date: Tonsdyach23,2021 43:00PU.
understand. We have a standing meeting between 12-1 EST on Wed, would a window there work
for you?
Thanks.
From: Todd O'Boyle<toboyle@twittercom>
Sent: Tuesday, March 23, 2021 12:28 PM
To: Crawford, CarolY. (CDC/OD/OADC) <ciyl@cdc gov>
Ce: Meredith Lightstone <miightstone@twitter com>; Megan Dorward <mdorward@twitter.com>;
Dempsey, Jay H. (COC/OD/OADC) <ifbS@cdc gov; Reggie McCrimmon <rmccrimmon @twitter.com>
Subject: Re: Vaccine Misinformation
HiCarol-
Thanks so much for getting in touch. We'd be glad to schedule a check in. With our CEO testifying
before Congress this weeks tricky- how does next Tuesday or Wednesday look for you?

On Tue, Mar 23, 2021 at 12:11 PM Crawford, Carol Y. (€OC/OD/OADC) <civl@cdc.gov> wrote:
HiTodd & Reggie | wanted to check back in to see if this was possible?

From: Meredith Lightstone <mightstone@tuitter com>

Sent: Friday, March 19, 2021 2:22 PM
To: Crawford, Carol Y. (CDC/0D/OADC) <ciy1@cdcgo>; Todd O'Boyle <tobovle@twitter.com>
Ce: Megan Dorward <mdorward@twitter.com; Dempsey, Jay H. (CDC/0D/OADC)
<ifbs@cdc gov»; Reggie McCrimmon <[ccrimmon@twitter com>
Subject: Re: Vaccine Misinformation
Hi Caroll | am adding in Todd and Reggie from our Public Policy team who will coordinate next
steps.
Many thanks,
Meredith
On Thu, Mar 18, 2021 at 9:12 PM Meredith Lightstone <mighistone@tuitter com> wrote:
Hi Carol and Jay, this sounds great! 1 wil chat with ou internal teamsabout next steps and will
follow up.
On Thu, Mar 18, 2021 at 8:34 PM Crawford, Carol Y. (CDC/OD/OADC) <giyl@cdc.gov> wrote:
Megan/Meredith —We are working on project with Census to leverage their infrastructure to
identify and monitor social media for vaccine misinformation. We would like the
opportunity to work with your trust team on a regular basis to discuss what we are seeing. |
understand that you did this with Census last year as well. Are you all interested in
‘scheduling something to kick it off and discuss next steps? I'm happy to discuss further as.
well
Thank you!

Carol Y. Crawford
Chief, Digital Media Branch
Division of Public Affairs
Office of the Associate Director for Communication
Centers for Disease Control and Prevention
404-498.2480
csrawford@cdegoy
Cel oxe

Meredin Lightstone | Government & Causes

| ToierDC Ofco Ambassador
shor | @narsighis
a

Mersdth Lightstone | Government& Causes

Tofu OC Oca Ambassador
shor | @mtsigis
a
 From: Cuts, CanY.COC/ODIONE)
To: (Gooal Aci;aonee;ChaeLepae: Gurl
ca
co ‘Dampiey.neH (COX/00IOKD)
Subject RE WY so
Dae: Wodnesta, pe2,20217:02:00
Wonderful, if Eva wants to connect directly that would be great. There is not a e-mail chain directly
that can loop you into though. This was received via a meeting.
Holly Scheer
Community Partnership Coordinator
holly
scheer@uyo gov
From: Genelle Adrien <genelleadrien@fb.com>
‘Sent: Wednesday, April 28, 2021 6:37 PM.
To: Crawford, Carol Y. (CDC/OD/OADC) <ciy1@cdc.gov>; Payton Iheme <payton@fb.com>; Chelsey.
Lepage <chelseylepage@fb.com>; Eva Guidarini <eguidarini@fb.com>
Ce: Dempsey, Jay H. (CDC/OD/OADC) <ifbs@cdc.gov>
Subject: Re: WY issue:
Hi Carol—Thanks for flagging this to us. | am looping in my colleague Eva who leads our State team
outreach. She can provide additional guidance here or connect with the Wyoming Dept. of Health
teamdirectly if you'd lie to loop her in.
“Thank you!
Genelle

From: Crawford, Carol Y. (CDC/OD/OADC)<civl@cdc.gov>

Date: Wednesday, April 28, 2021 at 6:25 PM
To: Payton heme <payton@fh.com>, Chelsey Lepage <chelseylenage@fh.com>, Genelle
‘Adrien <genelleadrien@fb com>
Ce: Dempsey, Jay H. (CDC/OD/OADC) <ifbs@cdc.gov>
Subject: RE: WY issue
Anything you all can do to help on this?
From: Crawford, Carol Y. (COC/OD/OADC)
‘Sent: Friday, April 23, 2021 1:46 PM
Tos Payton Iheme <payton@fb.com>; ChelseyLepage<chelseylepage@fb.
com>
Cc:Dempsey, Jay H. (CDC/OD/OADC)<ifbs@cdcgav>
Subject: WY issue
‘The Wyoming Dept. of Health mentioned to one of our groups that the algorithms that Facebook
and other social media networks are apparently using to screen out postings by sources of vaccine
misinformation are also apparently screening out valid public health messaging, including WY Health
communications. They were looking for advice about how to work with social media networks to
ensure that verifiable information sources are not blocked.
0 you have someone that could perhaps talk
to the state about this?
 From: Exc ms
Tor Taos0
GOc000M0)
co Yos DanaCO0/0D
aru n Pat,Soca (GD0ODIOC
IOCY GICI0200C008201
S):FtKaun8 sade 000
000)
lan:
pt wos,Gah ©(G0000/000tea. ot C00ORNI BAIC RORD CO:
Subjot: i Aca of ko Snes
one: Trude.Ao,202 105723 A
Atachmens: GOC15iAdCr As202 01
Good morning Dia and team.
Thank you for providingthis document and your quick response.
1 have provideda signed copy for your files.
Best,
Payton

FACEBOOK
Payton heme
US. Public Policy
‘Eacebook

From: Taylor, Dia (COC/OCOO/HRO)" <demd@cdc.gov>

Date: Monday, April 5, 2021 at 10:46 AM
To: Payton heme <payton@fb.com>
Ca: "Yassanye, Diana (CDC/OD/OCS)" <iged@cdc gov, "Parikh, Sapana (CDC/OD/OCS)"
<euh8@cdc gov», "Ford, Kenya S. (CDC/OCO0/0GC)" <kdf6@cdc.gov, Carol Crawford
<ciyl@cdc gov, “Stevens, Melody (COC/ODNID/NCBDDD/OD)" <sme1@cdc.gov>, COC IMS
2019 NCOV Response Policy Partnerships <eacevent337@cdc.gov>
Subject: Acceptance of In-Kind Services
On behalf of the Centers for Disease Control and Prevention (CDC) and by the authority delegated to
me through Section 231 of the Public Health Service Act (42 U.5.C. Section 238), as amended, thank
You for Facebook's non-monetary gift of Facebook ad credits, with an estimated value of
$15,000,000. Please see the attached letter regarding ths gift.
Dia Taylor, MBA
Acting Chief Operating Officer
{ ¢ US. DEPOFHEALT
ART HANOHUM
MEN AN SERVICES
T PsHest snc
| FE
Se Centers for Disease Control
iaPreven 50)
CSRS S03
April, 2021
Nkechi Payton Theme
U.S. Public Policy
Facebook
Washington, D.C.
Dear Payton,
Onbehalf ofthe Centers for Disease Control and Prevention (CDC) and by the authority
delegatedtome through Section 231ofthe Public Health Service Act (42 U.S.C. Section238),
as amended, han yo for Facebook's non-monetary if ofFacebook ad crdits wih on
estimated valueof$15,000,000. This gift will be used by CDC's COVID-19 response to support
the agency's messages on Facebook, and extend the reach ofCOVID-19-related Facebook
content, including messages on vanes, social distancing, rave, and other priory
Communication messages.
Publicity and Endorsements: As part ofthis gf, Facebook will not use the nameof the
DeparmentofHealh and Homan Services (HHS), ony component agencies incding CDC,
except in factual publicity. Factual publicity includes das, mes, locations, purposes, agendas
and fees involved with parner activities. Such fctual publicity shall mot imply that the
involvement of HHS or CDC serves sn endorsementof he general polices, activities, or
productsofFacebook; where confsion could esl, publicity should be accompaicd by &
disclaimer to the effect that no endorsement is intended. Facebook will clear allpublicity
material or his if with HHS and CDC to cours compliance wih this paragraph. By signing
and etuming copyofthis Iter where indicated below, Facebook acknowledges sceptance of
this condition. *

Please retum this signed etter the CDC Incident Management System Policy Urit
Parnership and Risk Management Team afsoceven370dgov
Suppor rom organizations suchss yours makes i pasible for CDC ta work toward
understanding and preventing disease. We deeply appreciate your hel.
Thank sou,
Dia Taylor, MBA
ActingChisf Operating Officer
“Publicity and Endorsements acknowledgement; wT AVA oue_flyn] lit 202
(CC: OD, 0GC, OADC, IMS Policy
Cc: Genelle Adrien <genclleadrien@fb.com>
Subject: RE: CV19 misinforeporting channel
Ok, ll send the appt and get a zoom. Then you can add on your folks.
From: Carrie Adams<carrieadams@ com>
Sent: Wednesday, May 12, 2021 11:06 AM
To: Crawford, CarolY. (CDC/OD/OADC) <ciy@cdc51>; Payton theme <pavton
fb.com>
Cai Genelle Adrien <genelleadrien@fb. com>
Subject: Re: CV19 misinfo reporting channel
Apologies for the bumpy transition with Genelle out ~ do you all have a zoomgov requirement? And
if s0, would you hold the calendar invite for this? Or does Census?
From: Carrie Adams <carrieadams@fbcom>
Date: Wednesday, May 12, 2021 at 10:51 AM
To: Crawford, Carol Y. (CDC/OD/OADC) <ciy1@cdc.g0v>, Payton lheme <payton@b.com>
Cc: Genelle Adrien <genelleadrien@fb.com>
Subject: Re: CV19 misinforeporting channel
Great! Thank you!
From: Crawford, Carol. (CDC/OD/OADC) <ciy1@cdcgov>
Date: Wednesday, May 12, 2021 at 10:50 AM
To: Carrie Adams<Carrieadams@bcom>, Payton Iheme <gayton@fh.com>
Ce: Genelle Adrien <genelleadrien@fh com>
Subject: RE: CV19 misinforeporting channel
Sorry, didn't realize you were awaitinga respond to your explanation. That time still works. Thanks!
But re-looking at this lt, please only include these people as we've had change over since we
started the chain:

From: Carrie Adams <carrieadams@fh.

com>
Sent: Wednesday, May 12, 2021 10:19 AM
To: Crawford, Carol Y. (CDC/OD/OADC) <ciy1@cdcgo>; Payton Iheme <pavton
fhcom>
Ce: Genelle Adrien <geneleadrien@fbcom>
Subject: Re: CV19 misinfo reporting channel
Bumping this calendar thread
From: Carrie Adams <carrieadams@ib.com>
Date: Monday, May 10, 2021 at 4:51 PM
Tos: Crawford, Carol Y. (CDC/OD/OADC) <ciy1@cdc.g0y>, Payton Iheme<payton@fb.com>
Ca: Genelle Adrien <genelleadrien@fb com>
Subject: Re: CV19 misinfo reporting channel
“Thiswould be for onboarding your tears to the misinfo casework/ reporting channel
From: Crawford, Carol Y. (CDC/OD/OADC) <civl@cdc.gov>
Date: Monday, May 10, 2021 at 4:04 PM
Tos Carrie Adams <carrieadams@b.com>, Payton Iheme <payton@fb.com>
Ca: Genelle Adrien <genclleadrien@ib com>
Subject: RE: CV19 misinforeporting channel
Time is good. | id ask Genelle this embarrassing question. | had tin my head this was for Crowd
Tangle. But on Thursday she explained tis or something else. Well, | didn't write it down and Im
honestly not sure what this is for. Sorry!
From: Carrie Adams <carrieadams@(bcom>
Sent: Monday, May 10, 2021 401 PM
To: Payton Iheme<0ay10n@(bcom Crawford, Carol Y. (CDC/OD/OADC) <chul@cdcgov>
Cc: Genelle Adrien <genelleadrien@fh com>
Subject: Re: CV19 misinfo reporting channel
Thanks, Payton
50 nice to meet you, Carol.
Look likes Wednesday the 19" 12-1pm option works best for our folks.
Does that option sill work for your side?
A
From: Payton Iheme <pavton@ib.com>
Date: Monday, May 10, 2021 at 3:28 PM
To: Crawford, Carol Y. (CDC/0D/0ADC)<ciy1@cdcgov, Carrie Adams
<carrieadams@fhcom>
 Ca: Genelle Adrien <genelleadrien@fh com>
Subject: Re: CV19 misinfo reporting channel
Hi Carol,
Genelejust wert[TBE] We are very excited or her and B16)
As such, we didn't want you to be a surprised that Carrie will pick up on the threads where Genelle
was leading startin today.
That wil include this one with scheduling raining for the government case work project.
Best,
Payton
From: Carol Crawford <civl@cdcgov>
Date: Monday, May 10, 2021 at 12:25 PM
To: Genelle Adrien <genelleadrien@fb.com>
Ca: Payton Iheme <payton@fb.com, Carrie Adams <carrieadams@b.com>
Subject: RE: CV19 misinforeporting channel
1m so sorry Fm out al day May 17 for[__TG8Y_] can we pick another one? My fault!
From: Genelle Adrien <genelleadrien@fh com>
Sent: Friday, May 7, 2021 11:27 AM
To: Crawford, Carol . (€DC/0D/OADC)<ci1Bcd go>
Ce: Payton Iheme <gayion@fhcom>; Carrie Adams<carrieadams@hcom>
Subject: Re: CV19 misifo reporting channel
HiCarol = Following up from our meeting yesterday. It looks lie Monday, May 17 at 12:00pm will
work for onboarding meeting. The overlaps with your standing Census meeting you mentioned. We
will lan to invite the email addresses below (those being onboarded).
Please et me knowif any flags on your end.
Best,
Genelle
a
Genel Quarles Adrien
Polis & Govemment Outreach
e: geneleadien@h com | w: facebookconga
From: Crawford, Carol Y. (CDC/OD/OADC)<ci]@cdcgov
Date: Tuesday, April 27, 2021 at 11:21 AM
 To: Genelle Adrien <genelleadrien@fb
com>
Ce: Payton heme <payton@thcom, Carrie Adams<carrieadams@fhcom>
Subject: RE: CV19 misinforeporting channel
Ugh, so sorry | missed this. It looks correct but| think so might have access already, but not sure.

From: Genele Adrien <genelieadrien®fh

com>
Sent: Tuesday, April 27, 2021 11:05 AM
‘To: Crawford, Carol Y. (CDC/OD/OADC) <ciyl@cdc.gov>
Ce: Payton theme <payton@fh com>; Carrie Adams<carrieadams@ibcom>
Subject: Re: CV1Omisinfo reporting channel
HiCarol ~ Hope the week is off to a good start. | wanted to bump this and see if you had any
edits/additions to the onboarding list below.
Let us know if you have any questions
Best,
Genelle
From: Genelle Adrien <genclleadrien@ib com>
Date: Tuesday, April 13, 2021 at 3:50 PM
To: Crawford, Carol Y. (CDC/OD/OADC) <ciyl@cdc.gov>
Ce: Payton heme <payton@fbcom, Chelsey Lepage <chelseylenage@ib.com>
‘Subject: CV19 misinfo reporting channel
Hi Carol - Hope the week is off to good stat. We're working to get our COVID-19 misinfo channel
up for COC and Census colleagues. Could you kindly confirmif the below emails are correct for
onboardingtothe reporting channel and if there are others you'd like to include?
Please et me knowif you have any questions.
Thank you!
Genelle
 a
Genelle Quarles Adrien
Polics & Government Outreach
e: genelleactien®@com| facebookcon/gea
From: SaneOninta
To: GaCoralY(00/00/
tor. 00)
I bonaes
an
Sublect Ra: Apnafor
Date: Thursday,Marchae?
16,2021 51:99
Attachments: madicoa
mace os
Thanks, Carol!
On Thu, Mar 18, 2021, 5:31 PM Crawford, Carol Y. (CDC/OD/OADC) <giyl@ede.gov>
wrote:
‘There is an update in progress on this but think it might not be live until Monday. Ill keep
you posted.

From: Stanley Onyimba <sonyimba@google.com>

Sent: Wednesday, March 17, 2021 11:55 AM
@cdc.gov>
“To: Crawford, Carol Y. (CDC/OD/OADC)<cjy
Ce: Jan Antonaros <jantonaras@googlecom>
Subject: Re: Agenda for today?

Hi Carol,

Thanks again for your time yesterday. Resharing the question on covid-19 treatments here

Are there plans to update the CDC treatments page (screenshot below) in light of the new
NIH recommendation on BamlanplusEtese ivimab vimah?

a
>z
Bests2
5: g: £2811
i!
s 5%

= g 3sfg iii
fi2:3
5%
g 2s Hi
o eid]
8
$ is
gg jl 11

g$ i 135s
2%
i 11
is
5Li sii4f
filER
ic is
> 344 i il
CE
g Hf

<
sill
@ £3
fg 131
OR 5%
$F 15;
i
2 EE i HEE
5 Ei
: HHH
£ B 1
8 1 1%
Hi
5 £3 LEE 5
§ 2, fil
2
2 a 1
:
fed
:
o o
OS
HE
$! | | f1/0i0
§ = t 1
2 = HEHE

: 3 f
al) © |
| i) if
gq
=)
=:
Specifically, we noticed that the NIH updated its guidelines recently to recommend MAbs
for outpatients. On the Anti-SARS-CoV-2 monoclonal antibodies page, they indicate they
are planning to update this section

Thanks,
Stanley

On Tue, Mar 16, 2021 at 10:44 AM Crawford, Carol Y. (CDC/OD/OADC)

<siyl@edc.gov> wrote:
Ah OK, glad your on it the attendees.

From: Stanley Onyimba <sonyimba@google.com>

Sent:Tuesday, March 16, 2021 1:43 PM
To: Crawford, Carol Y. (CDC/OD/OADC) <gjyl@cdc.gov>
Ce: Jan Antonaros <jantonaros@googlecom>
Subject: Re: Agenda for today?

Yes, Rosie is perfect and Nicole from the screener team confirmed that she will attend so
we're all set. Thank you!

On Tue, Mar 16, 2021 at 10:40 AM Crawford, Carol Y. (CDC/OD/OADC)

<ciyl@ede. gov> wrote:
T doubt I can get someone from the screener team to join at his late time....but Rosie,
who will attend, probably knows status of the pages in general —isthatWhatyouneed?

From: Stanley Onyimba <sonyimba@google com>

Sent: Tuesday, March 16, 2021 1:38 PM
To: Crawford, Carol Y. (CDC/OD/OADC) <giyl@cde.gov>
 Ce: Jan Antonaros <jantonaros@google.
com>
Subject: Re: Agenda for today?

Hi Carol,

It would be great it we couldhave a vaccine expert on the call as we'd like to discuss.
the vaccine screener and some webpages that the CDC screener eam will be following
as they develop the tool:

CDC COVID-19 vaccine webpages

‘WhenYou'veBeenFully Vaccinated|CDC
DifferentCOVID-19Vaccines|CDC

‘Understanding
mRNACOVID-10Vaccines |CDC

I've also included Nicole Maddox from the CDCself checker team to join.

“Thanks,

Stanley

On Tue, Mar 16, 2021 at 10:17 AM Crawford, Carol Y. (CDC/OD/OADC)

<ciyl@cde.gov> wrote:
‘Whodo we need on the call? I know your talking to Fred earlier today about the
API. Not sure what else we may need to talk about. I can have a vaccine expert on if
needed.
 [Stier Ory [Global Prot Parner|

[Siarvey Gryimba [Global Product Pariersips|

[Staniey Onyimba| JGlobal Product Partnerships |

From: StayOnin
To: Ca CoolY(00/00/
o. 00)
I fry——r EY
Sublect Re: COG COVI-19 Sate ofVaccineConfrc Inst por
Date: esdy 5:13:53PM.
WacnMach3,2021
Thanks, Carol!
On Tue, Mar 30, 2021 at 2:26 PM Crawford, Carol Y. (CDC/OD/OADC) <cjy]@cde.gov>
wrote:
Jessica Kolis who was on our call today pointed out that this confidence report may also be
of interest to Google/YouTube, 50 passing it on. 1 have copied Jessicaif you have any
questions.

‘Thanks for the meeting today!

came
StarteyOnyimba|Global ProductPartnersips | sonyiha@0agi
 From: Favonheme
To: GaCorelY.(000/00
tor. /0A00); Da 4.(GOC/ODIO.
a ms ADC): Lavon Kateen(COLIODIONO0):
Laba
CanaleAce;Chale n Kade
laEman;BonTato aeToot BahlLies
Subject: COGFac AdretOferter
boo k
oe Sindy,February 21,2021 85651
Sounds good Carol.
We will stand by.
Best,
Payton
Get QulforiOS ook
From: Crawford, Carol Y. (COC/OD/OADC) <ciy1@cdc.gov>
sent: Sunday, February21, 2021 8:57:00 PM
To: Payton heme<payton@fb.com; Dempsey, Jay H. (CDC/OD/OADC) <ifbS@cdc gov; Layton,
Kathleen (CDC/OD/OADC) <KYUS@cdc gov»; Genelle Adrien <genelleadrien@fb.com>; Chelsey
LePage <chelseylepage@fb.com>; Julia Eisman <juliaeisman@fb.com>; Airton Tatoug Kamdem
<airtonkamdem@fb.com>; Kate Thornton <kthornton@fb.com>; Rachel Lieber
<carlsonlieber@fb com>
‘Subject: RE: CDC Facebook Ad Credit Offer etter
Thank you for this amazing offer. We'll work with our policy staff on next steps.

From: Payton Iheme <payton@fb.com>

Sent: Sunday, February 21, 2021 5:43 PM
To: Crawford, CarolY. (COC/OD/OADC) <ciy1@cdc.gov>; Dempsey, Jay H. (COC/OD/OADC)
<ifbs@cdc.gov>; Layton, Kathleen (COC/OD/OADC) <KYUB@cdc gov»; Genelle Adrien
<genelleadrien@fb.com>; Chelsey LePage <chelseylepage@fb.com>; Julia Eisman
<juliaeisman@fb.com>; Airton Tatoug Kamdem <airtonkamdem@fb.com>; Kate Thornton
<kthornton@fb.com>; Rachel Lieber <carlsonlieber@fb.com>
Subject: COC Facebook Ad Credit Offer letter

Dear Carol and the CDC team,

Facebook is pleased to offer additional ad coupons and strategic marketing support services to
the Centers for Disease Control (*CDC), in order to aid in your campaign to fight the spread
of COVIDI9 (collectively, the “Support”). This letter outlines in detail the scope and value of
this Support, but if you have any questions please contact Payton Themeatpayton@fb.com
or Julia Eismanatjuliacisman@(b.com.
By utilizing this Support, you (CDC) confirm that you are in compliance with all rules and
regulations applicable to your entity or organization governing the acceptance of things of
value and that you have the authority to receive this Support from Facebook. You also
acknowledge that this Support may only be used to communicate content related to the current
COVID-19 crisis in your jurisdictionofremit. This Support can only be used for public health
‘campaign content specific to the current COVID-19 crisis, COVID-19 vaccine information,
and/or vaccine confidence (¢.g., content about how vaccines work). Please provide written
confirmation that you have authority to accept the Support.
“This Support shall only be used by you in support of your efforts and in accordance with
applicable laws and shall not be used in any way. directly or indirectly, to facilitate any act
that would constitute bribery or an illegal kickback, an illegal campaign contribution, or would
otherwise violate any applicable anti-corruption or political activities law. This Support may
not be used to support lobbying activities without Facebook’s prior written approval. Further,
this Support may not be used to make any contribution or expenditure, or for any other
political purpose, regulated by campaign finance, government ethics, or analogous laws that
apply to political activities.
For the sakeof clarity, Facebook does not request anything in return in connection to this
Support, Accuptarics of this Support Conitt iat ie Sunport, your tolationsiip wih
Facebook, and how you were selected for this Support has been disclosed to you. You should
not accept this Support if it would interfere with your official duties and you must not perform
any official action to improperly benefit Facebook.
“This Support should only be accepted if it complies with applicable regulations, policies, and
rules of the CDC; and applicable laws, regulations, rules, judgments, and ordersofany court
or governmental authority: and does not conflict with any other obligation you may have to
any other party. Please promptly inform Facebook of any circumstances that would make
acceptance, retention, or useof the Support inappropriate.
“This Support is further subject to the following conditions:
= This Support cannot be used for the promotion of politcal messaging or advancement of any
political purpose
This Support cannot be used to advocate for any changes to legislation or government policy
‘This Support cannot be used for the promotion of third party products and services
‘= This Support can only be used to target users within your jurisdiction
+ Anyads that feature or mention a government official should be flagged to Juia Eisman and
will require additional review and written approval by FB before they can be used with this
Support
‘You may not use Facebook's logos or trademarks without Facebook's prior written approval.
All requests for useofthe Facebook name or trademark must be submitted via the online form
available atww
facebookbrand.com/zequests. All Support provided by Facebook hereunder
are provided “as is” and on an “as available” basis without warmanties of any kind, either
express or implied. Facebook disclaims all warranties, statutory. express or implied.
including, but not limited to, implied warranties of merchantability, fitnessfor a particular
purpose, and non-infringement of proprietary rights.
 YourAdCreditCouponDetails
AdCreditValue:
$15,000,000 USD

Please note that your ad credit coupon can be redeemed in the United States and cannot be
used to send cross-border messages outside that jurisdiction. The ad credit coupon shall only
be used and redeemed by the CDC in support of public health campaigns related to COVID-
19. Any other use or transfer is strictly prohibited. Once we provide your coupon code,
please safeguard it like cash.
Please note that this donation letter must be readin conjunction with the Facebook Ads Credit
Coupon Terms & Conditions, available athitps:Aww
com/legal/couponterms.
facebook
Ads will be subject 0 additional pre-review that is required for ads about social issues,
politics, or elections (and may require a paid-for-by disclaimer that discloses Facebook's ad
credit support); this pre-review is required for any ads that are paid for with the ad coupon.
What Are Ad Credit Coupons?
Ad credit coupons are a form of payment for Facebook ads. They can be redeemed for
advertising on Facebook and/or Instagram depending on the typeofad credit coupon
that has been issued to you. Ad charges will be deducted from the ad credit coupon
first, then you will be charged through your preferred means of payment once the ad
credit coupon has been redeemed or has expired. Ad credit coupons cannot be used
against account balances that have already been invoiced.
Terms & Conditions
Useofad credit coupons is subject to the terms in this email and to the Facebook Ads
Credit Coupon Terms & Conditions, which are available here:
htps:/wse facebookcom/legalcouponterms. Please check the Facebook Ads Credit
Coupon Terms & Conditions for further details.

‘Eacebook AdsCreditCoupon Terms&Conditions If you do not agree to these terms,

You must not use thisadcredit coupon.
Facebook Marketing Partner Strategic Services
To support your COVID-19 advertising campaigns, Facebook is providing strategic marketing
assistance via an expert 3rd party (each a “Facebook Marketing Partner” or FMP"). Facebook
works closely with an ecosystem of FMPs who maintain a deep understanding of our tools and
platforms and can provide direct expertise and support to organizations, small and large
businesses, and Governments around the world. As part of our efforts to support Government
and NGO partners during COVID-19 with technical solutions and integrations, as well as
advertising campaigns, Facebook is offering direct access to certain FMP support in each
region as further detailed below. This support will help ensure you can scale your marketing
efforts and deliver critical COVID-19 related information to people in your country.

FacehookMarketingPartnerCOVID-19SupportProgram
Facebook Marketing Partner: [TBD]
Valueofsupport: $15,000 USD
Scopeofsupport: The Facebook Marketing Partner will provide your organization with between 35-
45 hours of COVID-19 advertising and creative campaign management
On behalf of the team,

Payton

FACEBOOK
Payton Iheme
US. Public Policy
‘Eacebook
 From: Eavonheme
To: Ca no 400);spent (COCDOIDNGIRDYOD): Sige,James
CorlY.(00/00/0
ferry .
oo
Subject: CU FcobaokSurveyAdva
Ro:baconVe:ona ate 10-:Fb27lasn
Too
Findings:J
Date: Monde. Mar c 12623PU
15,2021
Attachments: Qi ToonVacice Bacon2Z10R1256
Also, Katherine M./tear and our regular team would ike to set upameeting to discuss the findings
and receive your feedback. Would you let us know a few day/times this would work for you this
week?
Best,
Payton
From: Payton heme <payton@fb.com>
Date: Monday, March 15, 2021 at 1:16 PM
To: Carol Crawford <ciy1@cdc gov», "Jorgensen, Cynthia (CDC/DDID/NCIRD/OD)"
<cxj4@cdc.gov>, "Singleton, James (CDC/DDID/NCIRD/ISD)" <xzs8@cdc.gov>
Ce: Katherine Morris <katherinemorris@fb.com>, Genelle Adrien <genelleadrien@fb.com>,
Kate Thornton <kthornton@fb.com>, Julia Eisman <juliaeisman@fb.com>
Subject: CMU/Facebook Survey Findings: Jan 10- Feb 27

Hello COC team,

As we discussed, following up on our commitment to share our survey data on vaccine uptake.
We are sharing these findings regularly moving forward to help inform your teams and
strategies. Attached are our findings from January 10 February 27, 2021. Today, the report
will be available online.
Note that highlights of the findings are up top, a robust executive summary follows, and then
a deep dive into the methodology, greater detail on state trends, occupations, barriers to
acceptance. etc. Hopefully, this format works for the various teams and audiences within COC
that may find this data valuable. We're also open to feedback on the formatting.
Please let us know if you have specific questions about the findings or the survey itself, we're
happy to track down answers or book time.
Best,
COVID-19 Symptom Survey

Topline Report on
COVID-19 Vaccination
in the United States
SURVEY WAVES 6-8
JANUARY 10-FEBRUARY 27, 2021

The Delphi Group at Carnegie Mellon University

in partnership with Facebook

RELEASED ON MARCH 12, 2021

 “This report presents responses collected botwaen January 10and February 27,2021 from
more than 1.9 million Americans. Since December 2020, the COVID-19 Symptom Survey
conductedby the Delphi Group at Carnegie Mellon University and Facebook has included
COVID-19 vaceination behaviors and attitudes.
1. The proportionofadultswhoareeithervaccinatedorarewillingto get vaccinated
increased by5 percentage points during this timeperiod,from 72% to 77%,butwe.
stillneed to combat vaccine hesitancy. The proportion of vaccine hesitant adults
has remained relatively unchanged at approximately 23%, and the increase in the
population who have been vaccinated or are willing to get vaccinated is driven in
large partdue to an increase in the willingness to report on vaccination behaviors
and attitudes.
2. Vaccinehesitancymay be improved by addressingconcernsaboutsideeffects
from a COVID-19 vaccine. Among vaccine-hesitant adults, the percentage of
individuals who are concerned about experiencing aside effect is high and has.
remained stable over time.
3. Disparities invaccination
ratesacrosspopulation groups may be addressed by.
mitigating concerns aboutsideeffects. Concern about side effects is consistently
higher among females, Black adults, and those with an eligible heath condition.
4. Vaccine-related messaging through local healthcare professionals isapromising
channelforcombattingvaceine hesitancy. Th percentage of vaccine-hesitant
adults who saytheyare more likely to get vaccinated if the recommendation
‘comes from local healthcare workers s higher than from other information sources.
‘Additionally, trust in local healthcare workers among vaceine-hesitant adults has
increased significantly over the last four weeks while trust in other information
Sources has remained unchanged or even decreased.
5. State-specific approaches tomessaging against vaccine hesitancy may be
Valuable. There are substantial differences in vaccination rates and vaccine
hesitancy across states. For example, both Florida and Wisconsinhave higher
vaccine hesitancy compared to the national average. However, the potential to
counter vaccinehesitancy using messaging about side effects is larger in Florida,
because concern about aside effect among vaceine-hesitant adults is much higher.

COVID-19 SYMPTOM SURVEY | 01

I INTRODUCTION
The COVID-19 Symptom Survey is the largest ongoing COVID-19 data collection effort
in the United States, with over 50,000 responses collected daily and over 18 million total
responses collected since ts launch in April 2020. Currently, the survey tracks daily trends
‘on vaccination, symptoms, testing, mask-wearing, social distancing, mental health, and
more at national,state, and county levels. Facebook users in the UnitedStatesare invited
daily to take a survey collected by the Delphi Group at Carnegie Mellon University but
the surveys are collected off the Facebook platform and the Facebook company does not
collector receive survey responses. See Appendix A. Overview and Methods for detailed
survey methodology.
“This report presents data collected from January10to February 27, 2021 from more than
1.9 million Americans. We highlight below national- and state-level trends on self-reported
vaccinations (hereafter ‘uptake) and vaccine-related attitudes by key population groups
toinform potential ways to combat vaccine hesitancy in the United States.
The survey recently incorporated questions on barriers to vaccination acceptance,
‘and future waves of the survey will include questions on vaccine availability. The next
version of the report will therefore further highlight potential opportunities for improving
vaccination rates and vaccine hesitancy by examining comprehensive reasons for not
wanting to or not being able to receive a vaccination. Future reports will also provide
breakouts for additional occupational groups.
II GENERAL POPULATION
As expected, the proportion of adults who are either vaccinated or are willing to get
vaccinated has increased during thistime period. In particular, self-reported vaccination
rates among Centers for Disease Control (CDC) Phase 1 priority population groups have
increased faster compared to other population subgroups. However, while vaccination
uptake has increased, the share of unvaccinated adults who are vaccine-hesitant
has remained relatively stable at 239% in the most recent week of data, and it varies.
considerably by state and by race/ethnicity (20% and 29% among White and Black adults,
respectively).
The COVID-19 Symptom Surveyprovidestwa key insights related totargeting messages
‘about vaccine hesitancy in the United States. First, one way to address hesitancy may be.
with information about side effects, which have consistently been aconcern fora large.
COVID-13 SYMPTOM SURVEY | 02
 fraction of the population. In the most recent week of data, the percentage of vaccine-
hesitantadults who are concerned about aside effect is 70%. Second, specifically
channeling vaccine-related messaging through local healthcare workers may be a
promising avenue to combat vaccine hesitancy. The percentage of vaceine-hesitant adults.
who would be more likely to get vaccinated based on a recommendation from a local
healthcare worker has increased from 10% to 16% in the most recent week of data, and
this estimate is currently higher thanthe percentages for recommendations from other
information sources. Higher confidence in recommendations from local medical and other
healthcare professionals may be unsurprising given high concern over side effects, but this.
also presentsa challenge for vaccine-hesitant adults who donot have a regular sourceof
healthcare.
Athird insight sthatthere may begreaterpotential to takea state-specific approach
‘about messaging against vaccine hesitancy. There are substantial differences in
vaccination uptake, intent, and concerns abouta side effect across states. Consider
five states: Florida; Georgia; Michigan; Texas: and Wisconsin. Al five states have a
higher proportion of vaccine hesitant adults compared to the national average,butthe
percentageofvaccine-hesitant adults who are concerned abouta side effect varies across.
thesefivestates. In particular, there are potentially larger opportunitiesfor battling
vaccine hesitancy using messaging about side effects in Florida andGeorgia compared to
Wisconsin. Compared to the national average, the percentage of vaccine-hesitant adults.
who are concerned abouta side effect is the same in Georgia and slightlyhigher in Florida,
butmuch lower in Wisconsin. Seethetable below.

Florida Georgia Michigan Texas Wisconsin

Recelvedavaccination 25.4% 247% 305% 281% 296%
Did notreceivea vaccination
andhesitant 265% 209% 239% 237% 237%
Vaccine-hesitantand concerned
aboutasideeffect 713% 701% 688% 685% 623%

COVID-19 SYMPTOM SURVEY | 03

 Executive Summary

Il CENTERS FOR DISEASE CONTROL TIERING CRITERIA

[I ——
While the rate of vaccination uptake among healthcare workers has progressed as
expected, 15% of healthcare workers remain vacein-hestant. Amon hose healthcare
SRE
Wii Age
Vaccine hesitancy is lrgest nthe younger age groups of 18-24 years (3150) and 25-44
aA enide
So
Wii Eligible HealthConditions

acing tweens Adulte liiole spatial elytovais

hesitant than the general population (41 percentage point difference) but among those
a A SM a
thoseinthogeneral popuiation 01 percentage point diffrence). Vaccine-nesitant alts
withanaiile condition sre most ely to go vaccinated Ft were recommended b local

Key insights for vaccine messaging

1. We may be able to improve vaccine hesitancy by addressing concerns about side
effects.

2. Channeling recommendations through local healthcare workers may be a

promising way to combat vaccine hesitancy.
3. There may be greater potential to take a state-specific approach about
messaging against vaccine hesitancy.
COVID-19 SYMPTOM SURVEY | 04
 IV KEY DEMOGRAPHICS,
Wi Race/Ethnicity
In alignment with official aportingand other survey sources, vaccinationuptake s the
Highest and has increased at the fastest rate among American Indian or Alaska Native
adults, followed by White, Asia, Native Hawaian or Pacific sander, Black, Hispanic, and
Multiracial o Other” adult, Inthe most recent week of data, the self-reported rate of
vaccinations among American Indian and Alaska Native adults (375) relative to al ace
ethnicities (29%) is especially promising given vaccinehesitancy among these adults
(29% relative to a race/ethnicities (23%). This suggests that outreach and vaccine
availabilty efforts have been comparatively successful among American Indian and
Alaska Nativeadults.
Th survey suggests tha theresusfor Black adults are mixed. On the positive side,
Black acuits have had the fastest decrease in vaccine hesitancy, from 40% to 29% during
Blackadults have hadthe A is ARERR
time period. On the other IE
hand, lack adults
B I R have
VY the
bi ae lowest percentage who report having received both doses
astest decrease invaceine +111
hesitancy but have the highest (295 for Black adults compared to 23% for all race/
concern about side effects. athnicties) nd the highest rate of concern about aside
affact (81% for lack adults compared: to 70% for all race/
ethnicities) inthe ast week of data.
Wii Gender
Vaccinationuptake is higher among females (335%) compared to males (2656), but vaccine
hesitant females (775) who havenotyetbeen vaccinated are more fkely to report
concern about a sideeffectcompared to males (62%). This is especially notable because
the siz ofthe gender isparity(1 percentage points) in concern about a side effects.
larger than any other disparity between population subaroups, includingthe disparity
between Black adults and all race/ethicites 11 percentage points) in concern about aside
affect.

COVID-19 SYMPTOM SURVEY | 05

Table of Contents
1 DOAINTIONG coocnsisssnsismnsismimsimmmisammmsss
sss 8
1.1 COVID-19 Vaccination Uptake and INtent ...............ccowuumsuumseseesssssssssssssssssrsssss 8
1.2 Receiving Two COVID-19 Vaccinations 8
1.3 Vaccine-Hesitant Adults Who are Concerned about a Side Effect .................... 8
1.4 Influence of Information Sources on Vaccine-Hesitant Adults........................... 8
2 Detailed Results on COVID-19 Vaccination Uptake and Intent ...........ccue. 10
2.1 COVID-19 Vaccination Uptake and Intent: OVerall..............o...coevverrsssssssssenes 10.
2.2 COVID-19 Vaccination Uptake and Intent: By Healthcare Worker Status....... 11
2.3 COVID-19 Vaccination Uptake and Intent: By AGe ...........ccouuuumsmveersssssssnnenes 12
2.4 COVID-19 Vaccination Uptake and Intent: By Eligible Health Conditions....... 13
2.5 COVID-19 Vaccination Uptake and Intent: By Race/Ethnicity o 14
2.6 COVID-19 Vaccination Uptake and Intent: By Gender................ccccvssssssnneees 15.
2.7 COVID-19 Vaccination Uptake and Intent: By State ...............cc.ccccererssssnneees 16.
3 Detailed Results on Receiving Two COVID-19 Vaccinations ..............ss 18
3.1 Receiving Two COVID-19 Vaccinations: OVerall..............uuueeseeresssssssneees 18.
3.2 Receiving Two COVID-19 Vaccinations: By Healthcare Worker Status.......... 19
3.3 Receiving TWo COVID-19 VACGinations: BY AGE ..........wewrerersrrersererres 20
3.4 Receiving Two COVID-19 Vaccinations: By Eligible Health Conditions 21
3.5 Receiving Two COVID-19 Vaccinations: By Race/Ethnicity .................cueen. 22
3.6 Receiving Two COVID-19 Vaccinations: By GeNder...............coceveerssssssssenes 23.
3.7 Receiving Two COVID-19 Vaccinations: By State ..............cc.ceuceereeresssssnneees 24
4 Detailed Results on Vaccine-Hesitant Adults Who are Concerned about a Side

4.1 Concerned about

a Side Effect: OVerall...............ousmsissismisssssssssssss 28
4.2 Concerned about a Side Effect: By Healthcare Worker Status........................ 26.
4.3 Concerned about
a Side Effect: By AGE .............c.ccwereerseesseemsersierses 21
4.4 Concerned about a Side Effect: By Eligible Health Conditions........................ 28
4.5 Concerned about
a Side Effect: By Race/Ethnicity ..................coccuummmmsnicnss 29
4.6 Concernedabout a Side Effect: By Gender................ccewmmusmsssssssssssssssenes 30.
4.7 Concerned about a Side Effect: By State 31
5 Detailed Results on the Influence of Information Sources on Vaccine-Hesitant

COVID-19 Symptom Survey 6

5.1 Influence of formation SOUTCES: OVETall.............mwrrrrs 32
5.2 Influence of Information Sources: By Healthcare Worker SIatUs .............. 33
5.3 Influence of formation SOUTCES: BY AGE.........rmrmrrs 34
5.4 Influence of Information Sources: By Eligible Health Conditions.................. 35
5.5 Influence of Information SOUrCes: By RACE/EINICHY wre: 36
5.6 Influence of Information SOUTCes: BY GENGET............owmwrrmres 37
5.7 Influence of Information SOUTCes: BY SIAIE mss: 38
DTH]
A. Cian art sms 38
B. Table of COVID-19 Vaccination Uptake and INtent.....................oowew. 41
C. Table of Adults Who Received Two COVID-19 VaCOinations..................... 56
D. Table of Vaccine-Hesitant Adults Who are Concerned about a Side Effect.... 62
E. Table of Influence of Information Sources on Vaccine-Hesitant Adul.......... 68

COVID-19 Symptom Survey 7

1 Definitions
1.1 COVID-19 Vaccination Uptake and Intent
To provide a broad overview of vaccination uptake and vaccination intent in the United
States, we categorized our survey respondents into the following four mutually exclusive
groups. Using the definitions below, we estimated the weighted percentage of
respondents in each group.
1. Adults who received a COVID-19 vaccination: Respondents who reported “Yes” to
the following survey question, which was asked of all respondents: “V1. Have you
received a COVID-19 vaccination? (Yes/No/l don't know)"
2. Adults who did not receive a COVID-19 vaccination and are vaccine-accepting:
Respondents who reported “Yes, definitely” or “Yes, probably” to the following
survey question, which was asked only among those who reported “No” or “I don't
know" to V1: “V3. If a vaccine to prevent COVID-19 were offered to you today,
would you choose to get vaccinated? (Yes, definitely/Yes, probably/No, probably
not/No, definitely not)”
3. Adults who did not receive a COVID-19 vaccination and are vaccine-hesitant:
Respondents who reported “No, definitely not" or “No, probably not" to V3, which
was asked only among those who reported “No” or “I don't know” to V1
4. Adults who did not receive a COVID-19 vaccination and have unknown intent
because they skipped our survey question on intent: Respondents who reported
“No” or “I don't know” to V1 and skipped V3.

1.2 Receiving Two COVID-19 Vaccinations

We defined receiving two COVID-19 vaccinations as the weighted percentage of
respondents who reported receiving “2 vaccinations or doses” using the following
survey question, which was asked only among respondents who reported “Yes” to
receiving a COVID-19 vaccination in V1: “V2. How many COVID-19 vaccinations have
you received? (1 vaccination or dose/2 vaccinations or doses/I don't know)"

1.3 Vaccine-Hesitant Adults Who are Concerned about a Side Effect

We defined concerned about experiencing a side effect as the weighted percentage of
respondents who reported “Very concerned” or “Moderately concerned” in response to
the following survey question, out of all respondents who were vaccine-hesitant: “V9.
How concerned are you that you would experience a side effect from a COVID-19
vaccination? (Very concerned/Moderately concerned/Slightly concerned/Not at all
concerned)”
1.4 Influence of Information Sources on Vaccine-Hesitant Adults
We examined the potential influence of information sources on vaccination among
vaccine-hesitant adults using the survey question: “V4a. Would you be more or less
likely to get a COVID-19 vaccination if it were recommended to you by each of the
following: (Local healthcare workers/World Health Organization (WHO)/Government

COVID-19 Symptom Survey 8

health officials/Friends and family/Politicians)" For each information source,
respondents had the option of answering: “More likely"; “About the same”; “Less likely".
We estimated the percentage of individuals who would be more likely to receive a
COVID-19 vaccination given a specific information source using the weighted proportion
of respondents who reported “More likely” out of all respondents who were vaccine-
hesitant.

COVID-19 Symptom Survey 9

2 Detailed Results on COVID-19 Vaccination Uptake
and Intent
Note that these survey-based estimates of vaccination uptake are typically higher than
official values reported by the CDC and state health departments, possibly reflecting
survey biases. However, we expect these biases to not change dramatically over time,
0 that increasing or decreasing trends reflect true trends in the underlying data.

2.1 COVID-19 Vaccination Uptake and Intent: Overall

Trends for the overall group are summarized in Figure 1 (below) and in Appendix B.

COVID-19 Vaccine Uptake and Intent

Weekly weighted average estimates from Jan 10- Feb 27, 2021
IB Roctved a vaconaton |E p—
Didnotreceiv avaccination
and accepting [1] id notreceiv avaccinationand skippedquestionon tnt
on

a
Pe

. mm EE Hn
wos amps
SEWER mae
mE me
Ab fem-
RET Reus
ORE Fae
RY
Fo de SALES Ty
ER SA Sr ERR a Re,
Figure 1: COVID-19 vaccination uptake and intent for the overall group as estimated by
the COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are tabulated in Table
B.1, Appendix B)

COVID-19 Symptom Survey 10

2.2 COVID-19 Vaccination Uptake and Intent: By Healthcare
Worker Status
Trends by healthcare worker status are summarized in Figure 2 (below) and in
Appendix B.

'COVID-19 Vaccine Uptake and Intent by Healthcare Worker Status

Weekly weighted average estimates from Jan 10 —Feb 27, 2021
IW Aecomedavaconsion IB Dotrocoesvaccnstonaston
Ono recee avaccination
andscceptng | Di notreceiv a vaccination andskippedaves on tent
Healthcare Workers (HCW) Non HCW

CANEEEEE
a
x
we

Jan
Jono10 JanJanZsJon
17 Jon 2430 JanFebos
31 Fb07
Feb13Fe
FebZD14 Feb
FebZ721 Jn16
an10-4anZ)7 an28
ino0 hn
Feb1 007
Feb13 Fob14
Feb20 F021
Feb
ihe
LECL ER CnEb Era
Figure 2: COVID-19 vaccination uptake and intent by healthcare worker status as
estimated by the COVID-19 Symptom Survey, Jan 10 ~ Feb 27, 2021 (Data are
tabulated in Table B.1, Appendix B)

COVID-19 Symptom Survey 11

2.3 COVID-19 Vaccination Uptake and Intent: By Age
Trends by age are summarized in Figure 3 (below) and in Appendix B.

COVID-19 Vaccine Uptake and Intent by Age

Weekly weighted average estimates from Jan 10 — Feb 27, 2021
[TR — Il Dunotrocove
avacenasonandhesant
Didnotrocoive
avaccinationandaccoping [1] Dd ot eceve a vaccination an skiped question on tnt

pbb [11111
oss 4564
Ton
-
ne
a

ml amuEl Rh
2544 1824

on
manllll _mmmEm
Lan10-Ja
SERRE 7dan Bn31 Fab07-ot 14-Fab21= JaRRnhnialereeey
ATRIRERY 0- an 17 Jn24am 31 Fob07-14 Fb21
aToes Cpanel ag BHo yCOTS 8aban hvepo et Sag fo vey
ER ES SER eeBe,
Figure 3: COVID-19 vaccination uptake and intent by age as estimated by the COVID-
19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are tabulated in Table B.1, Appendix
8)

COVID-19 Symptom Survey 12

2.4 COVID-19 Vaccination Uptake and Intent: By Eligible
Health Conditions
Trends by eligible health conditions are summarized in Figure 4 (below) and in
Appendix B.

COVID-19 Vaccine Uptake and Intent by Eligible Conditions

Weekly weighted average estimates from Jan 10 — Feb 27, 2021
I Foconved
a vacsinaton IB rotrecuve avacciston
andhesitant
Didnotreceive avaccination
andaccepting [Ji] Didnot receive avaccinationandskippedquestiononintent

Eligible health conditions No gible health conditions

AENEAN
aon
wo

. mmll mmEl i
Jan10-
SEER an 7 an28 an31 Fob O7-Fob T4-Fob21- dan10-
MERTRIRE SSEEr dn17- Jan 24 Jan
RRR 01 Fab 7-14
Fab21
Ry
eSSs Lo Sind a Cor Lr mt Si a
Utoem
Figure 4: COVID-19 vaccination uptake and intent by eligible health conditions as
estimated by the COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are
tabulated in Table B.1, Appendix 8)

GOVID-19 Symptom Survey 13

2.5 COVID-19 Vaccination Uptake and Intent: By
Race/Ethnicity
Trends by race/ethnicity are summarized in Figure 5 (below) and in Appendix B.

COVID-19 Vaccine Uptake and Intent by Race/Ethnicity

Wekweightedaverageestmas romJan 10-Fab27, 2021
I Swett I curasonotoitoset
= Ctrstn cg [8 to rd nsint
Non span marca nana Aska Nave Non
spac hte
TTT] CTT

NonHaparicAsan NonHispanicNatsawaian oPaci sandr

NonHispanic Back Haparic

spcowomanca $1185503TTR
EY
~-ANNEEER

EE EE
BE an |

Figure 5: COVID-19 vaccination uptake and intent by race/ethnicity as estimated by the

COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are tabulated in Table B.1,
Appendix B)

GOVID-19 Symptom Survey 14

2.6 COVID-19 Vaccination Uptake and Intent: By Gender
‘Trendsby genderare summarized in Figure 6 (below) and in Appendix 8.
COVID-19 Vaccination Uptake and Intent by Gender
Weekly weighted averageestimatesfromJan 10 - Feb 27, 2021
IB ecoved a vaccnaton IB rotrecov avaccination
andhestart
= Drotrcove vacationsndscan [Doce cernand pnison rt
Female ™
Ton
oN ||] HEN
aon
on
on
[3
ter WERE NER
100%

- i |i
aon
on
on
Lan
SESE10 on 1 an
ET on1Fa 07 1-1
RTRIRIRNY
dS SE A LP ey
EERE ER en
Figure 6: COVID-19 vaccination uptake and intent by genderas estimated by the
GOVID-13 Symptom Survey, Jan 10 Feb 27, 2021 (Data are tabulated in Tzbie B.1,
Appendix B)

GOVID-19 Symptom Survey 15

2.7 COVID-19 Vaccination Uptake and Intent: By State
Trends by state are summarized in Figures 7-9 (below) and in Appendix B.

Adults Who Received a COVID-19Vaccination: By State

27,2021
Wekpiadaverage ssmaes om Fob 21 Fb
B? i} _— o
A [ fry, 2y
5 & =r

og £8 o —2

—~
~
A ~ »
9
CoT—
25 300 a5 4 don So
ee

Figure 7: Adults who received a COVID-19 vaccination by state as estimated from the
GOVID-19 Symptom Survey, Feb 21 ~ Feb 27, 2021 (Data are tabulated in Table 8.1,
Appendix B)

GOVID-19 Symptom Survey 16

 Adult Wh
On DidpotRecee
ro Vac
AccaningCOVI:13
By Vaccination
te
Wetmen ramson 1 POE151

tt “ -

—
Fr

Figure 8: Adults who did not receive a GOVID-19 vaccination and are vaccine-
accepting by state as estimated by the COVID-19 Symptom Survey, Feb 21 - Feb 27,
2021 (Data are tabulated in Table B.1, Appendix B)

Adults Whoode
Did noVacemeHestan,
RecelaCOVID-19 Vaccination
BySwe
Wd sn es oe31 eb181

4 NT :

CC
— a
ESE
Figure 9: Adults who did not receive a GOVID-19 vaccination and are vaccine-hesitant
by state as estimated by the COVID-19 Symptom Survey, Feb 21 — Feb 27, 2021 (Data
are tabulated in Table B.1, Appendix B)

COVID-19 Symptom Survey 17

3 Detailed Results on Receiving Two COVID-19
Vaccinations
3.1 Receiving Two COVID-19 Vaccinations: Overall
Trends for the overall group are summarized in Figure 10 (below) and in Appendix C.
Received Two COVID-19 Vaccinations: Overall
Wook weighted averag stato om an10 Feb 27 2021
Toon

Pa

” ante aye ana ann feos mew rene

mEOWE ORE WE RY ORE WY
Se oss psn05ctr tts freesCOU 19 cts dirty V2 ewer
BS mi So oyEinageaSeon so wa bao To Fare ET
Figure 10: Percent of adults who received two COVID-19 vaccinations out of adults
who reported receiving a GOVID-19 vaccination as estimated by the COVID-19
Symptom Survey, Jan 10 - Feb 27, 2021 (Data are tabulated in Table C. 1. Appendix C)

GOVID-19 Symptom Survey 18

3.2 Receiving Two COVID-19 Vaccinations: By Healthcare
Worker Status
Trends by healthcare worker status are summarized in Figure 11 (below) and in
Appendix C.

Recelved Two COVID-19 Vaccinations: By Healthcare Worker Status

Wes wood erage state om an 10 Fe 27,202
100% == oot veux
on nrasncun
g me
g
§ on
i
*® oo

o Gri ev mae nd eon fen Fear

REEF OBE Rb RE ORE wy
Sdnosepeeen9%cok
arls SheFacing
Ee woCOVI-1
edDeycatia
dodsngV2Howry
Ss le
El Mako Tonypnwir Cn do Foo5 21 ESSra oy
Figure 11: Percent of adults who received two COVID-19 vaccinations out of adults
‘who reported receiving a COVID-19 vaccination, by healthcare worker status, as
estimated by the COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are
tabulated in Table C.1, Appendix C)

GOVID-19 Symptom Survey 19

3.3 Receiving Two COVID-19 Vaccinations: By Age
Trends by age are summarized in Figure 12 (below) and in Appendix C.

Received Two COVID-19 Vaccinations: By Age

Wook wept average ssimate om Jan 10 Ft27, 2021
Toon =
=e
= mu
Er
§ 7%
2
HN == ——

—
i a —=F=
= Jan 10-dan 17- Jan 24- Jan 31- Fob 07 Fab 14- Feb21-
mEomE OWE Ar RW mE Ry
Sdwnsers 5 connect econCOU 13actorsdidsing2 owmary
a Er Suton COV 8 SyrenSyCand EansseaeUhesty

Figure 12: Percent of adults who received two COVID-19 vaccinations out of adults
‘who reported receiving 2 COVID-19 vaccination, by age, as estimated by the COVID-19
Symptom Survey, Jan 10 Feb 27, 2021 (Data are tabulated in Table C. 1, Appendix C)

GOVID-19 Symptom Survey 20

3.4 Receiving Two COVID-19 Vaccinations: By Eligible
Health Conditions
Trends by eligible health conditions are summarized in Figure 13 (below) and in
Appendix C.

Received Two COVID-19 Vaccinations: By Eligible Health Conditions

Wook weted avragostmt fm Jan 10 Fe 27,2021
Toon
= oy ogo roamconsin
= Reo rs cain
§
g
§ ox
:
® on

™ ani anys mae med Peon Feu fwee

mE WEBER Ar RE mE my
Stsrs5cfr sr,cee wnCOV. 19s fe sry 2 Homey
Pealcondtonsaotnedas Roy ey Cyhr FonSoc
Te outa100, CEH.SoSerchlit onyke To Boa 3Test akSpas
¥
fits
ES EaSy reg
E75 ios
RavearyloHi He conan”
yCans Hoh od parrywo
Urry ad Soe Go %
1Dt 0110-Fb
aceon 5Kh
581
Figure 13: Percent of adults who received two COVID-19 vaccinations out of adults
who reported receiving a GOVID-19 vaccination, by eligible health conditions, as.
estimated by the COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are
tabulated in Table C.1, Appendix C)

GOVID-19 Symptom Survey 21

3.5 Receiving Two COVID-19 Vaccinations: By
Race/Ethnicity
Trends by race/ethnicity are summarized in Figure 14 (below) and in Appendix C.

Received Two COVID-19 Vaccinations: By Race/Ethnicity

Wook wee avers estimate fam Jan 10 Fe27,2021
100% = Aman
BEooe oda Nasaa
S row NaeHamsancePachance
£ ~ Bick
orAan American
g = bw
i ©Wascoomer
§ on
£
3
# oo

™ wo nr mae mde Eee mew wr

wEORE OBE mb BW OWE ORY
FE ———
re
a
PsSE EE ER
PEER
Figure 14: Percent of adults who received two COVID-19 vaccinations out of adults
who reported receiving a COVID-19 vaccination, by race/ethnicity, as estimated by the
COVID-19 Symptom Survey, Jan 10 - Feb 27, 2021 (Data are tabulated in Table C. 1.
Appendix C)

GOVID-19 Symptom Survey 22

3.6 Receiving Two COVID-19 Vaccinations: By Gender
Trends by gender are summarized in Figure 15 (below) and in Appendix C.

Received Two COVID-19 Vaccinations: By Gender

Wook wet average esate om Jan 10 Ft27, 2021
Tox
= Fanan
== wwe
oe
g
£
=

:
i ” —
} 2% gi
= Jan 10-
dan 17- Jan 24- Jan 31- Fob 07- Fab 14- Fob21
mEOmE OWE mw RW mE Ry
ios tanAvan Cao
Soova Fpa mary
Ea eB ETSmt Soy laces ares een
Figure 15: Percent of adults who received two COVID-19 vaccinations out of adults
‘who reported receiving a COVID-19 vaccination, by gender, as estimated by the
GOVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are tabulated in T2ble C. 1
Appendix C)

GOVID-19 Symptom Survey 23

3.7 Receiving Two COVID-19 Vaccinations: By State
Trends by state are summarized in Figure 16 (below) and in Appendix C.

Received Two COVID-19 Vaccinations: By State

Weightedaverage estimates romFeb21 -Feb27, 2021

= >

Cr———
a0 15% 50%5% 60%69%
Baceingmo COVE13acrair dln ungV2ow gyCOV-1, 2

Figure 16: Percent of adults who received two COVID-19 vaccinations out of adults
‘who reported receiving a COVID-19 vaccination, by state, as estimatedbythe GOVID-
19 Symptom Survey, Feb 21 — Feb 27, 2021 (Data are tabulated in Table C.1, Appendix
©)

GOVID-19 Symptom Survey 24

4 Detailed Results on Vaccine-Hesitant Adults Who
are Concerned about a Side Effect
4.1 Concerned about a Side Effect: Overall
Trends for the overall group are summarized in Figure 17 (below) and in Appendix D.

Vaccine-Hesitant Adults Who are Concerned about a Side Effect: Overall

Wook weedsvorago otmates omJan 10- Fob27, 2021
100%

ee

sm

Fa

™ Gat wen wna na Fen Feu Fea

nROEmE OEE aR REY OmE Wy
a vaca ts V5Fo arcaranws To kyo wld rare 3Sl She TomsCOVID-10
Vionn Saree Se ne O70 eycheTO i wnoon ander
RyERE
Figure 17: Vaccine-hesitant adults who are concerned about a side effect as estimated
by the COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are tabulated in Table
D.1, Appendix D)

COVID-19 Symptom Survey 25

4.2 Concerned about a Side Effect: By Healthcare Worker
Status
Trends by healthcare worker status are summarized in Figure 18 (below) and in
Appendix D.

Vaceine-Hesitant Adults Who are Concerned about

aSide Effect:ByHealthcare Worker Status
Wes whavissts om 10 Fo £15021
wo = ont

id Ee
3 TT Te ————

Fon
H=

Tomr mE OEY WY ORY OWE omy

Ee
FE ep
pe
ey

Figure 18: Vaccine-hesitant adults who are concerned about a side effect, by
healthcare worker status, as estimated by the COVID-19 Symptom Survey, Jan 10 —
Feb 27, 2021 (Data are tabulated in Table D. 1, Append D)

GOVID-19 Symptom Survey 26

4.3 Concerned about a Side Effect: By Age
Trends by age are summarized in Figure 19 (below) and in Appendix D.

Vaceine-Hesitant Adults Who areConcernedabout aSide fect: By Age

Weyca rnsts fo Jn 10 Fb27,201

~
| p—
££
H
=

Be Jan10-
Jan17- dan24 dan31 Fobo7-. Fob 14 Fab21-
FESO
Ytoy pees Sch oySCOHwaCoCo
Tooe iss
odSeyoe
pe HE ELE SL
hE
Figure 19: Vaccine-hesitant adults who are concerned about a side effect, by age, as
estimated by the COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are
tabulated in Table D.1, Appendix D)

GOVID-19 Symptom Survey 27

4.4 Concerned about a Side Effect: By Eligible Health
Conditions
Trends by eligible health conditions are summarized in Figure 20 (below) and in
Appendix D.

acne Hsiant Adult Who ar Concarmed about

pct a id Ect: By Ell Heath Conditions
omenanone
=Somme
g 5% _--__—r—

3
£3
* a

"mr BF SY AY BY ms my
Een IE
peETom
A tr rE oT
Figure 20: Vaccine-hesitant adults who are concerned about a side effect, by eligible
health conditions, as estimated by the COVID-19 Symptom Survey, Jan 10 — Feb 27,
2021 (Data are tabulated in Table D.1, Appendix D)

COVID-19 Symptom Survey 28

4.5 Concerned about a Side Effect: By Race/Ethnicity
Trends by race/ethnicity are summarized in Figure 21 (below) and in Appendix D.

Vaccine-Hesitant
Adults WhoareConcerned
Weyma i tsfm 10 402720aboutaSide
21 Effect:ByRace/Ethnicity

ee

* [—
oe
oromE
dan 10-
Jan17-
BF
dan24
mv Fobo7-
dant
omy Fobomy14 my
Feb21-

Ra
Enea
Figure 21: Vaccine-hesitant adults who are concerned about a side effect, by
race/ethnicity as estimated by the COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021
(Data are tabulated in Table D.1, Appendix D)

COVID-19 Symptom Survey 29

4.6 Concerned about a Side Effect: By Gender
Trends by gender are summarized in Figure 22 (below) and in Appendix D.

Vaceine-Hesitant Adults Who areConcernedabouta Side Efect: ByGender

Weycad rn ss fo Jn 10 Fb27,201

1 -——

££
H
=

Be Jan 10- Jan17- dan24 dan31 Fobo7-. Fob 14 Fab21-

oR OWE ORF Mk WET omy omy
ae
Pe
EnEel
Figure 22: Vaccine-hesitant adults who are concerned about a side effect, by gender,
as estimated by the COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are
tabulated in Table D.1, Appendix D)

GOVID-19 Symptom Survey 30

4.7 Concerned about a Side Effect: By State
Trends by state are summarized in Figure 23 (below) and in Appendix D.

Vaccine-Hesitant Adults Who are

Concerned about a Side Effect: ByState
‘Weighted averageestimates fromFeb 21 ~Feb 27, 2021

A
CC
——
we ese on Ton
J
EE ————
Ee
fo a
Cane TURE eri wihFrc FEFBl
Figure 23: Vaccine-hesitant adults who are concerned about a side effect, by state, as
estimated by the COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are
tabulated in Table D.1, Appendix D)

GOVID-19 Symptom Survey 31

5 Detailed Results on the Influence of Information
Sources on Vaccine-Hesitant Adults
5.1 Influence of Information Sources: Overall
Trends for the overall group are summarized in Figure 24 (below) and in Appendix E.

Vaccine-Hesitant Adults Who are More Likely to Get Vaccinated

if Recommended By Various Information Sources.
Week wehied averageetmefomJan 10- Fob 27,2021
wo = Loimamaovoa
£Foams waranny
= Gommmentremn
VoraamOguiasion
oto
ox == banca
Pe
= —_—
. 1
Gato
ERE ant eae
EEA mae for
BET few
ORE Fear
wy
adn os ert contr tra,Mor
eB Momtotced
oirsddtdsr
tid Vi.Wo oubemr
deMos 2
ne
Be
es lh on Se Co as eer
Figure 24: Vaccine-hesitant adults who are more likely to get vaccinated if
recommended by various information sources as estimated by the COVID-19 Symptom
Survey, Jan 10 — Feb 27, 2021 (Data are tabulated in Table E.1, Appendix E)

COVID-19 Symptom Survey 32

5.2 Influence of Information Sources: By Healthcare Worker
Status
Trends by healthcare worker status are summarized in Figure 25 (below) and in
Appendix E.

Vaccine-Hesitant Aduits Who are More Likely to Get Vaccinated if Recommended By.
Various Information Sources: By HealthcareWorkerStatus
Wook wena averagestaes enn10-Fo 27,2021
[r— rnd nda
a
Po
a
" —— some
o
gu WasHaan Organ Covert es rcs
Foe
Fon
$
fon
£
io —_— Leen ceemtemcalsrnd
pol pone WERE RESTRY
Po
PS
= comtuoninmancrn
on = Voorn
© an 10 Jan17-Jan24Jan 31 Feb07 Feb 14 Fab 21-
SRE Em RTRSY
EEE
Sp FEete
HE aa
Re A reSH Ape RlTE
ERSS
eeER EE NER EEE
Figure 25: Vaccine-hesitant adults who are more likely to get vaccinated if
recommended by various information sources, by healthcare worker status, as
estimated by the COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are
tabulated in Table E.1, Appendix )

GOVID-19 Symptom Survey 33

5.3 Influence of Information Sources: By Age
Trends by age are summarized in Figure 26 (below) and in Appendix E.

Vaccine-Hesitant Aduits Who are More Likely to Get Vaccinated if Recommended By.
Various Information Sources: By Age.
Weyweedavon stmis ve i 10 Fab 27,2021
Locsin motes rd rata
Pr
PS
- ——
oxEE —
~
gun Wor Host Organza [————
g
Fo
fon
£ER
eeee vs ec
a —_—
a oi WERE ERENT
Po
PS
==u
Bu
on =Sha
mu
J a] a 21
papeBn
Jan 0dan 17 an 31Fo 07 Fab
peeget
Spd ve mr0 crocsrp Mo obot tng 8 sgV4.Wein
Ee rE Ea ly Feel
er Ve Te EyEe
SR Sey Sites Eh Ht ry aws Faso on 10°Fo 7 300 0
Figure 26: Vaccine-hesitant adults who are more likely to get vaccinated if
recommended by various information sources, by age, as estimated by the COVID-19
Symptom Survey, Jan 10 — Feb 27, 2021 (Data are tabulated in Table E.1, Appendix E)

GOVID-19 Symptom Survey 34

5.4 Influence of Information Sources: By Eligible Health
Conditions
Trends by eligible health conditions are summarized in Figure 27 (below) and in
Appendix E.

Vaccine-Hesitant Aduits Who areMoreLikelyto Get VaccinatedifRecommended By.

Various Information Sources: By Eligible Health Conditions
Weywi avon tmts fm on 10 Fa 27,2021
[r— rnd nda
a
PS
=
” |= —_—
o
go
WasHaan Orgzten Covrimnt sm cs
Fan
fax
§10% —_—
* on
rn 010-017-201
mE ERE FaRT07 RE
=r:
14-F21-
RY
re
Po
Po
a.
ran
ae
ox
JUD RL
Ja
SRR0Jan 17 an Bn
31Fb0
mt mR14Fab21
Sn
Ly vemr 0 crocs vp Mos ot ot ng 8 sgVt Wee
GEESE
eine eh
es
BE a RR
NRI SI Lt Cry

Figure 27: Vaccine-hesitant adults who are more likely to get vaccinated if
recommended by various information sources, by eligible health conditions, as
estimated by the COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are
tabulated in Table E.1, Appendix E)

GOVID-19 Symptom Survey 35

5.5 Influence of Information Sources: By Race/Ethnicity
Trends by race/ethnicity are summarized in Figure 28 (below) and in Appendix E.

Vaccine-Hesitant Adults Who are More Likely to Get Vaccinated if Recommended By

Various Information Sources:
oywesva snto 10 on 7.3
By Race/Ethnicity

o ———— Fenway
or 4
- :
= -
- a ===
o
gon WornOanzin ovement
evn tic
Fa
Fo
I
a ue
a
rons WEED
REREY
* ox

wo = tn
nc tat
on Br
- 2 Eee
a gi,
mm RT EY
© Jan 10- Jan17- Jan24- dan31 Fob 07-Feb 14-Feb21 = or

EE
DE
ER
postnatal abate,
RTeS BNR
Re ra esSem
Figure 28: Vaccine-hesitant adults who are more likely to get vaccinated if
recommended by various information sources, by race/ethnicity, as estimated by the
COVID-19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are tabulated in Table E.1,
Appendix E)

COVID-19 Symptom Survey 36

5.6 Influence of Information Sources: By Gender
Trends by gender are summarized in Figure 29 (below) and in Appendix E..

Vaccine-Hesitant Adults Who are More Likely to Get Vaccinated if Recommended By

Various Information Sources: By Gender
Weyweedavon stmis i 10 Fa 27,2021
Lcaiveumrs motes rd rata
Pr
PS
-
P. —_— —
o
gun WadHaanOrg [————
g
Fo
fon
£foe
® i ——— —————————————
Poi Poucars WERE ERENT
Po
woe = Fomse
10% BE
a F—————————
Jan10
SEmER dan 17 an Bn
mt 21
07 TF
31 FoRRS
Spd ve mr0 crocsrp Mo obot tng 8 sg
V4.Wein
mens,
fre Sa SeyEA
CrSv bios Cams isi rors Saris wlPacheco.a10 Fob53,01.
Figure 29: Vaccine-hesitant adults who are more likely to get vaccinated if
recommended by various information sources, by gender, as estimated by the COVID-
19 Symptom Survey, Jan 10 — Feb 27, 2021 (Data are tabulated in Table E.1, Appendix
)

GOVID-19 Symptom Survey 37

5.7 Influence of Information Sources: By State
Trends by state are summarized in Figure 30 (below) and in Appendix E.

Vaccine-Hesitant Adults Whoare More Likely to Get Vaccinated if

Recommended by:
Local heatthcare workers Friends and family
Wem stona021 F27 2521 Weaisto F021 £0027 321

— CC
—
World Health Organization (WHO) ‘Government health officials
Wehr eona21 F781 Witenes
eb21 e071. 8021

oN ol LN 5
am—
ae se teen am—
am en teen
poiticians
mts
Weeden 1-151

LY
CO ——

ey opeae toe ig Ys ad beeep crn esmd

So

Figure 30: Vaccine-hesitant adults who are more likely to get vaccinated if
recommended by various information sources, as estimated by the COVID-19 Symptom
Survey, Jan 10 — Feb 27, 2021 (Data are tabulated in Table E.1, Appendix E)

GOVID-19 Symptom Survey 38

Appendices
A. Overview and Methods
A.1 About the COVID-19 Symptom Surveys Conducted by Carnegie
Mellon University and University of Maryland in Partnership with
Facebook
Currently, Facebook users in the United States are invited daily to take a survey
overseen by the Delphi Group. This is the largest ongoing COVID-19 survey in the
United States (and likely the largest real-time survey ever conducted), with over 50,000
responses collected daily and over 18 milion total responses collected since its launch
in April 2020. The survey is also conducted globally by faculty at the University of
Maryland (UMD) Joint Program in Survey Methodology (JPSM) in partnership with
Facebook, and we are currently inviting Facebook users in more than 200 countries and
territories globally to take the survey. Sampled users see the invitation at the top of their
News Feed, but the surveys are collected off the Facebook platform and the Facebook
company does not collect or receive survey responses.
A.2 About the Researchers
The Delphi Group at CMU was founded in 2012 with the goal of developing the theory
and practice of epidemiological forecasting. This project is part of ts vision of making
epidemiological forecasting as universally accepted and useful as weather forecasting is
today. More information is available at hiips://delphi.cmu.edu/.
A3 Survey Information
«Realtime aggregate survey resus for the United States are available at
https://delphi.cmu.edu/covidcast/survey-results!.
«Documentation about the United States survey and procedures is online at
https//emu-delphi.github.io/delphi-epidata/symptom-survey/.
«The aggregate data underlying this report is availablefor download at
htips://cmu-delphi.github.io/delphi-epidata/symptom-survey/contingency-
tables. html
«Academic and nonprofit researchers may request access to non-public, non-
aggregated data for their research.
«More details about data access can be found here:
https//dataforgood.fb.com/docs/covid-19-symptom-survey-request-for-data-
access/.
A.4 Questionnaire
The survey instrument is maintained by CMU, which partners with the broader public
health community. The survey asks users about any current symptoms as well as other
factors related to their experiences during the pandemic. The instrumentis translated

COVID-19 Symptom Survey 38

into English, simplified Chinese, French, Brazilian Portuguese, Spanish, and
Vietnamese.
A5 Survey Weights
The Facebook company provides sample weights that adjust for non-response and
coverage biases. By non-response bias, we mean that some sampled users are more
likely to respond to the survey than others. To adjust for this, Facebook calculates the
inverse probability that sampled users complete the survey using their self-reported age
and gender as well as other characteristics we know correlate with non-response. We
then use these inverse probabilities to create weights for responses, after which the
survey sample reflects the active adult user population on the Facebook app. By
coverage bias, we mean that not everyone in every country has a Facebook app
account or uses their account regularly. To adjust for this, Facebook adjusts the weights
created in the first step even further so that the distribution of age, gender, and state of
residence in the survey sample reflects that of the general population. Making
adjustments using the weights ensures that the sample more accurately reflects the
characteristics of the target population represented. More details can be found in our
‘weighting documentation here: httpsz/research.fo.com/publications/weights-and-
methodology.-brief-or-the-covid-19-symptom-survey-by-university-of-maryland-and-
camegie-mellon-university-in-partnership-with-facebook/.
AS Limitations
The Symptom Survey weighted population estimates for characteristics such as age,
gender, and certain chronic conditions are generally comparable to estimates from other
data sources at both the national and state level. However, our survey population may
still over- or under-represent certain subpopulationsor characteristics related to
education, race, and occupation because we do not account for these characteristics in
the weighting of our survey responses. In particular, the weighted sample is slightly
under-representative of low-education adults as well as Black or African American and
Hispanic adults,
While the trends in vaccination uptake from the Symptom Survey may be comparable to
trends from other data sources on vaccine dose administration, the exact percentages
of vaccination uptake from the Symptom Survey may differ from other data sources and
should not be treated as authoritative. When comparing with official estimates,
differences may stem from a reporting lag. When comparing with other survey
estimates, differences may stem from differences in the instrument, sampling or
weighting methodologies. For example, while many of the Symptom Survey questions
on COVID-19 vaccines were developed in collaboration with the CDC to match their
instruments, there may be differences in estimates from the Symptom Survey and
estimates from other surveys fielding the same items such as the Census Bureau
Household Pulse Survey due to small differences in question wording, as well as
differences in the weighting variables used.

COVID-19 Symptom Survey 40

 | see= sess =g=s T
38 Sswl Scar =eny 5
ef FENg £333 ZFzds g
¢ sg 3333 8835 88:83 3
g23:%
§z 88 £8832 E¥s:
g¥83 838:
2833 8g
5 een sess cmeo -
£ |d2 SSs3 333s dss S
15:
: 333
FERE] : iii
33
822g
2833 3
$
§c [4s8 aoa
S333 233%=
ae
383%
om YT
$
©
§ [82 #283 gre; S333 é
3 geen sags gTE¢ a
=E §g |383% Sss&s33 882
883: ssgs%
ess sc
5 Es 2383: =5320 g§
8 2 (3% 2g83 BRES S833
£
on
1g
2 3 =
2
S532
coos
sssg as8g
sea~
sss§ =5s2
rr
gssg
gs=
S555 T8383
2: 2333 $825
8853 22a:
B83 22
£5 se S353 3335 33353 gz
2 fs I33%
5 = © 3a gE iii
B82 ¥8Rs =

Te 5 5 5

o 3 823 g 823 1 823

o 3 E8% sf 33F : INT
SE| |e 222 2% EEE S Zz: 5£2
9 3 § 5855 ®3 585 § _§§s
o 2 $8597 fyeiiy fsgiii gs
5 > 2ESES 5§ssss Sse is
°% fase BEfoaes pgoaas 3%
2 55 fis: §Stif: iti: £3
8 8 S38EE £§gifE g3ifE. [rs
Tog5 flees Bilsrsiilsrsl gif
a 88 |88zza rElzzacilizasc zal
S10
g935
Soi
S883
oRRf
ad¢€s
IEEE
“88%
Riu:
5323 g¢
3
§=c
seg
<©§=T
geeg
assss
eee
@aag
sco 9
sg=o
sesg
g
3
$3: SER: 33n: oat: g33z £
32s
_n
S583
_.
2383
mm
tha
Ene
8823
BREE
:
Ss
E
$55 S853 5885 283g S853 a
2ey g2ESy 23237 fos: gery 2
§25 2883 S885 =Gas 8823 a<
ssc =ssT £88 e@a3 sssz 3
$35
og ¥
35835
one
s85§
& wn
g33%
Seer
$853
SaaY
2
855 ©8x8 ©GERS o8§s gHEeS
gcc £35 c©ssc 533% sgss
SY
ges
ESS
Eas
§55%
288s
So8d
~88¢
s8sd
=8%cs

SE%
283
sSE
338
sce
828s
Sffy
%E3s
sgfd
Rigs
2 5 5 ss 5%
£: £: fs ge t f:y 3
Ti
LEE]
iF
LEE] 2:7
fi
LEE]
iF 5 ibe
g 5:7 2
558 o 585 g BEE _ EEE #g EEE T
§55 §& 555 555 § sss £% sss £
BEE OQ REZ YoPIf oo EE
$88 23888 25488 23888
BSoERE of
S=:28¢8¢8 ¢
gg gseg sgss SESsS gsEssSs ¢
Ss: §fsss Bfsss Efgss: SEisss §
FI CHiiE
S08 Boil LBfif
§pEii Cifii
fpiis. BLigii
giziiig
Feeislreisiesnig
$25: 80z225 10323 3 ral
0553; gajrraic
Srizasis
EEzedizzzsiizzzsddaze: siizazi:
sees ssa=s 8883 &£fgT STF
sssg sseg ccc Ss83% see
288: $283 S8fT 2233 :i:s
RER3 2385 588s 8833 KI§ 9y
TEER
sesg
sags
ssseg
ssas
ced
a@ses
ssds
ass
sss a
g
s28x
3583 gaa
“Gas sea
388%o 339
goo ses
g8¢8 5€
J cone som cre see EB2
Ssss sds 32283 838s Sse
E23 gP2Y fogs fesy 23F =@
8333 2385 #885 £335 8%: gs
J
cece crac
segs sosc
=ssf sree
sces see
sss 38
sssg sssg sce sssg see
233: 29% §f2X 322y fis
283s §38y £833 {ESS 2zs
ggss sass 233s 883 83%
Rao oso seas ons eas
88s e888 a5 8c ®Res “83

peer 523: 23%: 333z 3:3

23353 1382 F233 EE 283

Pes Pes 3 Pus 2.8 & 2.

£538 25% ¢ 25% 25% T 35
gi: §28 © git 588 2 1%
23 £83 23 §83 5 §2
BEE
EE BEEF3
BEE Ti
Et BEE 8E 2
TBE IB
§5% g E88 7 §£if $88 § £2
gE2Z ggfff 8 FEE 5 23% £ f°
FIO
EEE] §Z5scs gag Rguad
LBgU00%EE Sass ign
ITfess gfe
$288: EZTE8: oR Sse: sii ffi:
5886, U5388: sggiif CgfEE Tse
Bros
$xz33f
Bilrraiiflirseiyiresillss
[88st fifcectilzestiiss
£228: 5858388:51488388:28888544833
zt cess S@®T TET BEET @
<3 §a-3
JEFF sSseg
222% sSssg
fii: sssg
23g: ©
=
§ 3883 3335 8¢€%3 8883 ® 3%>
¢ 29%g 2L4E 999 $55 § ¢
3 gg7: $323 gis 3g £ 2
3 £325 ©S3I5S 8285 gs x §
eas coe een ceo oo EB
S Sd28 2388s ssss ssss so @
$+ ZSEzs 223y gg3s gg § oS
8 #843 3823 £3d: 8823 : ¢>
z ssss Fees Sooo geag © 8
S3 2325
Eire $883
S25Y sSsss
Sis ssss
goes ss ©
3 $885 ©%385 ab&s agds ©
g 233% 333% 333% 538 2
§ 888% 3335 fdss E385 F

z §8%s 333% 58s: ggg 2

I gc: zz: 2:33 £23: =
gg 28 £8 £g 28
Ey 3 rp. 2 e 5
3g € £53 £53 551 £513
Ty iii F iis 1d ie
2% § 8 g & 38

IF 33: Sf ii: EE: zs 22%

a£5g
F888 3st Faas
focs Sfass Eanes E888
2§sss 22
F3
$F Siig osfgs: ztii: sEziid 28
8 f-gB88. FgEEE. 23888 23888. 35
$538tisaii
2:
actstiael Sgateic)
598zzzi8zzztEinzn:
2582288
o0§Zzcooob6&coo0os§2acooos @LCco00S=Ea
gs3
Sat
822g
© = 8.
§28s
ena
t2ig
owe
§8g8
Noes
585 ©2%5s 35° ©oHN&c 828s ?
3
gz
seg
gsss
Sccg
535s
gees
S@3g 358s <
CELE cece @
385
fas ores
°58e $952
3950 3g=2
ggeo geze
g%ae° 5E
8
ggg
==
gasses
PR
235g
Pa
S@@g
PR
858s
PR
&
E

ge: Ste ges 33s ize 2

Eas =d5S 2¢8” 23335 8883 8
3
Ses
sm
82:28
Ssn<c
g§38y
Rote
:=22g
oonme
gssg
owes
5
za5 S85S $283 d987% 233°
§s5 eege 235g @oss Gog
eal S52 aves SSe- grag
3x5 S883 €dg3 883° e887
32% zai g883 23% Z2323
835 ngs 335% 838° 2883
§5%
seg
esas
d-es
255s
deed
@5@@
cg
938g
deed
Se soos Saes sos soos
8835 vgs S833 sgkN Sggd

fri
id£3
I3t
§8%
g£3
If
iid
£23
If
§8%
£3
If
§8
£3

88
g§8s 22888
TEES $2885
48s SE08E
88484
SEs 3¢
gsccf
sss SEess 28cc: §8sss
f5sss
$32 25111 fog: 58222 38222 ©
ggg. cgeete sgpiEg cgEEs _CgEEE. 3
Feriyivel Eilessigirreifrereiil
sz E8smss 253ssi88zzsiffzzaii
2335523885 2343885<88885528835%
888 888% SK@s @&8@c seas =
S237
sceg
33d
ses
3 rR
sSeg
33%:
Sssg
Ing:
zzzg
7
a
§98e g8e3 &520c 58%c 588° 8 9
3
23s= @83c @REs fags assg © ©
£28c 83%; 228 38%: iff i 4
$382 R®58: §sa3 8533 83% 0% §
es Ca a a Co _
g
E
5533
sceg 333:
geeg 3583
sSses 53%;
sSesg 22%3
zs 2% og&
TT
252%
3¢8- 335%
887 s83%
“G&S gmp
fges 33E:
RB88S 8oz o°
3
g§283
seed S383
cess 3Sssg
gsed sgsg
deed ifg
===S 22 0°
KER - Egka Ege foe E33 8
f83as; §8sc- @Rag @K8g S¥Tg ®
$S5S
eye
$5§®
gra
555%
r3e-
sssy
egen
&sst
ZK
§3:

s3ss 533s sEgs 95g sIs: oS

3853 8723 E83 Sge8 35¥% ©
§ g § g g
i | 3
§5% f3f f3T i £31
Bs Pw Fudd Pes Pus

HERHEERI
§EEF C8i i s5ii: ERI 2siid
ssi: ERLEoss
3988 33088 JESSY
FEST 255% $2888 grist
S088 Iriit
2088 ff
25
EEF S08
S80 BUiieB. gfe
5pBB0 LBGif
FoBi gRiii
Gotta;ii
Pereifiersiiierailiarsiiiasiis
dz23:38833:58338:582838:38833:832
S333t3izzzcsdzzzisizgzciizzziis
§zg
222 ggg;
$83: sggs
EEIr zEig
FEET ZIEf
gris gs
22
835 #582 3383 £23 EF€83 F¢ §
3
sss
as
835s
sssg
@©@gs
sesg
@e¥s
sSs=2g
88g
cg
IT
es
¢3
35
goo 398%
REN FESS
R¢8e° 2385
585° @gIse
EY&c 23
Re 3¢
_ PR PR PR PR Pa.
g
E
32g 333 337 g%FoFz 237 33 2
Se
e232
282e
sz
222e
sng
=E3c
gow
==2°
swsg
22
EE
=
5
feo fako {58 - eee R¥8so {8 o
$
fgg ©%9; @E8gy %99s 99% 4
Se
8
S823
S22 Sse3
Efe S888
SIF £228
EEEY 2228
rz: EY
838 ©Szgd 2983 g§ged ERS Eg
Seg 8T@c- Sag [TBI B8S8s ad
25S Soe SNS Sete see NI
Re ~- LE ITH8 f82- ey’ - ER

83g 833: $883 :£E%¥s 5Ees sg

22s 323; $883 23Iig s33g §%

2% S383 N§§3 ¥E¥S 38s RE

55
id
551
§8%
HE
g§8
55
id
55
id
3g
23 823 823 23 823 8

gg 8 FFT § TEE FEY _ FEE go %

S98
S53 £2038 9008 aff
3fsews 3fcas Nfses 85808
Tfsan £34
Hie
£22 58322 BUif: sioi: zfs: sis
888 CgBBE g888 cgBBE Eg88f 238
Feriglsrei
sz
fiers praia rail
B88:88sesi fist idznstiiznstids
3888s85388:£8288858£888:£43
Iz
SF
23%;
oe:
2I37
can:
2337
wes;
Ii;
owes
122
woe
83 ®F&3 g$33 R343 TIRS Es 9y
$c @f@c Kage @sss KE85s £a&@ ¢
2% FEES f2Py Eg3Y g2zr fz: 2
88 53INS £583 KEES &SRS 3s 52
_ PR PR PR PR PR E
2% 3527 3Z27s 3%o7s S7ZZr £2 2
£3 Eff S83: 228s EEEs PEP 2
§2 Ids" 8#33 ges" d¥R3 f¥8 ¢s
$= aseg @scg ssag Tacs @a@s
Sg
2% ossg
$2FS Sssg
IPsc Ss88
g23s Ssse§
fff: sss
E52:
8% 2ERT SEE" 238° Sag~ 2%¢d
¢z 988g 885g U85%g A565 E85
$5
ao
ZEST
egy
Iii
e888
333s
eg]
soes
eZ
fs:
td

$s g2gs 35s 835g SSS 25S

i8 fis fi: QE: fEf iE

£2 go EEE FEE Do FEE 2 EEE Not:
£5
se ysEdd
fiecc Bedif
gicoc g2ifd
ficcc Jeifd
Sic: Jedd
Fic
£5 3fg22 28222 stro: cf22z ffs
88 £3888 53888. 3888, 75888, E588
Feifiessi;
freiprraiitnaiaee
z3c28css fifo 58sE838
88528388534 888:34388584888:34833
-
S
cess
Zcg
race
e8eg
sco-
eeeg
sess
eeeg
cae
seg
SE F553 sms? Gea? SNe ars
© S82 R8¥e 8% 89d 8282
:
2

e
S
888%:
Teg
K¥Gec
eeeg
TEGc
eeeg
TETe
eeeg
KIT
eee
g
a
2 S55 3302 338% SEZ 35: GE
< 8B]
PR
IBF
PR
J8Fe
PR
LR
PR
LR
PR
gE
S

§ @&T8g @R@g @GR@s ST@IT= ORT a

° Scsg SSsSsg SsSsg SsSsg sss e
© 388s gZEv 2§¥T ggis EEE 25
@ ©@8ces @Reg @Rag TBI @a@ 8
g
2 323%
$38: 3338
33: 3s38
332 2835
iit E88
zis °
By CFL - Eg" eed a8 gge

s cssg 958s $395 goss @5s

3
o
S29:
eFao
Zo3:
TEE
PSE:
Re
323i:
tgIa
$30
ze

§ §%%s 35%3 3333 833s 5%

g g3%s 23°37 220% g9gTs eR%

5S 285 reas 3:03 shgs srs

i f3f fx fxr fxd i:

§ 52 §2f f38 825 £2

z §%zzz $igz: sfizc: §Eczz Biz:

P2U221 BiIEF BUI Biff iif
8 BsB38 Sso8f 2:88 CoiBB zzit
sisirssiafreeirereioisnaiiiee
BcEfzzzcEizzzsfizzzsfiznzeidzz
25582co-58coo-88coc88202E822
§
S
222%
orRae
888g
owN:y
223%
Goag
gf
Brey
es:
—nn
° 885° 898° 38° §¢3° 83d
2
8

z F83q eRe = aasc “838g g=s g

Ss s-egd sesg ccs ccd cs a
3 28s: 93s Sac g8¥s ssE ¢
° 888- £98 59ko NER g§¢3 5
2
$s: 3233 353; 323g RT.
283 3i3 a|
come aN © one FET ono 2
9 Sous S862 Brel S392 ooo a
° £88 - 82 Ege €58o d3de dQ
2
8
§ @8sg @fKRg <SI35 888s 88 3
S
§ EYE?
323% §E%%
3338 iif
=:238 S228
3328 Eis
8:3 2
‘ a¥8e eg8- S568 288 - 233

3$ SESS
5223 3IS
3383 §ISE
2323 Eze
3383 iit
Ii
v eLEo eBR- eB TY e838

g 8332 95% 3337 gz2%z 27%

2 S833 388% 2§RY JSgR? 338

I ORZE% 328% 238° EN R3¥

g 2 8 g 8
£ § § § §
i§
>
fxr
Pen

i:
fir
Pew

gE:
fn
Pus

fpf
inn
Pes

gE:
i:
2.

gd
3 git EEL TET it Ii
§ § 8858 o £58 §8f g E8% §5
fe 7Fz § 35s g 3°78 § 5%: o §f
$§ 22888 82588 22888 JESSCS
T2888 s2¢8¢8
PBfii:z zzz: 3ESCOL
FESSS jESeSe
29z:i iii: ii::
TESS
EHIIEHIIE IIEH IIR
8 BcBBE Coif Golgi gsi cin
sEfssefiiossiiloseiilossials:
ZséizzzséizazcaizuziBinzacisaz
st 88533588535 858833538z3
g Snes
5
$3zg Soce
2333 933s
3357 onze
II3z o-@
I%8
3 s§83 3388 5333 gs EE
g ©8%c gEsc gsce STse ggg §¥
§S 3853
Ig: §35S
283; 3923
333; gygss
23: ges
33% 4§
PR PR PR PR PR
2E
§§ 2223
2323 S885
8887 S285
3833 £28
s&sF ds
S88 2a
=S ESE
885s cecS
gg” asst
gges cess
§88- —ce
£88 a2
cro. ses. sere see. cos 8£
®3 g2Zg
EIFS 23%3
3EST 335g
SESE 233s
SSE $33
fis °
2 Bg¥r $gsy gEsy SRR gd:
es =ssg @sEg 5£EEg 8§TSc TET
$
-
§IsS sss. sEsc
Tee Lege ABE
gist
LER
gi:
e848

g £237 g%Sg 2833 §Igs sos

i g ‘ i g
§§_ fii
$3:
Est
fpf
fri
fpf
Exif
gps gd
18 31% Tif , 21 EI% 8 if
£5 555 8 555 8 5550 55:5; £%
§ 2 FEF g ERE § FEF GS FEE 2 EF
s§ EESEd EEE Sfuss
gfoos Sfcss S98dd zgoss
Feiid “fas
Bild
PEEEEE
=
cuff:
s
“iii:
=
Brig:
C838
gids
5.8%
E BcRiE Folil folil ggiif Bit
siflsssisiessiifareiilnaisiee
st38s3s 8st ist isi sz
ZsBizzzciizzzcBizuzciizzaciiaz
=
S
®ssg
zZtg
TUT:
eseg
EEE:
eeeg
£8Tz
eecg
TET
seg
S$ fase raver ooes cows a=
3 3843 g¢8S §58S g38S RE’ 9.
e
Ss
898%
Z=cS
EWC:
sess
KESc
sess
KEGTc
sseg
TAT
see
g
a
SsgS $885
488¢9 F382
Rego Fang
g9ko sas3
€8&e° PE€2d 5£
2
g$ cer.
25g soe.
$83Iz rac.
535g coo.
5333 ems
IT ¢E
SESS 29gf figs Egy IF
© §¥8% 8z83 £38 E23 §E§ s3@
§ J
KS%e J
ToT: oe
585g a
eEEg _..
gas 3
$Ss acd
333% ses
fri: ses
gEfs seed
FPF: sss
gis
3 3888 288" g¢8s° 288° 8g
= @®sce 88%: EESg ©SETg 8ST
S ©333 9oes ones seme enw
oi 2g 8 SERA 2838 - ege- Is

3 egg? 3g83 cSEg? £z§? =gg

s 25s g3gz g25S5§ 358s sig
& SERS fggN SF8S 38x? RFs

g g £ g £
i 55% 55% 551 §5% 55
§ ff gf gis gis 0%
Eg E35 2%:
, 227 SIRE]
gs B82
S155: £33
ssff %S533
22% 5fsiif
33% 251
8 3%
§ E§saa
es
gei88 ggasss
82088 Egsss
Jod8d tfooa
g2d88 €ess
5288
g gees Jfsee S82ee Hees size
§ F:-888 3giBi FoiBi ciive Bi
Bigi¥Ei
stE8ccs 2
eres
8c
srrvifovneafone
foes E8oetsins
85 28888:58888:54888:88888584833
 s
2
22:23
Fd
2583
on ® ig
2223
a-ey
3883
Sson
gs
— an
° §hes g§98c 388° I35° &§5 8 3
2
z Sasa eRe = esc gece 838 g
$ JFPSE P82: gE Pity sf 2
2 gg¢€3 g¥sd 398Y sss sg 52
PR PR PR PR PR E
¢ J2%s 32523 2%Rg 922 3222 a
®
2
EEEE
Nao
2%:
Sane
CoTE
698
S227
S592
2°32
Tex
@a
° cde SEN £98 - 288 - I8%3 o
s
= <T@eze 8F@g <TREg BF@g 8I8 8
S
® S228
PIEE 333%
28S: 222%
crf 38888
SPF: gg
gis 2
RS egT a rE 488- CER £83

e 9%fz 3333 2%%z 32%3 33%

$
«i
503%
agen
FIs
TB]
53ST
283 -
3Ss§
e388
sae
e833

g 3%Z3 g33%y E%%z 3833 33%

2883 558s IFET gad 23%
§ 8%%3 38% :2%23 gz3Ez 3822

i £3 £3 fry fez £g
& $8 E28 2: E28 3
Todi ii ii ap od
5 8 585 5 £535 & 5535 § 555 53
fj FEF 2 FEF § FET 2 Fi g FF
S E533: SfZ2:C 23:23: zfcc:c ¥icc
fopies: Iiii: sii: Sizes Zig:
§. 85888 F888 F888 EEE Egi
SIL il ci
2ifizzzciizzziiizzzciadizzzciizs
Bs £d838:848885358885848888:84883
§
>
32gz
woes
2233
FE3s
93s
ates
23g;
coo y
2:
cao
Ss §8Re {BI {82 88%8e 498
.
3

e
Ss
®88c
sos
@KSg
ccd
®HTc
seo g
@WEBe
soos
STH
Ese
g
@
2 23S gIET gs3sT gg82% Is: ¢
< 3° g8Lo E88 gBEo 59 €
2
Ss

§& gERs
838g Teme
35%; Bove
8337 news
85%8%z Sew
gz aLo
€ B38 ZEZ5E 28%: 2322c === e
= d§88°s ggee g3a- ®B-S £3§ 82
=Ss 838g %99g $8%s §gZz 838 3
S PEES
SscoSg
SPFr
cccg
3gss
sess
gir
sees
23s
sso
o S88 =geso S88 88% - 858
= £88g ©9%g $9%g 9I8Tg EIT
S$
o
Ess
CYR
Sigs
IRIS
Sas§
Lan
aces
egra
sas
858

3 238° #73: 2338 233° 33s

£ 23%3 23%: 3733 13323 332
§ 383% SEsn REIT RRR? £3g
g 2 2 g 8
§ § § § §
5 Pes Pun Pus Pes 2.
3 55% £538 £53 25% £5
g 2838 38 3g gg 8 3
3 111 iid g2¢ 823 if

fT _ FEF pg. fFf z_ iFi g 5%: § ‘5%

§ ®8sss
s
B3988 Zgsas
¢5800 ES
go888 23808 35¢8¢
EEE] Egass E233
£28222 Bio2z gaze cff2s size
BE BgiEl CgliE cSgBBE goEii pit
siciessiileseilareis
2 E8szpr fizz
ini Piosst Sissi fiss
0§5ac000é6§S5cooo0f§Saco0o0oé§zcoonbé§zacon
 §g 8533
322% 22g
3ZE=e
© fee 8&3 - 8
3
e eR@ = aay g
Ss sseg cccg 3
3S 2332 3:8: c
Ss €88e
PR
888°
PR
g
5
E
s 353: 32:3 &
3- ZIgpis
feg- 22:2:
8880 28
s3 @seg essa 38
2 S33f
sessed
33:8
cdg
Rl 2H 893
-

32 £823 fis)
a eT ccag oS

E87 #§3T| 3%
CBE BBE 2
a Soog ass 5
S$2
Ss
$33:
sssg
$3¥>
553s
SESg
33°
g3
g

5
gS ggg
Sdes
222g
@eos
| 3B
3
Ss Reg? e23§d 5
5 c 2
£ £ § 2
|| z 3 =
g Le £3
£2 £5 Fps
i: Pit
is igs
258222
® TEE TR | 28
I, Ni fEt fs
Bg BEF,3. £22|L,
£ g E28 f2E 3 2
35% 58 gs 8
§: 22888 35888 83
8ics: size: (2
PEiIE:
8.55888 Fiifi fE
ppiBi B38
sEfisssiiisesl
3sffzzzsflizszs22
 - 3 fo a | 8 § & TT a a
3&8 < Ss S s 8 & 2 S
8 = <= ® ~ w o <
2 [EE 3 5 8 g 5 & Bb 5
2 b= = = ET Or Be & B
g [ig § 2g 23322 2
g$ 38
weg
5 s 3¢
3 5
EEE
8 3 5 2
=
2 - oo JO -
gg [sg
53 &= Ss S3 sgsss Sg
8 |€5| ¢ Kg g 8 5 & 3
2 lio ® TT s § a a a
5 So 1-1 e € e ee z e
3558 © sx ~ @ @ go >
” Fh 8 8 & 2 3 5 = &

Ss 5s £ : 2 g§s¢8:2 g
FEiEs 3 ig S83 3 2
g 32.
= 8g 58 =<
3 s 8
Ss s
gs sa
Ss ss se =
®
s
2wT 3355
=|”
©& 3
== Tf:
w & 3
3& 5e
82 BE.
BS =- gso a sgca 8g -a
gifige
©
o
58/83 3
BS e
£¢
&
2 ssE:
Za4
9§ ==
8oo
g 523 Sw
3g - 2 3
&§x =<
23
iy
2
=,Bese 13z
eo 25 §Ez BE3f g zg
2222 £32
0g zg E25
= 3% £ 383% _Ssf.f f fpf;
25; Ff BE ivE minigisy fois
3 88 ge %E2fe Gefogzofe ERoR
25 go ¥gafe Goiodsls 88s
52 35
22 23
3 $3838
220% 5288828
Fgeceges
Fish
2:32
5 2% £2 fe2:22 CEe2efef S220
S52 SF $233: s§3fvfsiy fr i
c HIRI
Be HEH
88 33%:2 HEL
zésdidied iis
3 2 @ 253 73 gs 83 a Bb
= ew ow ov 2 a e = ao s g
2 8 5 8 8 8 8 & 8 8 8 8 a
a Sd §@ @ § § & §
2 F232 3+s 228 @
2 I
g s£
1 Ss @ 8 ~ a a § e ow =o E
8 gd 2 8 8 8 2 8 z ¢ 8 ¢ &
-3 CoDa8CDT scoo g- a¢
S° ss
s2 23 28 a8
83 28
5 = N oe n Ss2 355 =35 2ER a
5 2 3 5 5 5 ¥ 3 ¢ § 8 3 8
9Ss cs 8
€ £2 = 8 L
2= 5€ sg % 8
Ss ¢ ©
soS
2 EEE Ff $: 3 ¥
8 gE 3283 1% £2 2% 5
® ss eT ® ® 8 gs % 8 7
> tests $2 g
8 et 83 8% ER RI 3
>= F222:
« ° = © 2 w Ss
$Y:
o Ss ~
E©
S 2 8 2 2p 8 8 Ss Ss 3 s
z EEREBE. 2 2k 3

3 5s 2Z
3 § 3
2 :.5
§ 8¢f §55%5%% ¢ 2 £3 2

:2§ 93: Z22Z%ti8cgs:

P22: fgissi fof
123295282282
Gi, 2
82a2_%
_%
=z2
5%
2 55035280855 2352¢g¢ pogeze Je
83 £23:335:3:58558
$58583858585828 4J3%353
28:78:38 13
38
g Eoelsseisizles:
3:
(3giegs of
22383°%35323833°38 £.3238°8 Ef
BEifiscs:g:fzz: 83:53:35: 25:
E§ T8ff353883838¢E8
FFEi28iacEc2i5: 25383323
sifgise 2:88
asc
 $2222
gts:
2338¢82¢
g8 3 8 8 ¢ = 8>?
5 g
iiit
2 a2 8 2SESE
323233833& iiigrey
re:
EERE EE :3:
sii 3l5% 2331138 : :
!
EE EEE
132 ¢ 3 8 3s,5:s83:
8 8 & 22d :
©
ggzs:2z2
Ti
$i
28%:
iii Ess:
3 2
iid
5
3 3:8 33 EESEE ¢: 8
F1I3IIEEIIETL]
EERE88EE
ids iaERE: ¥ EN
133

88 § 3 i 2 iils

Psst § 8
38 3% 3% 5 38: ¢ : 2 Pl
g 2 g.8 2 2 3 § §
$3 2 BEE i
3£5 Refit
EF % i. iii
§ £5 Yersiizigifiiigisctin
fl
faftreliiiaieqiiiiatenidite 5
Pia
1828583858883
2858333 3855253ijiasis
cggscgdss sicsficitis
§sEsescgcses
ndnminnn £3 Bgfgriiils iis
gil
BiihEigizas
$ @ § @a c 3 @ ®@ & @ § § 8 § 8 8
2 2 2 28 2s 8s 8 3
S 8 © & - 3 § = es & 5 a ° 3 @ 2
§€ z 8 8 8 5 ¢ 8 8 8 3 2 8 5 8 s
af
gE?@ 3FI 8 @aETE
3 8&8 ITET
8 @ @ =
ET& OS@ s£
FS 5S aon ot 8 moa 8 Zo@ oa os oa g
¢ 3 8 ¢ 8 ¢ & ¢ ¢ 5% ¢ ¢ 5 % @
cs seas
easceaeaca
2 22 2a 22S 222d ded
2g
MEE EEE EEE EEEEE s
§d § 2 3 ¢§ 3 ¥ 5 8 8 5 ¥ 8 3 8
s § 5 @ @ @ a 8 5 @ a © @ § @
2 42 £2 £5 8&89 £© £@ ©@ £= ©5 5£ &w §= §o oa
4

¢ 8 8 2 3 8 8 8 8 8 8 35 8 8 8

FE frre
8 8 £ 3 8 8 8 8 5 2 8§ 5 8 ¢ 8

> iris
§ & 2 5 8 2 8 x 8 2 8 8 § 2 8
33:32383:22838¢%8:; 3 8 3
2 2 8 8 8 4 3 & 88 82 8 2 =

£§ ££ 8 58 5 5 8 8 53 2 §8 §B EB :
FE FF Ff SF FT FT EEO OEe%
§ 8 8.8 § Bii-So8g3
888 848
ggefese ofeiesobasegefagagate
gle geo Boyoiaoajadddageyeiegse
318232879328°3283350823282343%3
95525254535 02300 020"
2EE2CEC258Cc2828c2 2522888225 23¢2
indi
3,3F3535323535383 35323238 :35¢3
3538533505805 5:0¢88235883851838
 = $5 8 8 a a &@ § § 8 8 @ 3
2 2 8 & 8 8 2 2 8 & 2 8 = s >
4d 3d 22 3 3 2 38 8 8 3 s
§2 @ 8 § = § § &@ ® § § fF § ® E
= 8 8 8 8 = = 8 © = 4&4 = © 2
¢
EEE
5
65 8
EEE
5 5 8 8
EEE
3 5 3
EER
8 8 3
g
&
a @ § § § 8 TT @ 8 @ 8a T @ § 2
EE EETegieg
ggggs segsesOS
EEE EESED 32
5 3 ¢ ¢ 8 ¢ 8% ¢ 5 F¥ 2 ¢ 8 ¢ 8
§ 8 § = = § Rf ® = ® ® RF ¥® &
£
EE EERE
££ £
EERE
££ §
EREEEE
= £ ££ £ 8 £ ¢& ££ ©

g§ 3 8 5 8 8 ¥ 5 5 8 § 8 8 8
EEE EEE EEE EEE
§ 8 8 58 8888323 8:28
Tf ftir gz:
ti tt le
I xf 3 Fg 8g °° ¢E

EERE EFEEEREEREEREER
fF fgf
$58 ©528 §ff sof FoF § O82
© 8z%
sS%ssenci
SHB BRREIIEBRR
egekedogs s8egojeredajalage
2020508070808 080505080505e883g
558525°58 5:525338558533588
€3E388,353383358
¢:3¢
85¢2585353483
FEgi ipipiaiyiiinioinigisini,
Hills bsIRIN IE s
ii
23335383833 £E3:832823883883883¢38¢
EER ERRPERERR EEE
a
£
88 8£2 8£ §2 §££ 39 °3
4d
88 85 58 55
8 8 oa8 32
aTe 5s2 8fg =TEE
8 a 32 SEg
cs 222:<¢:z:d
3 - ~ = ~ 5 E
2 8 § ¢ © 8 ¢ @
ce
s§ @
ze
§8
=
=
2
&§
=
& @
ae
28 2:22
§ = § 8 5 = 23 8$
2 8 8 8 8 8 ¢ 8
es 8s2 2£ 8© 88 a££ §¥
I $2 E28
4

8 § 5 8 ¢ & 8
§a 8:28
a © © =
¢2§
= ~
¢2
£5 8s 4 ¢
ces ass aga g §
2
2 ££ £ © § © 9 &
iF 8 8 fw 8 8
g ss 5 8 5
Sp 238 8 4 3
:2 £3dg rz
Bd 3 § i§
£
2
£
gg
£55 8 5 5 8 3¢¢
§ 5 5 § 5 §2%§
ff igigt tT 3%:
§ 8 BsBics 2
2fe8eSejolese
§2
sieusisysiess §
§3828288°83838 3
133 3
3 52222

sfefessgscecs 5 2
Hii:
3£3:3P3832%8
832¢
gssfisesdsese
22
 te 8 s 8 2 8 5 8
88 © F * 32:
= [BE 2 ig FFE 8
3
® a 5 a
3 [#8 ¢ EI gd 3IT &= @
2
g [38 ~ Ss 3 sss:
g8 |€F 8 g 8 gg 8 8
§
° 1 a ® a a a @
5 8 [82 es 2 s ¢ 8 ¢
g£3082;
2 g 85 52% 35383
2 2 8
$e |, 5 g @ Gs 8 & ®
@ 3 [88 < es = s 8 ss
ws 8 [£8 © < © ~ © © o
53 E [3% gr Te eR
| 8
© 2 ! 5%
a ™
S a
a aE
& & & ®
8 § (38 s
22 Tz S S =se Ss
S Ss
ao¢ 8
=
£8 8% 8 gg RRR
£3
Sz |=g
goS %s 82 TofS
ER
e 2 |ts o = ~ a
§ 5 133 RoR 2 EX 2
25
2 a 5 I cs FF 3
zz se 3 ER s 3 3 3
£8 55 3 2 a ° 3 e =
33 [5° = TR #8 2 %
gi
EE
Ss 5g 2Zr
7 £8 £
$ 28 43 _F 5 @
§ 3% 3 $258 ©3 _383%3g: §
£ 58 gs 388g 25538553 §
88 gt
31] 2g
£3 FCs?
Ee8p 3og osfsis¥s
§9282%8:% 33
25 2S|
$5]
8:
=z:
2§:if
33:2
; 2:i3sizsi:
gEe3c3ed §
g8 38
=3 33 £§PE9F
Cc?g2if0 _,2%5PsEsR
Eicidci f=
Fag s§ FEC855 sgsfsf2f ©
23 BF 238ifi <°8383fzf ©2
sc, B8|
28 2S
83 285815 >45BSw8ds
E8213 2882848323 a
 s S es = d& Ss = 8 8 Ss
2 2 gE 32% 8 2 838 Foz
<
a a @ & & IS 5 a 2
es
-
S@ EE
o ~ = -
A
£€ oo =
S
0
£
3
gg ® 8 rR 2 2 8 © g
@
I a @ ® = a § a a a 2
se es = & Ss = 8 8 s a
Rg 8 2 & & 35 8 gE 38
se
ea o es= 8<8x °€ &i ss
5 =~ <@

a a a & r @ 8 ® a a
oN = 8s 2 ~N e @ =
gr € Tg ® § 8 2
a a 2a § § @ 8 @ a s
2 = e Ss 5 = NX a S

s 2 se Ss & sz Zs S
gE 8 fF R88 8 * 8&8 g

3 k] ® 5 3 2
Eg 2 2 g 2
f5 23 sg wu wf 2 & wf S 2253 & 524 2 %
£TT 8g
5% 8 % _f3
8% §© Ey
©§ BEgg £38
585g & &
=%
8 et gw 828 9-9 28 gs-ee 8s
S£ $85
Sz §s $3sb
_g3% $f:
sGa< $2
a5 §.8:3
sfazs a8
Ss
£ 5g; $d:7 21335 $f sE:is J £
2 3 2533593238 38 2 z
S S82 5 ESERIES EE fsgfsés «3
253388 U53:33°83%;82585328
2ecgye BEceB2e-csfceTzege-t
£83
Bot
Jeo
i5sYs 8 2335sfE3g-2238:888
z25BE58583535253585 388
288
<Z202Z0 @TO<XCO0O<0@WzO02ZECEOSO0 ado
 Ea EI
§ 3 i822 EERE*IR 3
£
s = § = &@ § & § 8 = 5 = z
s 2
ss GS< 5s$22 a2 =ee a ~8sa83 ss 2
835 8Ek
z 8 £8 8 fr 8B 8 8 8 ® g
&
TF 8 § § § 8 & § 8 5 = 2
EER
3 2
EEEEERERE ER
B32 RR IL EEEB 8
s 2 28 2 28 2:28 os 2
5 8 3 8 32 2 3 8 3 8 %2 38 8
s a a = ass fc @ 8 @ _ § 8
i: fiiiizz:E:i:
IT 8 § § & 3 3 8 ] @ . sc 8

3 dg 225832
3% 38
Ss
-
8
o
2
-
$2Py o22838
a w a
3
©
8
~
3
5
2
«
=
o
8 6 © ®» 8 p 8 © © <2 8 RN

— #8 EE Bal LAW TB
£
i 3 E 8 8 8,8 Bcg 228 § §
§ 5
_8_38 <5 5 535855535588 _55%
Sgcsggfss8egs8ggss8s
g8s% 858888383828°8:38085¢8
Hi iii
Robs Jo-oholololosgsicla8ays

z8z
5383
S83838ciesEa
;sgBciGig 85888548
5335328235883
BBcE
CECE SEE gE: s8582853
CBSE
csc FEELREBEstaigEns
$382
28068
Sijzdilifsiziiciizsiiis
883x838 <8<8338686888adudéd
 s 8 2 223223383822
885 88% 3 ERS EEE 3
g
Ff 8 = ®& ®&8 & © ® © ® &§ 8 & &® 2
g
5S dd- 82 ZT2 3£ 92 2££ oa2 odd @= 3= a= 32 a= 2£
Ng 8 8 5 3 8 8 5 ¥ & b » 8 ££
@
®@ § = & @ § & ®& § ®& & § & ® 2
gs & £2 2 2 2 2d < 2 = = 2 a
g 8 2 88 38 33 F883 F 88
s® 88 2:22:22
3 = 5 5 @ 28:2:
= @ @ © 22
© ° =

s 8 8 § @8 KR @ @ ® @ @ & R” @
ew 2 2 © ® 8 3 ® © 3 ® @
5 fF 8 f 83 8 ¥ RB 8 B® § § B&B XR
= 8 8 © RR RR & §8 § @ ® & RK «
KN oo KN - % @ = © o @© a = @

$d 223d :2:238 23:32

FERRE RR ER ER EEE

22 EEE OE EEE E°E_EB_EcE

$ 5.5 5 S 5-525 So5IS5Q5EERS
Sols ogudeyniotohalaclalsZals
Foes joe 2=dcz 3c 23232
25382822878255283322¢83 s§83¢
$8285858185438888-828¢4388¢88+°¢
SEiriicyrEiipirilEiivgifily
S552 fsC585 5855255358523
FiflElslsiitsisnEcEitiii;
23883583E38323283383233838853%838
 2d dd sds
<
$s @ 7 @a ® a § 8 8 a @ aa ©&
£ gd ¢&§ 32 8&8 2 8&8 = = 828 €& ££ 2 =
IEE EERBEEEEREER EEE]£
8 8 8 8 5 5 8 RN R ¥ 88 6 8 8 E
&
§ @ @ ® @ § © & = & & @® & § 2
2 4 8 §& ¢§ ££ 4d 86 2 ¢ ££ g & 2 o
§ 8% 2387 F788 %8 88s 83
23d
SN = 238
a © ases
© a 5 o = = a =

a @ ® 8 @ a § 8 § @ ®@ @ @ &
x - - 9° 3 @ @ @ 8 = § w =
R 8 8 ®¥ &~ & NR © ® 8 RR R RR ¥
§ @ 5 5 § § ® ®@ & @ @ @& @ &
- 2 vw + 3 ® o ~ T oo 9 Ww ~ ©

2 8s 83 28 2 <3 2:8
2 2 8 3 8 $8 38 2 8 fgg =¢s

FF §F $F F-§oF FOFRE EB. 34:

5535s 52525555575 °% 58% _%©S
$3838 803358¢878282328:,853288238
IXEEEEES EESEEREREEL ERIE
jsYcdegstasvsedoooialbolayals
£2525535235838383335553¢8583235¢53
532382 23s 13832275
BEER HEE
Cerise feirizenfeieizezcai
Fcfcicgescscfescdcdeechfezcese
8858883883838
2565853535853 8¢885888¢E¢8
5355555£E5258556
£32328232832323282323863838638238
 es 23
© a ©
233;
- 0 © g
22s
-o
2 ©g
o Ee) 5
§ 7 8 = 8 3g ° §& g 8 g 8 =

§ & IT §&§ ® &§ @ & @ = @ Ff

:
a
EE
S$ 2 sac 3 2a = 5a g£
8 R 8 8 3 8 8 5 8 2 8 g£
&
f 8&8 § § 8 ®@ & § @ © © Bo 2
3 £ 8 2 8 dd 8 2 2 8 = 3 a
F3SifIpifiiz
8 R z RN 8 3 RR 5 8 8 % 23
Ss 2 85 2 Ss 8 8 = 2 2 2 3
RE RRR ESR RK BH
ae a Fe ow ores 3
ggg
8 = © @ w vw 8 IT @ § @ ~ °
fF Ee 223 EFF: 3 ¢
es 2 5 = 2 35 = 5 5 5 = « B
2
S 2 8 = 8 2 3 = 2 2 2 4 g
ST 2 5 : 8 8 § a @ 5 o 8
£ fT 8 8 fg 5 8 ¥ f g8 8 8 3%

£
202oo ©2 ©8&8
Kf © =»
2 WwZod@ ~= ~og
@®
82
Z f{i 2g8 &8 2R 8RR2 88 8BR £= 8RR gg 2¢

5g
£5
3 2
@ g¢1
$S888sF
E 5
2 § § PcESE._}
T8885 3/33
§8353835 ££ S.55588g55%2382
gEae8
2858287838
EERE IES 808881828808
IEEEEEEEREEL 5RE2
§occfesoysfrdciogsiazedc 8k
5888532232838 35833¢3258%:28%838/¢3
pif8g8ci-8T85858 8.82888 ¢3
$853283323 8538230858285
2E3g8Egceceptecgepesfeec2e
28 2
385358833838 38E8233883E¢8 ¢ 5
253523555558 585858585¢25285|8
£3338823285823858532838883| 2?2
 inl §===3% Saass ggs=sd
=3 (88 S338:
2333: 355923
85327 B55%%
85523
3
8
2 |lizl 52cm
ye 2
2asas
& EE
a8c=c
a
$ 38 S553 $8335 33853
5 |8€] 68382 ¥N388 £8d8s
5
E = = a ea
§ [82] SsE853 c8388 cesses
2 § [83 3353: 28285 3333:
5
TT 2.
€ 2B, | cecen sHene WIESE
£ 8838 SsS5% 3833s Sssss
£538
gS 55|%F stser
s=ssc SESSE
R3IN3 Sziss
39583
i 3 I o
$ 2old8| 535553 8335 3885353
8
§ 8c
§53%(55 Seoay
sfzan w-ene
25988 KNoaga
E383
26 220]
£8(ta|
eweee
SSSS5
CREE
easas
REEDS
g§3===
§5|58| ssss¢ 8838 Sc8ss
8g 52
53/58 rf2z=as
52339 “son
S8385 eanean
28385
3 Es
& BE|se|
SEIS
§3===
Sess
esses
cecece
§Sscc
geese
§£ 8855)
FE|83 10350
23339 gpg
$3332 S:vys
38333
8a
§ if2
E 3% z
5 82 §
= ul 3
8eg 2%
£2 5 £2
gE g
2
3 5 : 5% 3 E $8 2 58
2 8E| 3 £8 e §§ 3 3%
E >g 2g 23 £5: 1: 3 $52
5 38 122835 SEEZ EE z8%
s §=| [32852 p3BESE § Bsc:
2-3 22258, Epsesi.E0585%,
FC oug| |[SESEEf SEEJICEEYECECE 4
28|
uw BE (3:33:
855588 Z3seigsifeiics
#£5c=288225:5288 of
&
 92392
3385 333°r7
$8555 33372 R37
ec88ss 88838 2g
ss g3
IYISS
g gE0355 ©$3333 23333
gs 22
g 32
_
fegsc _Ssccc _%9g=c S%aas
_ _gg 3€
Scccs Scsss SSscs8s SSssso Se 8
oo on~ Tomo a YVomnw YQvoa 2 2
Rode Lomadc L2w6ado IsEOS 2 © E
@a
Sesay
95332 Sseeer
53282 USscr
33382 S%oew
32333 2s
23 ¢e3a
25552
Oiro®
S383 Sge=2=
Yocoo-
S888C 352°
TO9nmo
$2582 2gans
“Yona
28358 ex
5
és 38

g3ags sg§gcs s¥sss g8asc 8

835227 323327 5722F 23235 53
2335z 3335s 3355 §3a23g s3

83335 28385 28335 sggzgg gg

C@2es
$2382 Sri-e
SIT? BSSees d&889s
29883 So2aen 23
gd

3
n
g g @ 28
§ .¢ 8 _,8 _,& _, E2
3g 85 zp 8% 2g 8% 2g HT $E 3
28-85 3825% 3Pz3f 3fzEE £3 fz
E95SF e955 e958: evEs: 3f ii
$5258,85258,825%8,8525%, zdgs®
HHI HHI IHR
§5322335323gsEes3gsges
gleBisdieiislasiscincis: mies
E182
227
css Qzzzz
ecsss og7uz QgoEn
eesSe cesce oni
gg 4oR
858 £88382 22232
FE 833838 §228
LEE] g3
_ _ _ J a
gc< §§==s<o cogaq IFREAT Naag g
cso Sess Sess Tceee Sco 8
2 oa 2c0o R%0uwuwm Noerur N29Ya
S33 22383 28382 8352% g¥ead Eg
&
>
§55
222
<Sssss
e572
$3338
Sense
28883 sZt
wines owmoe
o
sNz
S87 83 EE
se8lc 28 533
58533 8 s5se
85582 ges?
ges: 83
Ig= =8=== $23ag scaass Sasa
2%
S58
33g
S833
$2857
feend
FuscT Fa:
R333? sdsg

$3% §3gsY PIiEE :EESS Ii

237
N= w
3333
28 ca-
22Q33
Sy5ee
gmesE gigs
2-<r~o Srey
$3 2833: S333 35372 scfes

_ 2
55 ® 3
ce 2B £8 g ce £ 8 £8

BE: ® 3,82 538,52 8 §,82 gg. 82

SE £ $25f E2328f : 22Ef TEr8f
$5 3
£%
1E3F
eco:
§3iifi E£og =5£F
§Ccs2EF
iisE z:iss
Feof:
$gee;558¢ge §5§82e§TEs82e2gs§:
SiERgfgo ir defoEEniilogtiiif
Siceafi2kss TEieEscRiirEscaizis
S822258288 F2552828325538228¢828
S 22s8s cds S8Sss esssS§ 7
I 82352
#2 :533% 83353
g 335%%
e 3 72
_ _ _ _ 3£
sSs %%ssg
SesSss
,,,,, %assg Fsc=%
kkkkk Scecce Sess gS
2% 9%cee
@sSRNge 22227 Yuoue
28828 Ysony
238%3 EEg
@a
gss @©3sss
ss33s
Y%sas Tose
SSder S8888
I§g==8
S858%
=
2
5§ Rees
3F2®=Ix HRpioa
Rg3sT Smiee
F333 Jeoaw
FEges 8
5 I8sas L:::: ©8%@§ §¥s=g
So Syses
© SNS -
£8288 F-255
NSGBas
SoSSs
orvag

2 $3I3sy g5csce 2839s §¥ssg

2 3$3Igesy §%seg 28393 §¥ss3

a @%ass 8835c seesy Ios

S eScsos 2a22d Ssscce S22SSS
GS§ rSsea
29382 0odYY%e
93er-? coees
33838 2Noee
29388

- 3 13
£§ 58
i% 58
:2 58 % 58
.g
8c 38; ii §
85 8&85
I,Eo 58 ¢ 85 30 85 8, 85 3g
T $232 % ZrRf RFit Ezie 3
§ 355% fgf55f 3955% 28588 2
(25288, 052287,35288, 82288, §i
Es" BS PEETIBCFEEgEo2EEBCES Bo
HIME EE RE HE
2az3r=882c3c=s8c23cs82s3cs8¢ ae
33522
s8355 33372
38535 -33°%¢%
=3883 23333
£3333 $28
&23 goa
$3352
g E5533
8 352:
£ 5538
£ ss
8 32
_ _ _ _ _ 3
Sgccc §8gcs Sages S%sog %aa £
Scsss SSe88 Teese tess Sco 8
E5883
REE
ES¥IS
0 Roo
ZREn2
NoenNo
$8988
2lnove
$33
Tow
g
B
@
@
SS555 233855 =283% £3583 338 ¢
282-2
82353 2822s
F982 Inge
RFI se5g52
53%88 2°89
£28 38

§8ccz §%§cs sfasss 2T%eas I=

§2882 58233 833% R8ses 38%

SoESS S3Egs Srnec ges 3:

S335 2583s F238 32533 S8§

S223
FNS ~
Sores
EAR
sacss
FREER
sSnse
~KNewoo
a=
Nw

£8 £8 £8 g <8 <
£8» E82 5 13 ¢ E3 of
£52 § 2% Zp E3 Be 23 3% 2
228% 28% §2z8% Z2z8% yz
$565
sc 238 18is:
jess: 238: 3385%
EEss £358
SI5E
£285,528, 38288, .Ssrfi, Bs:d
Eafe B cscs SRR rE E a
3EEsianeiicEisiis £33885: 81:¢
3558883588583 c=8¢ d33rs8833kcs
23
ZS Jz377
Teese Sager
T:zsss fogs
SSssSs fogEr
TIsses MI
TT 4Q
22 32373
¢ INIT
= @E230
$7 E333T
% 83
gs 3g
_ _ _ _ _ @
5a “ssae fsses S%asy Sscaea 8% £
ee Tsesee Tcesce SS8sss TcosSsses TT £
S53
SS
Zoace %a-rew 22-35 Le-es 93
Fasa- KRESS NZRIZ FsYds £8
@&g
>
5K Terese OWzes ©0gass T-Res G8
33 £3533 £=333 £8333 =Z=383 == ga
2
I3 jeune
93558 2%5ee
22332 ZIay;
8ZRYT 2%ees
Zed? Zs
§3 33

§% 335sy s3sss %%msae SIggs =°

5
22 SISSY
388°3 RETEY IaSSe 3ISET
RNe3RS §e3LR se¥8: if
Is
5% sacs 5358s 08ssy staas 98

Zs T3205 sZzes f8sss SZses I§

$5 s¥gss 23sgg 85ggg 2%3sg 2%

ow ©%2<on Y%6ne %Q%sve 2hreo NE
33 32332 27853 $5332 §:283%2 fe

2
£3 5%2 83 s8a 82 s8—© 582 8©
£3 gf: gfe EE: 22%
:og5.82 J§.8: 235.82 JE.52 3%.
fF SsoEf Cspff
§.5£85%, tspfEf8,55858,8%5
55,8585 Es3Er Fs
ERpIcEREicilziRofirgiiiieii;
§ciizsssiizssssia sds:
2%3:5828%3:c=:8283¢5=28885¢5=238885¢
SSS $2288 Liikkk SSSSs SSsss ©
$Y g3ces
g 222% ggzIne ges:
ig g3
23
_ _ _ 3 _
sg Ssses ,,,,, Socas TTascy ۤ
cee Sd=ee fiikikf Seecee SSess s¢
ore
35% ores
gegen 2222% 2rave
25832 S8cow
28838 §oS
gg
@a
sas
832% S%aa=
33232 ,pppp 2ases
23333 Zsass
232223 Ta¢
ges 2%: LLiLkL teses Edges ¥ 28
oe
Yes
2Aqen
gYvad zzzzz Farag #3332
s353Y Juweoc 8
ses =3sss ,,,,, ©2ses c2%asas ©
cee cScce LLL, eSece esses o
Soe
Gace
segas
OTC <¥oo
S25EE 5-555
cv -
Sgncae
albus
owo

§sg
ccs
sga@ss
9¥%c£<s
,...,
(EEEE
2%393 @3asy
©2c5se eSess
§do
gS sf33y 22222 Somer 3guss 3

Ges ena-s 25%55% sol evase 9

sss 8%sas ,,,,, @2ass @%asas 3
£ce C8cce (EEEE c2eSs efees ¢
55%
332 31y3e-
Fdascs £5535 033%
583% SoSSs
38383 ou¢

&
2z
58 8 58 2 58 3 5% : 5%
HENRI IERIE
Sf3 18.5: $3.5: 95.8:
£85 Efzps
$8.8: 3
1:F55 2:%%% 3
S35 S:p£F
£: 33553 23553
S:ps: Z2358%
Fipf: 358%
fspsf 2%
EB:
§2e.p5cg2ed5o58 e583 ,55888022%
Jeg den dt iii tacit
SESfc8ssCEcecsigc8 Boas iss
F223 eggs §5355885%8% 255s
B5ralib sala ssalabirgiiessit
§22% 22333
diz 2388 $5239
383s £3337
£8888 23533»
ctiZsse ©
S255
: 325532
8 (3352
= 23332
8 3han2
% 3g
_ _ _ _ @
seas 235@® 358%y S9ssss IIR@T £
dc-cce Tccee €€sces Tsessse TIoSss 8
©®-o Now uw “2c w®« Sosrw RZ ao- B
3352 =28%°538 ©C-333 ¢3388 w832¢ E
@&
>
@ace NTseas =2rass 22aac S358
8258 £23383 £3338 8s3335 ==383 ga
S59
85333 23e~z
833853 $2295
32335 28ees
£24323 Zoos
e:f33¢ 33

gecs 25ses 53ess 53esy sezaEs

255% 3555S S3IocE SESEf sis:
8382 28323 387257 Rd3IIE 3353838
cske asses SEass K2ess 5-88
F

S3gg T0asce ©%esa STesa Tass

sd28 22383 3533S 88838 zd
SEs PERSEY 2222 23372 rose

$377 22357 22337 28337 fizz

2ucy Z9-wx %%0re eivar IsIno
283% £2823 25388 Re¥ds e83%2

HERI IEE I IR
RIETRIETRIETR IRIE
5% I9E5F Iifoy diff siff 2
39%
$E£% 22s92
§zpfz $2sS2Z
Fcpfz §2s9:f
Ss3fr 22s2%
Fs3fz §8
58ge2gaggecgsggetyaggelgagyet
gTESCE oTEs BT TERE TES,
poe 3gescegeeseSgeeseggeged
esse obsic
2828558855582 cE sss
85c=82283¢cs8¢2¢2
22837
£2888 32333
22838 2283%
2288S S533%
SE388 SI:838
:£::588 e
8ggses 2895-8 3Is%°
¢ §S335
8 gE
ge EY §g
_ _ _ _ _ 3
Gsacs Sseag %8cses Sasse @hsas €
T£e8s Tcese Ttssee Y£ces TITcss s
SR3I2
Q2aaoa
II883
2<wwow
FINN 23328
22anN a Lo aan
F858
“Con w
Eg
g
&
eg
23833
FSI%% -3838
RUST c-g5gg
TUTIc 22358
SzugT 1233
ron ¢
gosee
83522 SnaN:
35Y¥Y3 gees-
¥23I]- Izees
¥sqe3 Sess
sags: 30B

c%sce s3ces 53ces S@3sE II5E@

SSZGe
Bw mo
3Seo-
oV¥<Far
N%res
G2GNC
Yoee-
CZOYNT
yeaze
BBO T=

T3382 232337 23333 33393 22937

2e5cs T®o-8 T93ey —o-Sw
587583 Seata
8:33°
$8857 3333% 3233T

FE se § £2 £2 § £2
gf 2 32 sf 31:85 i
eg #3
$r8E
uo 23 Fo F3 Be FF Ta £3
Z8r8E Z328f sPzBE Z2Pzps
250% §95c2 fghoz 23fof F35o:
£285, 5ee85, 58,058,588,
BEC EfE ICERE IIECEoRiEPR
REE
TERISEEEisincEicsiucBai iii:
SEzodx3i30a33f20a=s3L20as3izod
 22878
£2882 33333
23233 23333
25832 23858
223888 833%
=338 »
$5332
é 32305
¢ 333°
g 335%:¢
gg Ise
3 32
_
2%sss _Secas _ _ _ 3
®csss Tccas Same E
EEESS
Tcc-cog
2UI33
FIoe®
Sssese
£3353
FoIST
Tess
23843
Frifss
TZsSsss
Feear
Prgs
Tess
Faor
£
E
az
©8:c58
cc23d Sessa:
$3335 2sses
22883 992s
:c8dd 2883
£3383 c&
32%9>
28v@n 23372
Nomen 33352
N-are §35982
2%rew g332
Sewn §
3

S5ss® sSess =%sss -955@ 2389

28827 733% $335 £3RES Reif

S253s S=nee S5o-e s¥soe oes

29833 33337 27377 93%3g 1233

3s5S8 S322 =ngEf Ss5SY Cad
PPlova ofuwesr YOY oc ofomd SToA

I 588 588 5388 s22 53

S88 3 88s $8 3 §& =z 38
Be,g2 Sg.8F 2g. 02 25.92 Fg, 42
SE285 232285 sEz8§ EFizss zEizgs
£280F
EE
3RE0F
E SE
ERECE
E28:
cSREcf
—eSEE
Ries
s SE
Bc255,55285,352558,85285,5582%53
§c8fsgiciisgrciiegcieennnse
§s8osifsgosiste
cE 5 58 5583288
S155
E5202 E3f20ac83L20ac8ESE20a8E3C3
§S $2238 25383
£2388 523538
£2238 32338
$2238 228
£3 e
3 $2333
2 3I¥5T3
22 32IIc
3 ERS
2 38%
2g g
5
_ _ _ _ _ 3
SRssce ~“Neosso aed Passs T-a E
ce S8£oce Sctc-se Tcee Sc-=Zc-e tctg 8
®@
2 2araco
23532 Stew
33332 2oo-a
2235 0B “aann
23332 28
3:25 E
a
eg
§Ww 277835 283% °%E3% 353a3F 233 0»3
22 g3S-%
$333 Sm-vs
"more
82533 S3ees
©Pnrwe
23332 S2oee
Stmono
233%8¢° SE-B
°%S®mowo
335
o-
8
§ =3sss @Sscs I%c=cs 3Icacas 33a
5 3888" 338%: 2383 3R93y 883

S S285T SITSS 553Se seFgs s=s

s Sgass §5sss s%ass sgsss 39s
5S© ences
wNemo
22338
Srewaoc
ejoee
oVoar
wesos
wSoa=
25%
TON

cz «+ cz cz $5 cz §
g§ £88 238 £3: £83 %
is £2
2328% is £2
Z2>8% 3% 22
928% £2.32
ST 9>3f EH
F2>gg
3050F
EE2: 385SI
2 E 23553
BES: £3ESE
$i8:z2 cis
2:
SCEREE, 55058, 05255, 05855. 0512%
§8fg EEfigiEEgBtERSiiEEing:
SEiciissizissiieissaizzssaizt
22320223020 aZz3E20aZ23E30a82363
82
SS 33737
zZZsS 353277
e2S8Sss 2337%2
esSsss 22772
Zils 22
es?=
3° 35333
8 $2539
£2 3338°
2 3$5sss
z iY
z 32
_ _ _ _ _ 3
es Poe
s 2REeTe EFsa Lugs Ba E
ee tctecsce S€cssc SS8csss S¥-sSs Sc £
Ce
5% Shens
8I3%3 SNeua
22882 28-3e
$8538 “Soon
$8928 9-
#3 3
@
@
$3 22288 $s338 85838 33228 sg g
Sy
58 g2ese
82832 IN-NY
$238 93e3%
£383% 8Sz2ze
$1832 55
35 88

£5 @3¥cse @aSesy @3asy Ssaas ad

SY
$Y SZ555
52897 S3S58 tetas eseas
$88%2 52882 grgss No
XZ
5% 22383 $3333 25age c£3avy ag

2% JAZZ SE %Y T.%ce sxe Ey

8% §S¥E5 883953 53383 $s §S

5%
$2 §955%
38887 ¥Scoe
£d38% mhosm
33832 e-oa8
$33%Y of
38

g & g
s+ & 28g 28 2 8 a
37 23% 33% 11 1% ;
5 2g
£
8%
Efr3L
5g 3%
ZPr3f
3g
cS223f
8% 5g 8% Eg
B523r3f giz
§ SPESE 3E5F FEES: SEES: Fut
2 SE82% E2j2% Zj2jic: fifc: 1::
5.25258, 25255 ,205238, 285838 ,85¢8
PREiofpricicsigiifraiioiesfis
e33fescrzfescssfescssfeitas
§ciizEssiieEssiia ss isis
@Z3E30az3L30a023C30a23E36a03d
$33
SSS 13833
£3883 1:258%
css 33383
ssdds 33833
3:88 ¢£8g
3h% 32332
g 833°
83 33353
é 33TIT
i 2g
og
_
$95 ®%ces _ _ _ a
eee Ttese
Tcsee
Tess
S%gas
SS€sss
559.8
S¥acc
§= 8
E
222 3§323Y
cue NTtoany
2332:
Z2aon-
23332
IV-—veo
Fes
“WV¥a-o
2
©
aEB
g

eg
233% 53337 232337 38333 33822 2 ¢
$22 Zoeve
Yo® 33332 NB9-0g
23572 [Iwan
23925 avesn
33222 I3 8
3

sas
S35 s-ees
22832 Saas
c:zS83 88sas
£5228 38Fe@
£8332 ~©
272 3333Y 23292 33372 23388 2
$835 3%53% =ZI358 28333 §5%@s% 8

92S 3I3nose shoe s3ene SSNS =

23g ¥%ass %%aay =@%8I® ,,,,, &
gee “tess T=-cse © sess EEELE
222 Eooss SSS Sess
B3z 23232 33332 3d22:- Egg: ©3

o § g z
sg
28 58 sg.§ sg rR sg 8 53%
32
$23 $3 7 43 2
Sf3 28.5%
ETF $3.5:
2E¥Ps 88.5:
SifP3 Ef.5:
CffEF £3
§
58 EB3§0% Z3§c0F S3ESE L3ESE £3
£5,55258,5285%8,82258,5825%8,3¢
2EESE EE Eos EE RB ESE PERCE
BESS IERIEERIEISEIIEsiiuiRiiie
£88355588c65558883528883558¢883
eS8s $d cSsSss SesSs Tiss 5
ges
£ P83ny
E 53523
2 93U32
gE 535333
2 72
_ _ _ _ 3
sass §0asas asase Bases 8aca €
cece S8-c-c Sscscs Sssss TITosSso 8
Tw on 2am aon = meta ow Nlan~ ao g
S988 S792 33°C £33AT ZdaR3 £
@a
Frcs Toasae
$8228 22aas
288838 S8sac
$8385 SIERaE
ZZIgss ea
S538
S35
Soar ==3ns
Yomro SI5y- ©YY6mc
fSoo- B5gos Cavao
3s5egme 3o
sass acesa t2ase afses f8gsa
535%
S382 T2558
58885 Seyss
3£982 or nse Nucaa
SIsIT gdegyc
2eas 33sec S2aess BGsesg IIsaa

$S8s S82Zs sSesSe $eds8s criss

282% 33332 22339 23333 232:=2

S385
Foo
Yates
CToerfoe=
S%e-0
Sree
Nfsae
CEINS~-
22aca
S¥cvo

£8 & cs 8 53 5% I]
$e 3 8:8 ¢ $28 $& . £8 §
§2
£25 28.8:
CEESS 28-5:
ETEESS 85.8:
iEST 58.8:
TIES 22
§OE 850% £8502 28502 3850% 3
B58 85255.85258852858, 352858 25
SEpEERIopREiiosciiiiriiiiies
BE SEE iE Ei ET Ein EisE
f38285:s3885=88R28¢58855¢5=28¢82
LEkkk
Ekkkk cooos
TSSeS 22883 TIsse
TcsSes 22388 23332
cesses 8«
22222 23232
EE %$2332 EB#3233 suze
o 23
_ _ _ _ _ 3
Sccse 2%esy Secsa @§5@e Taasa £
Cddcs TSeee Tes8s8s Tc-c-esS TosSsSsS 8
Nauoaw m2an~® Qoaom Nrone 2xowxwn
85383 FEZI33 £3338 2538 s8323 E2
&
>
Sogsy 220s YSses Isaes -sees
44928 883833 £:=333 £2383 =388¢ 2a
Seve
S88Y2 %gn2e
$3332 I2y3s
£5838 Ign:
Z8¥53 22292
83338 83
s8ecs @%ces s3ceg 3958s afca@a
2058
SeR38 aScen
3233%% Nfase SIs 3-333
S883 $8538 3ooose
gTere 22ces saKes —Wees 8358

sees S2cos S%sea alass @Icea

@se25% g339@ 39255 avo=a atsona
£3725 32773 I%37% Tosgy zisss
SUSE JES FUSES Sore Zoggs
~NKNaao o¥Nmo Fhe No oa GZ
®6 oo

%
£8 g §8
. 8
g
,
58
8
® gs
s F
8 $3
%
ge § 5 3 sg 2 sg 8 3¢
g E23 5% FEET IERIE IR
2285 28785 52285 cfzf zizes
$558 $3558 £1558 Si55F Bilis:
£25: BSsoE:
£258 .C525E sui: EsnE: EEE
285258, 552 555258
Boffo a fiepa fie lR bic ag ice
BEIZERiEciEIiEBi
553885353 IiiEIsin
8885538825 iiis¢
¢528855888
 £2283
gc 22
INscg F
-_ 3<
TTF IT g
S-ogog £
£3338 3
@
@
s33%§
Seceg es
FERRER
83338 3g

scg=g
ans
ERE an .
EY
g
scase Bo5
25233 ¢
nese
Tee g
2
acagsg 2§
Zac8y
reavy 3
5328 3
Ssovy
sss §
. 8g
gg
£E
38 8
25
8
2 5% |£3
2 2S | 8 3
3g. 83 18%
2igk5
FRESE | |e
52
Ef: [8
fiscinss
2§sfdz 2 3

$38: 5 2
s5s8¢ 2 ©
FACEBOOK
Payton heme and Genelle Adrien
US. Publ Policy
Eacebook
 From: eat lame
To: KabanMoos;Crnvrd,CarlY.(C0C/00/04D0)
co ActateThomo;AtaEsa
Genel i;
Subject Ro: CAAFaca book a 10- Fb27
SurveyFirings
Dae: Tuesday,March 16,202 2:47:13Pt
“Thank you. You will ll have seen that | extended the time on Thursday to allow for the discussion on
the CMU survey.
Best,
Payton
From: Katherine Morris <katherinemorris@fb.com>
Date: Tuesday, March 16, 2021 at 10:43 AM
To: Payton heme <payton@fb.com>, Carol Crawford <ciyl@cdc.gov>
Ce: Genelle Adrien <genelleadrien@fb.com>, Kate Thornton <kthornton@fb.com>, Julia
Eisman <julizeisman@b.com>
Subject: Re: CMU/Facebook Survey Findings: Jan 10- Feb 27
Hi Payton and Carol,
Yes, that would work for us. Thani you! We are looking forward to the discussion.
Al best,
Katherine
Katherine Ann Morris, PhD
Research Scientist | Demography andSurveyScience.
770 Broadway, New York,NY 10003
Eacebook | Mobile{— (BYE)

From: Payton Iheme <payton@fb.com>

Date: Tuesday, March 16, 2021 at 9:23 AM
To: "Crawford, Carol Y. (CDC/OD/OADC)" <ciyl@cdc.gov>
Ce: Katherine Morris <katherinemorris@fb.com>, Genelle Adrien <genelleadrien@fb.com>,
Kate Thornton <kthornton@b.com>, Julia Eisman <juliaeisman@fb.com>
Subject: Re: CMU/Facebook Survey Findings: Jan 10- Feb 27
“Thanks Carol.
Katherine,
Does that work for the research team as well?
Best,
Payton
Get Qutlook for(05
From: Crawford, Carol Y. (COC/OD/OADC) <ciy1@cdc.gov>
Sent: Tuesday, March 16, 2021 9:21:20 AM
To: Payton Iheme <payton@fb.com>
Cai Katherine Morris <katherinemorris@fb.com>; Genelle Adrien <genelleadrien@fb.com>; Kate
Thornton <kthornton@fb,com>; Julia Eisman <juliaeisman@fb.com>
Subject: RE: CMU/Facebook Survey Findings: Jan 10-Feb 27
'm checking dates/times here but s it an option to add on to our 3pm on Thursday meeting and
extend thetimea bit? (1 believe that might work for our Vaccine with Confidence team as they were:
attending the 3pm).

From: Payton Iheme <payton@fb.com>

Sent: Monday, March 15, 2021125 PM
To: Crawford, Carol Y. (CDC/OD/OADC) <ciyl@cdc.gov>; Jorgensen, Cynthia (CDC/DDID/NCIRD/OD)
<04@cdcgov; Singleton, James (CDC/DDID/NCIRD/ISD) <xzs8@cdc gov
Ce: Katherine Moris <katherinemorris@fb,com>; Genelle Adrien <genelieadrien@fb.com; Kate
Thornton <kthornton@fb.com>; Julia Eisman <juliaeisman@fb.com>
Subject: Re: CMU/Facebook Survey Findings: Jan 10- Feb 27
Alo, Katherine M./team and our regular team would like to set upameeting to discuss the findings
and receive your feedback. Would you let us know a few day/times ths would work for you this
week?
Best,
Payton
From: Payton Iheme <payton@fb.com>
Date: Monday, March 15, 2021 at 1:16 PM
To: Carol Crawford <civ1@cdc.gov>, "Jorgensen, Cynthia (CDC/DDID/NCIRD/0D)"
<c4@cdc.gav>, "Singleton, James (CDC/DDID/NCIRD/ISD)" <xzs8@cdc.gov>
Ca Katherine Morris <katherinemorris@fb.com>, Genelle Adrien <genelleadrien@fb.com>,
Kate Thornton <kthornton@fb.com, Julia Eisman <juliaeisman@b.com>
Subject: CMU/Facebook Survey Findings: Jan 10- Feb 27
Hello COC team,
As we discussed, following up on our commitment to share oursurveydata on vaccine uptake.
We are sharing these findings regularly moving forward to help inform your teams and
strategies. Attached are our findings from January 10 - February 27, 2021. Today, the report
willbeavailable online.
Note that highlights of the findings are up top,a robust executive summary follows, and then
a deep dive into the methodology, greater detail on state trends, occupations, barriers to
acceptance. etc. Hopefully, ths format works for the various teams and audiences within COC
that may find this data valuable. We're also open to feedback on the formatting.
Please let us know if you have specific questions about the findings or the survey itself, we're
happy to track down answers or book time.
Best,

FACEBOOK
Payton Iheme and Genelle Adrien
US. Public Policy
Ezcebook
 From: eto hana
To: DaoyH.(0C/00
tos. /OADCY Cr Carl.(CDC/ODIO
os. ADC): Lavon,Katee(CDE/00/OA0)
I bd amanGoal Ain;Co Lec;AnTato aren
Subject Re: COVID1D Cutetocommutes wore
Date: Monday,Fobra 8,221 5.4424
You bet.
Best,
Payton
From: "Dempsey, Jay H. (CDC/OD/OADC)" <ifbS@cdc.gov>
Date: Monday, February 8, 2021 at 5:28 PM
To: Payton heme <payton@fb.com>, Carol Crawford <ciy1@cdc.gov>, "Layton, Kathleen
(CDC/OD/OADC)" <KYUS@cdc gov>
Ce: Julia Eisman <juliaeisman@fb.com>, Genelle Adrien <genelleadrien@fb.com>, Chelsey
Lepage <chelseylepage@fb.com>, Airton Tatoug Kamdem <airtonkamdem@fb.com>
Subject: RE: COVID-19 Outreach to communities worldwide
Great ~ Thanks for the update Payton!

Jay H. Dempsey, M.Ed.

Social Media Teom Lead, 1: Centers for isase Control and Prevention
Mymobieno. hs changed [TERRY]
rotowus on uit
Boson acainnt.

From: Payton Iheme <payton@fb.com>

Sent: Monday, February 8, 2021 1:24 PM
To: Crawford, CarolY. (CDC/OD/OADC) <cjy1@cdc.gov>; Dempsey, Jay H. (COC/OD/OADC)
<ifbS@cdc.gov>; Layton, Kathleen (CDC/OD/OADC) <KYUS@cdc.gov>
Ce:Julia Eisman <juliaeisman@fb.com>; Genelle Adrien <genelleadrien@fb.com>; Chelsey LePage
<chelseylepage@fb.com>; Airton Tatoug Kamdem <airtonkamdem@fb.com>
Subject: COVID-19 Outreach to communities worldwide

Good afternoon Carol, Jay, and Kathleen,

We wanted to make sure you saw our announcements today about running the largest worldwide
campaign to promote authoritative COVID-19 vaccine information and expanding our efforts to
remove false claims on Facebook and Instagram about COVID-19, COVID-19 vaccines and vaccines in
 ‘general during the pandemic. More details are in our Newsroom: authoritativeCOVID-19vaccine
information andCOVID-19andvaccinemisinformation.
Helping People Find Where and When They Can Get Vaccinated
Starting this week, we'll feature links in the COVID-19 Information Center to local ministry of
health websites to help people understand whether they're eligible to get vaccinated and how
todoso.
«And in the coming weeks, as more information becomes available, we'll continue to improve
this feature, making it easier for people to seewhere and when they can get vaccinated in just
afew taps.
‘Sharing Credible Information About COVID-19 Vaccines
«We're working with health organizations and community leaders to run campaigns on our
platform promoting accurate information about COVID-19 vaccines and encouraging people
to get vaccinated.
«We're giving over $120 million in ad credits to help health ministries, NGOs and UN agencies
reach billions of people around the world with COVID-19 vaccine and preventive health
information,
«In the US, we're partnering with the Johns Hopkins Bloomberg School of Public Health to
reach Native American communities, Black communities and Latinx communities, among
others, with science and evidence-based content that addresses the questions and concerns
these communities have.
‘+ We're also working with AARP to reach Americans over 50 with educational content about
COVID-19 vaccines, including Spanish-language content designed to reach Latinx and Hispanic
communities.
CombatingVaccine Misinformation
+ We are expanding oureffortsto remove false claims on Facebook and Instagram about
COVID-19, COVID-19 vaccines and vaccines in general during the pandemic. Since December,
we've removed falseclaims about COVID-19 vaccines that have been debunked by public
health experts.
» Today, following consultations with leading heath organizations, including the World Health
Organization (WHO), we are expanding the lst of false claimswewill remove to include
additional debunked claims about the coronavirus and vaccines. We alreadyprohibitthese.
claims in ads.
+ Groups, Pages and accounts onFacebook and Instagramthat repeatedly share these
debunked claims may be removed altogether. Weare also requiring some admins for groups
with admins or members who have violated our COVID-19 polices to temporarily approve all
posts within their group.
‘+ When people search for vaccine or COVID-19 related content on Facebook, we promote
relevant, authoritativeresults andprovidethird-party resources to connect people to expert
information about vaccines. On Instagram, in addition tosurfacing authoritative results in
 Search, in the coming weeks we're making it harder to find accounts in search that discourage
peopl from getting vaccinated.
«As noted
we lastmonth in response to guidance from the Oversight Board, we are committed
to providing more transparency around these policies. You can read the detailed updates in
Facebook'sCommunityStandards and in ourkelpCenter.
Providing Data to Inform Effective Vaccine Delivery
Last year, we began collaborating with Carnegie Mellon University Delphi ResearchGroup and
the University of Maryland on COVID-19 surveys about symptoms people are experiencing,
‘mask wearing behaviors and access to care. With over 50 million responses to date, the.
survey program is one of the largest ever conducted and has helped health researchers better
‘monitor and forecast the spread of COVID-19.
«To help guide the effective delivery of COVID-19 vaccines, the survey data will provide a
better understanding of trendsinvaccineintentacross sociodemographics, race, geography
‘and more. The scale of the survey will also allow for faster updates on changes in trends, such
as whether vaccine intent is going up or down in California in a given week and better insights
‘on how vaccine intent varies at a local level. We'll share these new insights including vaccine
attitudes at acountylevel in the US as well as globally.
These new policies and programs will help us continue to take aggressive action against
misinformation about COVID-19 and vaccines and help people find where and when they can get
vaccinated. You can read more about how we're supporting COVID-19 reliefefforts and keeping.
people informed at ourCOVID-19 actionpage.

On Behalf of the Facebook team

FACEBOOK
Payton heme
US. Public Policy
‘Facebook
 From: Eavon ane
To: Gono, CorelY.(G0C/00/0HD0) CareAdams
I ancl Aden
Sublect Ra: V1 mlto reporting chamel
Date: Monday, ay10,2021 32854 PH.
Hicarol,
Genelle just went on (EYE) We are very excited for her and [XE]
As such, we didn't wan you to be a surprised that Carrie will pick up on the threads where Genelle
was leading starting today.
“That will include this one with scheduling training for the government case work project.
Best,
Payton
From: Carol Crawford <ciy1@cdc gov
Date: Monday, May 10, 2021 at 12:25 PM
To: Genelle Adrien <genelleadrien@b.com>
Cc: Payton heme <payton@fb.com>, Carrie Adams<carrieadams@fb.com>
Subject: RE: CV19 misinforeporting channel
im so sorry = Fmoutall day May 17 for a (EXE) Jean we pick another one? My fault!
From: Genele Adrien <genelieadrien@fb.com>
sent: Friday, May 7, 2021 11:27 AM
To: Crawford, Carol Y. (CDC/OD/OADC) <ciyl@cdc gov
Cc: Payton Iheme <payton@fb. com>; Carrie Adams<carrieadams @fb.com>
Subject: Re: CV19 misinfo reporting channel
HiCarol ~ Following up from our meeting yesterday. It looks like Monday, May 17%" at 12:00pm will
‘work for onboarding meeting. The overlaps with your standing Census meeting you mentioned. We
will plan to invite the email addresses below (those being onboarded).
Please let me knowif any flags on your end.
Best,
Genelle:
FACEBOOK
Genelle Quarles Adrien
Poliics & Goverment Outreach
©: genaleadrien@thcom | w: facebookcom/gea
 From: Crawford, Carol Y. (CDC/OD/OADC) <ciy1@cdcgov>
Date: Tuesday, April 27, 2021 at 11:21 AM
Tos Genelle Adrien <genelleadrien@fb.com>
Ce: Payton heme <payton@fh.com>, Carrie Adams <carrieadams@fb.com>
‘Subject: RE: CV19 misinforeporting channel
Ugh, so sorry | mised this. It aoks correct but | think so might have access already, but not sure.

From: Genelle Adrien <genelicadrien®@fh com>

Sent: Tuesday, April 27, 2021 11:05 AM
To: Crawford, CarolY. (COC/0D/OADC) <ciyl@cdc.gov>
Ca: Payton Iheme<payton@fbcom; Carrie Adams <carrieadams
@fbcom>
Subject: Re: CV19 misinfo reporting channel
HiCarol ~ Hope the weeks off to a good start. | wanted to bump this and see if you had any
edits/additons to the onboarding lst below.
Let us know if you have any questions.
[=
Genelle
From: Genelle Adrien <genelleadrien@fb.com>
Date: Tuesday, April 13, 2021 at 3:50 PM
To: Crawford, Carol Y. (CDC/0D/0ADC) <ciy1@cdcgov>
Ce: Payton heme <payton@fb.com, Chelsey Lepage <chelseylenage@ib.com>
Subject: CV19 misinfo reporting channel
Hi Carol ~ Hope the week is off to a good start. We're working to get our COVID-19 misinfo channel
up for COC and Census colleagues. Could you kindly confirm if the below emails are correct for
onboarding to the reporting channel and if there are others you'd like to include?
Please let me know f you have any questions.
Thank you!
Genelle
 :

FACEBOOK
Genello Quarles Adrien
Poliics & Government Outreach
e: genaleadien@t.com | facebookcom/gga
Attaching the latest CrowdTanle content insights reportfo the period of February 24-March 10
(attached). Here's
thequicksummary:

This week, we also are includingaone-off content insights report we dd looking at Spanish-language
content relevant to the US, which we thought might be interesting for you (a always, please do not
share externally)
Let us know if you have any questions or particular keywords/topics you'd like us to explore for the
next report
Thanks,
Kelly

From: Kelly Perron <kperron@fh.com>

Date: Monday, March 1, 2021 at 6:03 PM
To: "Crawford, Carol
Y. (CDC/OD/OADC)" <civl@cdcgov>
Ce: Lauren Balog Wright<lbw@fbcom, Payton Iheme <pavton@ibcom, Chelsey Lepage
<chelseyienage@th.com>
Subject: Re: CrowdTangle COVID-19 reports

And adding in Chelsey, apologies!

From: Kelly Perron <kperron@ib.com>
Date: Monday, March 1, 2021 at 5:47 PM
From: SaneOninta
To: Muli
CO0 ScotL.
0/0
HadarSin:Ya! Gos ADC o(TR)
Ls )Jon St.Fred
etre:Waal,Seca(COC/OD/OADC ):
(COCOA: Cu Cao tt (COCO0IONE)
Subject: Fe GogKnown Ute
Date: Tu Voy4,202130459
y,
Thanks, Scott! We'll make the changes in the next update cycle.
On Tue, May 4, 2021, 12:00 PM Mullins, Scott R. (CDC/OD/OADC) (CTR)
<svmB@edc.gov> wrote:
Hi Stanley,
‘We updated the markup for the Treatments Tab to reflect the change below. It is now live
on hutps://www.cde.gov/coronavirus/2019 indexhum
-nCoV -
Thanks,
Scott

From: McDaniel, Rebecca (CDC/OD/OADC) <ldyS@cde.gov>

Sent: Monday, May 3, 2021 1:33 PM
To: Mullins, Scott R. (CDC/OD/OADC) (CTR) <svms@ede.gov>
Subject: RE: Google Knowledgebase Update

Hey Scott,

My mistake ~ can you please add the highlighted content back in to the Treatments Tab at
the bottom?

Treatment Tab (under Medical treatments)

Treatments used for COVID-19 should be prescribed by your healthcare provider. People
have been seriously harmed and even died after taking products not approved for COVID-
19, even products approved or prescribed for other uses. Your healthcare provider will
decide on what approach to take for your treatment

‘Your healthcare provider also may recommend the following to relieve symptoms and
support your body's natural defenses.
 + Taking medications, like acetaminophen or ibuprofen, to reduce fever.
+ Drinking water or receiving intravenous fluids to stay hydrated.
+ Getting plentyofret to help the body fight the virus.

Ifsomeone isshowingemergency Warningsigns,get medical careimmediately.Emergency.

Warningsignsinclude:
« iGublebréathiiig
« Persistentpainorpressureiin the chest

e——
i
Becky McDaniel
Cell

From: Mullins, Scott R. (CDC/OD/OADC) (CTR) <svm8@ede.gov>

Sent: Monday, April 26, 2021 3:33 PM
To: Stanley Onyimba <sonyimba@google. com>; Hadar Shkolnik <hadarth@google.com>;
‘Yael Grossman Levy <yaclgro@google.com>; Jan Antonaros <janionaros@google.com>
Ce: Crawford, Carol Y. (CDC/OD/OADC)<ciyL@sde.gov>; Smith, Fred
(CDCIOD/OADC) <evp9@cde.gov>; McDaniel, Rebecca (CDC/OD/OADC)
<ldy8@ede.gov>
Subject: RE: Google Knowledgebase Update

Hi Stanley,

‘Were there any problems with these changes? We haven't seen any feedbackorseen these.
updates reflected in the Knowledgebase.

If there were problems let me know and I'll work to address them.

Thanks,
Scott

From: Mullins, Scott R. (CDC/OD/OADC) (CTR)

Sent: Tuesday, April 13, 2021 3:01 PM
‘To: Stanley Onyimba <sonyimba@google.com>; Hadar Shkolnik <hadarth@google.com>:
Yael Grossman Levy <yaelgro@google.com>; Jan Antonaros <jantonaros@goagle.com>
Ce: Crawford, Carol Y. (CDC/OD/OADC)<ciy
@ede.gov>: Smith, Fred
(CDC/OD/OADC) <evpd@cde.gov>; McDaniel, Rebecca (CDC/OD/OADC)
<ldyS@cde.gov>
Subject: RE: Google Knowledgebase Update

Hi Stanley and company,

‘We have made the following edits to the JSON+LD markup for the knowledgebase.

Prevention Tab
To help prevent the spread of COVID-19:
«Weara mask to protect yourself and others and stop the spread of
COVID-19.
«Stay atleast 6 feet (about 2 arm lengths) from others who don't ive with
you
«Avoid crowds and poorly ventilated spaces. The more people you are in
contact with, the more likely you are to be exposed to COVID-19.
«Geta COVID-19 vaccine when it's available to you.
«Clean your hands often, either with soap and water for 20 seconds or a
hand sanitizer that contains at least 60% alcohol.
«Avoid close contact with people who are sick.
«Cover your cough or sneeze with a tissue, then throw the tissue in the
trash.
«Clean frequently touched objects and surfaces daily. If someone is sick
or has tested positive for COVID-19, disinfect frequently touched surfaces.
 «Monitor your health daily.

Treatment Tab (under Medical treatments)

Treatments used for COVID-19 should be prescribed by your healthcare provider.
People have been seriously harmed and even died after aking products not approved
for COVID-19, even products approved or prescribed for other uses. Your healthcare
provider will decide on what approach to take for your treatment

Your healtheare provider also may recommend the following to relieve symploms
and support your body's natural defenses.
«Taking medications, like acetaminophen or ibuprofen, to reduce fever.
«Drinking water or receiving intravenous fluids to stay hydrated.
«Getting plenty of rest to help the body fight the virus.

These are live,hutps://w

gov/cwiw cde. virus/2019:nCoV/inde
orona huml
x

Thanks,

Scott

From: McDaniel, Rebecca (CDC/OD/OADC) <ldy8@cde.gov>

Sent: Monday, April 12, 2021 3:01 PM
“To: Mullins, Scott R. (CDC/OD/OADC) (CTR) <svms@cde.gov>
Ce: Crawford, Carol Y. (CDC/OD/OADC) <ciy1@de.gov>; Smith, Fred
(CDCIODIOADC) <expd@eds.gov>
Subject: Google Knowledgebase Update

Hi Scott,
Please see edits below for the Prevention and Treatment tabs. Please let me know if you
have any questions.

©)15)
 ©6)

Becky McDaniel
Health Communication Specialist
(404) 536-6002
From: SaoOninta
To: Batter ster FosamaryCOUDOMDNGIELIOD)
I Ga Coro do (COC/DDIDAGCIAONDY: on
Y_(GDC/ODIOADO) abr,Kathen Arter
Sublect a Googe metry st. .
Date: Tunsyeu 16,201 11:42:41PU
‘Thanks for sharing these key messages, Rosie!
On Tue, Feb 16, 2021 at 1:09 PM Bretthauer-Mueller , Rosemary (CDC/DDNID/NCIPC/OD)
<zhk0@ede.gov> wrote:

1. ProtectYourselfandothers{romCOVID-19
Even after vaccination, we need to continue using all the tools available to help stop
this pandemic as we lear more about how COVID-19 vaccines work in real-world
conditions.
+ Wearing a mask over your nose and mouth
« Staying at least 6 feet away from others
« Avoiding crowds
« Avoiding poorly ventilated spaces
« Washing your hands often

2. Use the hashtag #SleeveUp

Vaccination works better when we do it together. #SleeveUp for a future safe from
#COVIDIY.

2 i i ‘
COVID-19 vaccination is an important tool to help us resume life.

+. Mil ing of & COVINIS acti

Millions of people in the United States have received COVID-19 vaccines, and these
vaccines are undergoing the most intensive safety monitoring in U.S. history.
 5. K=12schools should be the last settings to close after all other mitigation measures in
the community have been employed, and the first to reopen when they can do so
safely.
« All schools should use and layer mitigation strategies.
« Schools providing in-person instruction should prioritize two mitigation strategies:
© Universal and correct use of masks should be required.
© Physical distancing (at least 6 feet) should be maximized to the greatest extent
possible.

From: Crawford, Carol Y. (CDC/OD/OADC) <gjy1@sde.gov>

Sent: Tuesday, February 16,2021 2:06 PM
To: Bretthauer-Mueller, Rosemary (CDC/DDNID/NCIPC/OD) <zhk0@edc.gov>
Ce: LaPorte, Kathleen (CDC/DDID/NCIRD/ID) <wng2@edc.gov>
Subject: Google meeting at 4

‘They said they do want to discuss vaccines: ®08) Jin

additionto general timelines/key messages for upcoming campaigns.”

Hoping you have his updated appt butif not here is the right teams info:

Join on your computer or mobile app

Clickheretojointhemesting
Or callin (audio only)
United States, Atlanta
(0X6
38) ited States (Tol-ree)
 Phone Conference o ee}
Eid2 local number |Reset PIN
LearMore |Meetingoptions

‘Sartey Ony
|GlobalProduc
ima tPatnersips | soniiTha@uogie
com
en
rms.
rome
vaccinefiner.org over to a .gov tomorrow but not sure if this issue is related. 1 do not seeit so |

wil Verizon LTE 1:48 PM 66%.

QL ® EC
2 .
Your Stor archiveatla.. markmcgin... atlantapizz.. georgi

bmyers7505, People 16 and Older Can Now

Get a COVID-19 Vaccine in Georgia
We can all help keep each other safe. Find
vaccine appointments for you, your family and

Change State

Chief, Digital Media Branch

ccrawford@cdc.
gov
 mc
TL
be EEE
BETan
Payton — | was hoping to discuss how Facebook/Instagram/Etc. could help WH/HHS/CDC to promote
the other ways to access the vaccinefinder (vaccines.gov) call and text numbers? WH/HHS asked me

Text your zip code to] (B)6)

 From: Dempsey, Jay H. (CDC/0D/OADC)
Sent: Fri, 11 Jun 2021 16:30:57 +0000
To: Julia Eisman
ce: Crawford, Carol Y. (CDC/OD/OADC)
Subject: CoC Ads
Attachments: VTF Paid Ads Content draft 6.8 VTF_aeh prp9 JIC Clean doc,
FINAL_Appeals_testing_messages_6.4.21_clean.docx

Hi Julia- Following up on yesterday's cal, saw that someof the ads that | mentioned as coming to
Facebook were review were sent practically as soon as we closed the call. But, sending these your way in
case youhave any insights on adjusting the ads spends or any other details to optimize their
performance. I'm also sharing these with Code 3to seeif they have thoughts on how to improve the
creative on future runs using similar assets. Thanks again for pointing us intheirdirection!
Best.
say
Jay H. Dempsey, Md.
Socal Medi Team Lead, Digs Meda Branch, Division of Public Afar
Office of the Associate Director for Communication,
US. Centers or Disease Control and Prevention
TELEWORKNG
PS——
Bpotom uron wir
Enis on pscaons
 i
ii
5 @
iz
8 =

tz
8
8
5
]
8
8
8
5
8
 From: Crawford, Carol Y. (COC/0D/OADC)
sent: The, 4 Mar 2021 18:58:01 +0000
To: LaPorte, Kathleen (CDC/DDID/NCIRD/ID);Jorgensen, Cynthia
(COC/DDID/NCIRD/OD);Sokler, Lynn (CDC/OD/OADC):COC IMS JICLead -2
Ce: Cory, Janine (COC/DDID/NCIRD/DVD);Bretthauer-Mueller , Rosemary
(COC/DDNID/NCIPC/OD),CDC IMS JIC OADC LN -2;Dempsey, ay H. (CDC/OD/OADC)LaPorte, Kathleen
(CDC/DDID/NCIRD/ID);Layton, Kathleen (CDC/OD/OADC);Vazquez, Germaine (ATSDR/OCOM)
Subject: Re: Awareness: Facebook "I got a COVID-19 Vaccine" frame

When Tget a copy, Tl share. They would Te to

launch it around March 15.
From: Crawford, Carol Y. (CDC/OD/OADC)
Sent: Monday, March 1, 2021 11:19 AM
“To: LaPorte, Kathleen (COC/DDID/NCIRD/ID) <wng2@cdcgov>; Jorgensen, Cynthia
(COC/DDID/NCIRD/OD) <cx4@cde. gov>; Jones, Christopher M. (COC/DDNID/NCIPC/0D)
<FIRO@cdc.gov>; Bonds, Michelle E. (CDC/OD/OADC) <meb0@cdc.gov>; Sokler, Lynn (CDC/OD/OADC)
<2520@cdc.gov>; COC IMS JIC Lead -2 <eocjiclead2@cdc.gov>; OConnor, John (CDC/DDID/NCEZID/OD)
<jpo2@cdc gov>
Ce: Cory, Janine (CDC/DDID/NCIRD/DVD) <jyc5@cdc.gov>; Bretthauer-Mueller , Rosemary
(COC/DDNID/NCIPC/OD) <zhk0@cdegov; COC IMS JIC OADC LNO -2 <cocevent202@cde. gov;
Dempsey, Jay H. (CDC/OD/OADC) <ifbS@cdc.gov>
Subject: RE: Awareness: Facebook "I got a COVID-19 Vaccine" frame
Update: Looks lke]
CBr [iikeepyouponed

From: LaPorte, Kathleen (CDC/DDID/NCIRD/ID) <wng2@cde.gov>

Sent: Monday, March 1, 2021 8:53 AM
To: Crawford, CarolY. (CDC/OD/OADC) <cjy1@cde.govs; Jorgensen, Cynthia (CDC/DDID/NCIRD/OD)
<cjd@cdc.gov>; Jones, Christopher M. (CDC/DDNID/NCIPC/OD) <FIRO@cdc.gov>; Bonds, Michelle E.
(€DC/OD/OADC) <meb0@cdc.gov>; Sokler, Lynn (CDC/OD/OADC) <zs20@cdc.gov>; CDC IMS JIC Lead -2
<eodjiclead2@cdc.gov>; OConnor, John (CDC/DDID/NCEZID/OD) <jpo2@cdc.gov>
Cc: Cory, Janine (CDC/DDID/NCIRD/DVD) <jyc5@cdc.gov>; Bretthauer-Mueller, Rosemary.
(CDC/DDNID/NCIPC/OD) <zhk0@cdc.gov>; CDC IMS JIC DADC LNO -2 <eocevent202@cdc.gov>;
Dempsey, Jay H. (CDC/OD/OADC) <ifbS@cde.gov>
Subject: RE: Awareness: Facebook " got a COVID-19 Vaccine" frame
HA,
Also, some additonal information from KEF showing the benefit of people sharin their own vaccine
experience with thei network.
KEF COVID-19 Vaccine Monitor: February 2021| KFE
 rot
Those With Closer Connections To People Who Have Been Vaccinated
Are More Likely To Say They'll Get Vaccinated As Soon As Possible
henan POA arora cc fo COVE 135 alate you to, da ou ik ouwl.
Gets som pss Meat anaes Mon ge reuse MOST rk gk
Serr ass occas (E50 5
Con tor ary cca: ES 5%SsECS
oo scr dn cr ES SS 5EN
——————— ————————]
a— ev

We aso saw positive teraction ou is campaign f5evelp to HFightHy effort om socal media.
xe
From: Crawford, Carol ¥. (CDC/OD/OADC)<ciyl @cdc.gov>
Sent Friday, February 26,2021.457 PM
“To: Jorgensen, Cynthia (CDC/DDID/NCIRD/OD) <cxj4@cdc.gov>; Jones, Christopher M.
(CDC/DDNID/NCIPC/OD) <FIRO@cdc.gov>; Bonds, Michelle E. (CDC/OD/OADC) <meb0@cde.gov>;
Sokler, Lynn (CDC/OD/OADC) <z520@cdc.gov>; CDCIMS JIC Lead -2 <eodjiclead2@cdc.gov>; OConnor,
John (CDC/DDID/NCEZID/OD) <jpo2@cdc.gov>
Ce: Cory, Janine (CDC/DDID/NCIRD/DVD) <jyc5@cdc.gov>; LaPorte, Kathleen (CDC/DDID/NCIRD/ID)
<wng2@cdc.gov>; Bretthauer-Mueller
,Rosemary (CDC/DDNID/NCIPC/OD) <zhk0@cdc.gov>; CDC IMS
JIC ADC LNO -2 <eocevent202@cdc.gov>; Dempsey, Jay H. (CDC/OD/OADC) <ifbS@cde.gov>
Subject: RE: Awareness: Facebook got a COVID-19 Vaccine” frame
Answering what 1 have read so far none e-mail
oma [my

(©)5)
From: Jorgensen, Cynthia (CDC/DDID/NCIRD/OD) <cxid@cdc.gov>

‘To: Crawford, Carol Y. (CDC/OD/OADC) <ciyl@cdc.gov>; Jones, Christopher M. (CDC/DDNID/NCIPC/OD)

<FJRO@cdc.gov>; Bonds, Michelle E. (CDC/OD/OADC) <meb0@cdc.gov>; Sokler, Lynn (CDC/OD/OADC)

Te
<zs20@cdc.gov>; CDC IMS JIC Lead -2 <eociiclead2@cdc.gov>; Connor, John (CDC/DDID/NCEZID/OD)

Ce: Cory, Janine (CDC/DDID/NCIRD/DVD) <jyc5@cdc.gov>; LaPorte, Kathleen (CDC/DDID/NCIRD/ID)

<wng2@cdc.gov>; Bretthauer-Mueller, Rosemary (COC/DDNID/NCIPC/OD) <zhk0@cdc.gov>; COC IMS
JIC OADC LNO -2 <gocevent202@cdc.gov>; Dempsey, Jay H. (CDC/OD/OADC) <ifbS@cdc.gov>

Cynthia
JIC Co-Lead( March April)

Reconuncain
Sean AS
—

From: Crawford, Carol ¥. (CDC/OD/OADC) <ciyl @cdc.gov>

‘To: Jones, Christopher M. (CDC/DDNID/NCIPC/OD) <FJRO@cdc.gov>; Bonds, Michelle E. (CDC/OD/OADC)

<meb0@cdc.gov>; Sokler, Lynn (CDC/OD/OADC) <zsz0@cdc.gov>; COC IMS JIC Lead -2
<eadjiclead2@cdc.gov>; OConnor, John (CDC/DDID/NCEZID/OD) <jpo2@cdc.gov>; Jorgensen, Cynthia

av CocoNGR i) csc ore Kae COCoDONGHOID)

(CDC/DDID/NCIRD/OD) <cxjd @cde.gov>

<wng2@cdc.gov>; Bretthauer-Mueller, Rosemary (CDC/DDNID/NCIPC/OD) <zhk0@cdc.gov>; COC IMS

JIC OADC LNO -2 <eocevent202@cdc.gov>; Dempsey, Jay H. (CDC/OD/OADC) <ifbS@cdc.gov>

Facebook has approached CDC (and HHS) about creating a single US “frame” where people who have
 ng
ove
From: Crawford, Carol Y. (CDC/OD/OADC)
sent: Wed, 12 May 2021 15:46:46 10000
To: Layton, Kathleen (CDC/OD/OADC);Dempsey, Jay H.
(CDC/OD/OADC);jennifer.shopkorn@census.gov;Clewitzke @reingold.com;shuxley@reingold.com;kstan!
ey@reingold.com;Carrie Adams;Payton Iheme;Sokler, Lynn (CDC/OD/OADC);Galatas, Kate
(€DC/0D/0ADC)
Subject: Training for Facebook's Misinfo Reporting Channel

Holding 1 hour but expect ttbe loseto30 minutes

Join ZoomGov Meeting
(0X6)

Meeting ID:[_(0)6)
passcode EE]
One tap mobile
US (San Jose)
©X6) US (New York)

Dial by your location

5 (San Jose)
6 (New York)
5 (San Jose)
5
Meeting ID] B16)
passcode!
ind your localoie)
number: [
From: Claire Wardle (Google Docs)
sent: ri,09.Ju 2021 10:55:06 0700
To: ‘Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID)
Subject: CDC Draft Curriculum

Claire Wardle resolved comments in the following document

Bloc pratt curriculum

Resolved
3comments

Resolved
Comments

Introduction efecvefack checks and fling information and content gap: how
10 word headines or factchecks without causing more harm.
El Wil
‘what about increasing collabs wit actcheckers? How 10 work wit ouros
more effectively?
Be Warde
Marked as resaved
Replyopen

Wessages
Ewi
How about straight up content? Not ust messages? Thinking about talored,
culturally refouant content in any longuages and formats,
B Claire Wardle
Marked as rosoved
ReplyOpen
 “Tuesday — Introduction to Social Listening
a EIWil
Stealing from Terr, but maybe we consider adding “observations” meaning
understanding interactions such as an AMA or community dynamics such as
holistic or mommy communities and community norms and how they can
hamper or accslerate misinfo/info voids.
Ew
Another important component o this: recognizing th fmitations of social
listening: e.9. the iceberg problem, and listing a more fulsome set of data
sources HD staff may have access to such as tp nes, surveys, especially
witha focus on offinelruraldisproportonatel affected pops
a:
Also, think we need mention of access and equity here--communities ith
limited health or network access are aiso more ely o be vulnerable to ower
vaccine uptake and outbreaks. Systems we use are meant for English
speakers and are inherently biased. We should unpack this so that
assumptions are not made based on limited data collection on only a small
number of platforms.
| co vem
Marked as resolved

ReplyOpen
Google LLG, 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA
You have recived is emai becauseyou are a partion in te pod (GOOGlR”
discussion treads. ChangewhatGoogleDocssends you. You cannol reply
otis emai,
 From: Nuadum Konne (Google Docs)
sent: Tue, 16 Feb 2021 14:13:37 -0800
To: Kolis, Jessica (CDC/DDPHSIS/CGH/GID)
Subject: Healthcare Worker survey questions_protocol_vl

Nuadum Konne resolved comments in the following document

Blhtcaitncare Worker survey questions_protocol
vi

Resolved
2
comments
Resolved
Comments

Now, I' going to read a series of phrases regarding theCOVID-19vaccine and Id ike you to
let me know if youve heard them wih a yes or no. COVID-19 vaccine (mRNA) causes an
ieversible damage to your genes Vaccinated kids are not as healthy as unvaccinated kids.
COVID-19vaceines caused deaths in the U.S. Vaccine contains microchips Vaccines contain
aborted etal cells:
Atsuyoshi Ishizumi
1 wonder if we can just explore these as probes under Q1 as opposed to reading them
aloud... for example, “have you heard anything specifically about mRNA vaccine platiorm?
If So, can you explain? Do you believe itt be true?" or something like that
Nuadum Konne,
This is a good idea and I'm ok with either sot up, will defer to Halim.
3[3
agree with the comments above, since the predominant rumors can be diferent in each
country. So would suggest a probe instead
ly] Jessica Kolis
So does this feed ino the same issue as the quant survey that we are putting rumors out
there we don't need to? Can we just solicit rumors and maybe give categories? For
‘example? Have you heard rumors about COVID-19 related to,
Vaccine effectiveness
Vaccine safely
ete?
 Nuadum Konne
Thank you for the suggestion, | think a variation between and Atsu's suggestions works!
Nuadum KonnelZR8
Marked as resolved.
ReplyOpen

{Askif they answerQ1)Whats your impression of thess rumors on your health seeking
behavior? From your perspective, do you think COVID-19 vaccine misinformation has impacted
your health seeking behavior?
Nuadum Konne
Which question makes more sense?
[+ Ra
Ithink | ke G2 better! Maybe we can ask more directly how these rumors have changed
how they feel about COVID-19 vaccines?
Nuadum Konne
awesome! and agreed,a follow up question on how the rumors have changed how they
feel about COVID-18 vaccines is great. Joss and others to weigh i
Elodie Ho
agree with editing the question and focus on vaccine perception instead of health seeking
behaviors, since we wil interview CHWs. Should we be even more specific on the
behavior and ask about their willngness to gt vaccinated?
Nuadum Konne
Totaly agree on this fron, and we have speci questions on perceptions and willingness
10 get vaccinated inthe survey section. Ideally, we would select participants for th in-
depth interview based on thei stated interests from the survey 501 think we would have
data around their illingness to get vaccinated from their survey responss, but might be
worth asking here too,
[|
Can we do that with declassifying (select people based on their responses)? If so then
Some of my comments above aren't needed. Are we worried about their behaviors or
patients? think the 2nd questions is bette and like's Atsu's edit.
1 don't think it would hurt to ask about their willingness to get vaccinated, it might give us
more information then the 5 scale we have.
Nuadum Konne
Love the discussion on this question. | definitly don' think it would hurt o include a
question on thei willingness to get vaccinated here.
I ee seo
agree with moving away from the question on health seeking behavior, aiso not sure what
a Nuadum Konnelf
Hermes
ReplyOpen

summa
threads. Change what Google Docs sends
‘Google
you.You can not reply to this email.
From: Daiva Yee (Google Slides)
sent: Sun, 08 Aug 2021 21:21:49 0700
To: ‘Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID)
Subject: SMC RCA Presentat... - Can't remember if we decided to keep . .

Daiva Yee added a comment to the following document

(CsMC ROA Presentation 8.3.21. ppix

vaccine
Bg ove ved
Can't remember ifwe decided to keep this demographics side. Probably can
remove for adults f we arent including for adolescents
Open
Google LC, 1600 Amphitheatre Parkway, Mountain View, CA 04043,USA
You have recive this email because you ar subscribed to al discussions
piripisadunir vice midriemgi
You. You cannot repy to this email View SMC RCA Presentation 6.9.21 pte
CLL
orepy.
From: Scotti Michele Leonard (Google Slides)
sent: Vion,
09Aug 2021 05:15:22 0700
To: ‘Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID)
Subject: SMC RCA Presentat... - Confirm with Terri

Scotti Michele Leonard replied to a comment in the following

document

Dsmc REA Presentation 8.3.21.ppix

Methods and Audiences

@) cov vecons Contin cont
Contim wit Terr
a Elisabeth Wilhelm
Addo Toon bubble: Changeo Aduls in Family” and “Aduls, Outside of
Famiy®
Li] Scotti Michele Leonard
| wil update igureand add to sce
fl Scott Michele Leonard
Updated

Open
Google LLC, 1600 Amphithest Parkway, MouraView, OA 84043, USA
You havewhat
Chango recived
GoogleisDocs
emaiSand
because
you, you
Youarea
cannotparicpantin
aly 0 tisemaiwens.view (GOOG
SMG ROA Prosonaion 5321 ppt top
 From: COVID-18 Vaccine Conf. (Google Sides)
sent: 1,06Aug 2021 16:18:54-0700
To: ‘Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID)
Subject: SMC RCA Presentat... - | think this will be covered in MPBGC...

COVID-19 Vaccine Confidence Consults added a comment to the

following document
Dsmc Rea Presentation 8.3.21.pptx

Teens and Social Media

(@) 019 Vacsine Condonce Conte
1 think tis vil be covered in MPBGC presentation
open
Google LLG, 1600 Amphiheate Parkway. Mounai View, CA 4043, USA
You have recetve this ama because you ae subscribed to al discussions
emi eres.
Jou. You can reply to his aml, View SMG RCA Preseniation 8.9.21 ppix
Cro0gle
ron.
 From: COVID-19 Vaccine Conf... (Google Sides)
sent: Sun, 08 Aug 2021 14:58:40-0700
To: ‘Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID)
Subject: SMC RCA Presentat... - moved this oneupearlier

COVID-19 Vaccine Confidence Consults added a comment to the

following document
CsmG ROA Presentation 8.3.21. ppix

(©) 019 Vacin Condon Const

moved this on up earlier
Open
Google LLC, 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA
Vou have recive this email because you ar subscribed to al discussions
onsite Compe Goober. GOOG
You. You cannot repy to hs emai, View SMC RCA Presentation 6.5.21. pptx
orept
 From: COVID-19 Vaccine Con. (Google ides)
sent: Fri, 06 Aug 2021 14:48:59 0700
To: ‘Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID)
Subject: SMC RCA Presentat... - There were some teens, family members...

COVID-19 Vaccine Confidence Consults added a comment to the

following document
smc Rea Presentation 8.3.21 ppix

Limited direct interviews

® COVID-19 Vaccine Confidence Consults
There were some teens, family members, and community members we came
across who were hesitant
Open
Google LLC, 1600Amphitheatre Parouay, Mountain View, CA 94043, USA
You have received this email because you are subscribed fall discussions
repens Sion rams Cogs os an
You. You cannot reply to tis email. View SHC RCA Presentation 8.3 21 pix
G0OGle
to epi.
 From: COVID-19 Vaccine Conf... (Google Sides)
sent: Sun, 08 Aug 2021 17:39:13-0700
To: ‘Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID)
Subject: SMC RCA Presentation 8.3.21.pptx

COVID-19 Vaccine Confidence Consults resolved comments in the

following document
CsmG ROA Presentation 8.3.21. ppix

Resolved
2
Comments:
Resolved
Comments
©) 0:19 Vass Comtnce Consus
1 think this would be a great closing side,
(©) 500-1 Vaso Condon Corse
Marked as resolved
Open

Hyperiocal targeting and airingof outreach and clinics High-touch direct

oulreach to talk through concens and answer questions.
(©) 00:10 Vassin Conder Corse
1 moved these up and underlined because | heard often but now am
wondering if you were underlining for diferent emphasis?
(©) COV:1o Vacsin Connon Conutel
Marked as resolved
Open
Goole LLC, 1600 Amphihoatr Parkay, Mountain View, A 84045, USA
You hav received is omai becauseyou roa paricpant in re pated (FOO
discussion
ons onalheads. Changewha Googe Docssendsyou. You cannot pl
 From: Aybuke Koyuncu (Google Docs)
sent: Mon, 12 ul 2021 14:59:36-0700
To: Wilhelm, Elisabeth (COC/ODPHSIS/CGH/GID)
Subject: SMC RCA_Oraft Qua. - Could add additonal questions here ..

Aybuke Koyuncu replied to a comment in the following document

Blswic ReaDraft Quant Survey

Trusted information sources? Online conversations?

Aybuke Koyuncu
Could add additonal questions here, could leave this section bank and allow
them to come up with questions
a:
Other ideas:
Have you had conversations about COVID-19 vaccines with family and
friends?
Have any of these conversations been prompted by sharing of concerns or
misinformation about COVID-19 vaccines?
How would you characterize the information you get about COVID-18 on a day
to day basis?
Too much information
About the right information
Not enough information
Don't know
Getting at overload]: Have you changed the amount of ime you spend on
social media since January?
Increased
Decreased
About the same
Don know
 How would you describe in a word how you eel about getinga COVID-19
vaccine? open answer]
How would you describe ina word haw you fel bout your family getting
COVID-19 vaccines? [open answer]

just some ideas

Aybuke Koyuncull®
Lis most interested in last 2
Aybuke Koyuncu[B%
Where are people getting information

Open
Googe LLG, 1600 Amphihats Paka, Mia View, GA 8404, USA
You hve recived is smal becauseyouar a parca in is wns. (GOOGl@”
Coane whet
ne casein, Gola Bor ends Yo. Your 0 rh ora 1
 From: Charlotte Santon
Sent: Mon, 28 Jun 2021 10:33:39 -0700
To: vsi-early-users-external@google.com
co Tomer Shekel
Subject: VS! Early Access Users External] Google VSI: your feedback and artifacts

Dear VS early users,

Many thanks to those who have already shared your feedback on the vaccination
search insights data!
Ifyou haven't yet provided feedback on what you like/don't ike about the dataset,
please do so asap by filling in this form. Thank you!
Since starting to work with the data, have you found an interesting correlation that might
benefit others? And/or have you already integrated the data into your workflow?
To help newcomers understand and use the data more easily, we would like to post
examples of how you are using it alongside the published data. Even if you are in the
early stages of working with the data, we would love to know your inital ideas on a
potential artifact you might like us to publish to help make it easier for others to use the
data.
With gratitude,
Charlotte on behalf
ofthe VSI team

WARNING: There are external email addresses on this mailing list. Do not discuss any internal
or confidential information.
‘You received this message because you are subscribed to the Google Groups "VSI Early Access
Users [Extemal]" group.
To unsubscribe from this group and stop receiving emails from it, send an email to vsi-early-
users-extemal+unsubscribe(@ go gle.com,
To view this discussion on the web visit hitps:/groups. google. com/a/google.com/d/msgid/vsi-
carly-users-externallCAOWYrfU2dt6QbNYk-
ma2mWQCDyeRZIRST6kIDH?:2B3jdSwffw?idOmail gmail.com.
 From: Richard DeFiore
sent: Tue, 15 Jun 2021 08:45:26 -0400
To: Wilhelm, Elisabeth (COC/DDPHSIS/CGH/GID)Lubar,Debra
(CDC/DDID/NCEZID/OD)Koli, Jessica (COC/DOPHSIS/CGH/GID)8rookmeyer, Kathryn A.
(CDC/DDID/NCHHSTP/OSTOP)
Subject: New Google Tools for COVID-19

Hiall,
Just another FYI ifyou haven't seen this already:
Sharing several new tools we've developed to help public health officials and
researchers better understand the vaccination needs of their communities (seeblog
post for more details):
COVID-19 Vaccination Access Dataset: In an effort to support local and state
public health officials in their vaccination efforts, the public tool quantifies
access to vaccination sites, taking into account travel time (from Google
Directions API, no user data) via different modes of transportation. We hope
the dataset can help public health officials, researchers, and healthcare
providers identify areas where vaccination sites are inaccessible or hard to
reach, and inform interventions such as pop up vaccination sites or
transportation support. This dataset powers Ariadne Labs & Boston Children's
Hospital's new Vaccine Equity Planner dashboard, which integrates and
visualizes our data with data from other relevant COVID-19 sources.
« COVID-19 Vaccination Search Insights tool: We've heard from leading
public health organizations and researchers that they have a difficult time
knowing what information their communities are seeking about vaccines and
vaccination and that they lack localized, timely sources of data that could
inform their vaccine campaigns. Using aggregated and anonymized Google
Search data, the insights tool (currently in early access phase, with upcoming
public release) will show trends over time at the county and zipcode level
representing the relative search interest in COVID-19 vaccination. The data is
normalized such that users can compare the trends in different regions, and
over time, without exposing any individual query or even the actual number of
queries in any given area.
Both tools will initially be available in English and in the US to start, with plans to explore
international expansion in the months ahead.

Richard DeFiore | Google Cloud Federal Team | rdefiore@google.com | 703-598-8767

from: Titer
sent: Sat, 04 Apr2020 1:45:12 40000
To: Kolis, Jessica (CDC/DDID/NCIRD/OD) (CTR)
Subject: Paul Offit Tweeted: HowtoCure Coronavirus - with Dr. Paul Offit vi...

ooking for up-to-date info on COVID-19? Read now

v
Your Highlights

Paul Offit
Spat
How to Cure Coronavirus - with Dr. Paul Offit via @YouTube
3 uw on
 From: Wilhelm, Elisabeth (€DC/DDID/NCIRD/0D) (CTR)
sent: Tue, 16 Feb 2021 13:42:39 40000
To: irenejay@google.com
Subject: RE: Training Opportunity First Draft’ Vaccine Insights Bootcamp

Thanks forthe signal boost! ©

Hope youre doing wel, Irene
Sincerely,
Elisabeth Wilhelm
Vaccine Confidence Strategist
| Deployed to CDC Vaccine Task Forceas Team Co-Lead of Vaceine Confidence Team
| Day Job: Demand for Immunization Team, Global Immunization Division
™
&:nlzs@ede gov

1 Contractor with Technals Consulting

From: renejay@google.com <irenejay@googie.com>
Sent: Tuesday, February 16, 2021 6:36 AM
“To: Wilhelm, Elisabeth (CDC/DDID/NCIRD/OD) (CTR) <nlas@cdc.gov>
Subject: [Training Opportunity) Fist Drafts Vaccine Insights Bootcamp

Hello Elisabeth,
1hope alls well | wanted to pass along an update fromEirstDraft, which has launched the Vaccine
Insights Hub o help roportrs, publi health communication speciaists, policy makers and community
organizations tackle health and vaccine misinformation.
They have also launched an amazing 10-part bootcamp - offered in 3 time zones, which kicks
off today and features First Draft APAC's own Anne Kruger and Esther Chan!
“The program isdesigned and runbyFirst Draft’ highly experienced team, working on the frontline in
the fight against misinformation. You can join as many online workshops as you wish. They're free, easy
t0.access, and only take 30 minutes.
With the abilty to build your own syllabus, lie interpretation in your language and on-demand lesson
recaps, this highly customizable course is designed for busyschedules and varied levels of knowledge.
and experience. Registerhereto build a new set of razor sharp skills and become an expert n search,
monitoring, verification and more.
The course is available in nine languagesand across three time zones:
* Tuesdays: AEDT (English, Mandarin and Hindi).
* Wednesdays: GMT (English, French, Arabic, Italian and German).
* Thursdays: ET (English, Spanish, and Portuguese).

Vaccine Insights Hub

BTHm ——
public health communication specialists. pliy makers nd community organizations fckle healthandvaccine
misinformation in the fst half
of2021.
‘These resources include aVaccineInsightsHub and related weekly newsletter, flexible online leaming materials
and cri iulations. Below re rhe details about whats availble and you will oe the 30 minute
{raining opportunites ied (ating 16th February 2021)
wehope hat BRC Media Action wil be terested in
poicpaing. To the dealout our sollcgaes and you can sl ig up yith
An online resource for vaccine insights
onto 0h prjet isth Vain Isis Hu I's amonlin resource and centerof experts or tie insights.
nihgenes and apron ubdance os It vac misdormition. wi hr ese, coe she an
raining slong with ky opis nd trends gathered fom online conversions.
Sign up to our Vaccine Insights newsletter
We hope you fin this projet counter vaccine misinformation ss vlusbl and important as we do. Ifyou sign
her, we'il email you our weekly briefing with all the narratives we are tracking, top tips and the latest onour events
and ining.

Build Your Own Bootcamp

Stating from February 16 yes -tomarraw for 10 weeks we will be runing Flexible Leaming Cour across
{htc continents nd nn languages ht ofes gins the chance 1 igh up 0 a many ise 30-minute ecues
and workshops a they ike, aor other own eess an eeds Thy can aso prac in hosted rowp
chats and recap sesions 0 practic ils and shire knowledge. ign up no ihs
Vaccine Crisis Simulations
1 April we wil un rss iu ole criss simlstions, placing participants st th heart ofa hight.
ightimpact breskin vaccine story, challenging the o make elm poring decisionsa events unfold. Ags.
‘you can attend by registeringviathehub.

And much more.

We have plentymor nthe pipelinefo the months ahead, inchinga nw rescsch study exploring and analyzing
cxampisofvaeine misinformation, weekly nights newilte, monthly rns reports. snapshot aishects and
Checks, our brand nc CrossChck platform fo collborton, nd some relly Exciting nw student and creative
Penwork a help support us mov work
Inthe meantime, you can discover ourThebuilding blocksofreporting anddiscussing Covid-19 vaccines’ PDF,
that offers guidance on how to tackle misinformation on vaccines. Download thePDE here.
 From: singleton, James (COC/DDID/NCIRD/ISD)
sent: Thu, 18 Mar 2021 19:47:46 10000
To: Payton Iheme;lorgensen, Cynthia (CDC/DDID/NCIRD/OD)Abad, Neetu S.
(CDC/DDPHSIS/CGH/GID);Priva GangollyCrawford, Carol Y. (CDC/OD/OADC)Layton, Kathleen
(CDC/0D/OADC);Dempsey, Jay H. (CDC/OD/OADC),ChelseyLepage:Genelle Adren;Katherine Morris
ca: Airton TatougKamdem;Nisha Deolalikarulia Eisman;Stephanie Bousheriiz
Lagone:Kate Thornton;Kolis, Jessica (COC/DDPHSIS/CGH/GID)
Subject: RE: Call or VC- Facebook weekly sync with CDC (CDC to invite other agencies as
needed)

Revised intent question for Census Household Pulse survey 3.1.o start April 14 (survey will be on break
during March 30-April 13)
Universe: If QUI does not equal Yes
QU3. (GETVACC) Once a vaccine to prevent COVID-19 is availabletoyou, would you...
a. Definitely get a vaccine
b. Probably get avaccine - sk WHYNOT
<. Be unsure about geting avacine- sk WHYNOT
4. Prokubly NOT get a vaccine — ask WHYNOT
. Definitcly NOT get a vaccine - ask WHYNOT

Universe:If QU3 = Probably get a vaccine, Be unsure about getting a vaccine, Probably NOT get a
vaccine,orDefinitely NOT get a vaccine OR if QV2 = No
QUA. (WHYNOT) Whichofthe following, if any, are reasons that you [only probably will /probably
won't/definitely won't/ are unsure about whether to] [get a COVID-19 vaccine/won't receive all
required doses ofa COVID-19 vaccine? (elect al that apply)

Scripter: randomize
a. 1am concerned about possible side effects of a COVID-19 vaccine
b. I don't know if a COVID-19 vaccine will work
c. 1 don't believe | need a COVID-19 vaccine - go to WHYNOT2
d Ldon't like vaccines
. My doctor has no recommended it
. Iplan towait and seeifitssafe andmayget it ater
8. I think other people need it more than |do right now
h. 1am concerned about the cost ofa COVID-19 vaccine
i. 1 don't trust COVID-19 vaccines
1don't trust the government
k. Other (leasespecify:___) [ANCHOR]

Universe:If Qua = | don't believe Ineeda COVID-19 vaccine

QUS. (WHYNOT2) Why do you believe that you don't need a COVID-19 vaccine? (Select all that apply)
Scripter: randomize
a. already had COVID-19
b. Iam not a member of a high-risk group
c. 1 plan to use masks or other precautions instead:
d. I don't believe COVID-19isa serious ness
e. 1 don't think vaccines are beneficial
1. Other (pleasespeify:___) [ANCHOR]
For a planned adult survey to launch in April using the National Immunization Survey sample frame, we
are adding a question about when respondents think they would get vaccinated, to get at the “wait and
see” group:
[SHOW IF VAX2=2, 99]
VAX.
Oncea COVID-1 vaccine is available to you, would you.
RESPONSE OPTIONS:
i. Definitely get a vaccine
£ Probably geta vaccine
h. Be unsure about getting avaccine
i Probably <u>not</u> geta vaccine
i. Definitely<u>not</u>get avaccine
(SHOW IF VAX6=1, 2, 3]
AKG.
Once a COVID-19 vaccine is available to you, when do you think you would get it?

RESPONSE OPTIONS:
1 Immediately
1. Within a month
2. Within three months
3. Within six months
4. More than six months
5. Twouldn’t get it at all without more information

Thanks,
sim
Original Appointment.
From: Payton Iheme <payton@fb.com>
Sent: Tuesday, March 16, 2021 1.07 PM
To: Payton heme; Jorgensen, Cynthia (COC/DDID/NCIRD/OD); Singleton, James (COC/DDID/NCIRO/ISD);
Abad, Neetu 5. (CDC/DDPHSIS/CGH/GID); riya Gangolly; Crawford, Carol Y. (€DC/OD/OADC); Layton,
Kathleen (€DC/OD/OADC); Dempsey, Jay H. (CDC/OD/OADC); Chelsey Lepage; Genelle Adrien; Katherine
Morris
Ce: Airton Tatoug Kamdem; NishaDeolalikar; Julia Eisman; Stephanie Bousheri Liz Lagone; Kate:
“Thornton; Kolis, Jessica (COC/DDPHSIS/CGH/GID)
Subject: Call or VC- Facebook weekly sync with COC (CDCto invite other agenciases needed)
When: Thursday, March 18, 2021 3:00 PM-4:00 PM (UTC-05:00) Eastern Time (US & Canada)
Where:
FB will go over the CMU report during this call
Carol Crawford
——Original Appointment
From: Payton Iheme <payton@f.com>
Sent: Wednesday, January 27, 2021 6:44 PM
To: Payton heme; Priya Gangolly; Crawford, Carol Y. (CDC/OD/OADC); Layton, Kathleen
(CDC/OD/OADC); Dempsey, Jay H. (COC/OD/OADC);Chelsey Lepage; Genelle Adrien; Katherine Morris
Ce: Airton Tatoug Kamdem; Nisha Deolalikar; Julia Eisman; Stephanie Bousheri Liz Lagone; Kate:
Thornton; Kols, Jessica (COC/DDPHSIS/CGH/GID)
es needed)
Subject: Call or VC- Facebook weekly sync with CDC (COC to invite other agencias
When: Thursday, March 18, 2021 3:00 PM-4:00 PM (UTC-05:00) Eastern Time (US & Canada).
Where:

New attendees Intro

CDC needs/questions
-FB Product updates/feedback request (COVID-HUB)
-COVID-19 Projects- CMU/FB Data Survey Update, Misinfo collab status, other

Ways to join

@® Computer or Mobile:
©)6)
= Facebook Conference Room:
Use the touch panel toenter the join code © pndpin
8435

BO Telephone:
Dial in on (©)6) Jor find an alternative
number then enter ID ®16)___ Jollowed by participant passcode
(6X6)

Enabled by Rooms.
 From: Brookmeyer, KathrynA.(CDC/DDID/NCHHSTP/DSTOP)
sent: Fri, 19 Mar 2021 00:24:43 +0000
To: payton@fb.comPriva Gangolly;Crawford, Carol Y. (CDC/0D/OADC}Layton,
Kathleen (CDC/OD/OADC)Dempsey, Jay H.
(CDC/0D/OADCchelseylepage@fb.comgenelieadrien@fb.comkatherinemorris@fb.com
ca Airton Tatoug Kamdem;Nisha Deolalikar;ula Eisman;Stephanie Bousheriiz
Lagone:kthorton@fb.comKolis, Jessica (COC/ODPHSIS/CGH/GID)
Subject: RE: Call or VC- Facebook weekly sync with COC

Hi Facebook team,
apologize that my sound cut out on th cal today! It was great tohearyou present on your excellent
work.
In terms of understanding and building vaccine confidence =what would be incredibly helpful to our
teamsifyou had the vaccine willingness variables and perceivedbarriersto vaccination variables
segmentedbycounty,oreven by tate. We have had an incredibly hard tine getting granular data at
this level and this would be so usefultoour mapping efforts and our Insights Reports — a well as
understanding the loca factors working together to impact vaccine confidence. In both our mapping
efforts and Insights Reports we use multiple data sources to beter understand th factors currently
affecting vaccine confidence and uptake. Our funded states and Jurisdictions would be so happy and
eager for this data as well
D0 you think such segmentation is possible? How often does your datarefresh?Are al your vaccine:
confidence data indicators asked the same way at each wave of ata collection?
Kindest regards and look forward to hearing your thoughts,
Kate
Kate Brookmeyer, Ph.
Behavioral Scents
Vacciate with ConfidenceTeam | Insights Unit
Vacine Task Fore| Cie Medical Office
CenterfoDisease Control and Prevention
Mobile:[— (6)6)
Division of STD Prevention
National Center forHIV/AIDS, Viral Hepat,STD and TB Prevention
Centers for Disesse Control and Prevention
Work: +1.404.6398058

Original Appointment.-—-
From: payton@fb.com <payton@fb.com>
Sent: Tuesday, March 16, 2021 10:43 AM
To: payton@fb.com; Brookmeyer, Kathryn A. (COC/ODID/NCHHSTP/DSTOP): Piva Gangally; Crawford,
Carol Y. (CDC/OD/OADC); Layton, Kathleen (COC/OD/OADC); Dempsey, Jay H. (€DC/0D/OADC);
chelseylepage@fb com; genelieadrien@fb.com; katherinemoris @fb.com
Cc: Aiton Tatoug Kamde; Nisha Deolalkar; Julia Esman; Stephanie Bousheri; Liz Lagone;
Kthornton@fb.com; Koli, Jessica (COC/DDPHSIS/CGH/GID)
Subject: Call or VC- Facebook weekly sync with COC (CDCto invite other agencies as needed)
When: Thursday, March 18, 2021 3:00 PM-4:00 PM (UTC-05:00) Eastern Time (US & Canada).
Where:

Original Appointment-—
From: payton@fb.com <payton@fb.com>
Sent: Wednesday, March 10, 2021 9:55 AM
To: Payton heme; Priya Gangolly; Crawford, Carol Y. (CDC/OD/OADC); Layton, Kathleen
(CDC/OD/OADC); Dempsey, JayH. (COC/OD/OADC);chelseylepage@fb.com; genelleadrien@fb.com;
Katherinemorris@fb.com
Ce: Airton Tatoug Kamdem; Nisha Delaikar; Julia Eisman; Stephanie Bousher; Liz Lagone;
Kthornton@fb.com;Kols, Jessica (COC/DDPHSIS/CGH/GID)
Subject: Call or VC- Facebook weekly sync with CDC (CDC to invite other agencies as needed)
When: Thursday, March 18, 2021 3:00 PM-4:00 PM (UTC-05:00) Eastern Time (US & Canada).
Where:

New attendees Intro

-CDC needs/questions
“FB Product updates/feedback request (COVID-HUB)
~COVID-19 Projects- CMU/FB Data Survey Update, Misinfo collab status, other

Ways to join

© Computer or Mobile:
©X6)
Facebook Conference Room:
Use the touch panel to enter thejoin code| ()) and pin
©X6)
BO Telephone:
Dial in on B16) or find an alternative number
then enter ID[— (mys) Jollowed by participant passcodef5y@)]

Enabled by Rooms
 From: Wilhelm, Elisabeth (COC/DDPHSIS/CGH/GID)
sent: The,8O6t 2020 12:11:06-+0000
To: Irene Jay Lu
ce Joie Gohitrin Three;Chelsea Sim
Subject: Re: Thank you Elisabeth! - TMS 2020
Attachments: wanted-nfodemic.unicorns. pg

Hilrene,
actually met Alexios and Care together over a year ago when they were at TED. Alexios is a cool dude!
“The link, deseibe and even video for the unicorn program are below. Even if people feel ike they dort
quite fit the mold, 1urge them to apply—we need diversity of experiences and sks to successfully
combat the waves of misinformation that a new COVID-19 vaccines or vaccines will bring about. The
world and ending this pandemic depends on this piece in contextof a robust public health response and
more medical and behavioral interventions in our arsenal
Thanks for the signal boost! 0
Video link: http youtubecom
s//w watchv=XSHDIG
uw. LUWSM
Short description:
Infodemic managerunicornssought! Apply for WHO's ist comprehensive global traning on tracking,
analyzing and addressing misinformation that affects people’s health behaviors and help heath systems
respond more effectively to COVID-19. Searching for people with public health, digital, behavioral, data,
and communications skis. Apply today! Deadiin is October 18: itps://swws whoint/news:
toom/articles-detail/call for-applicants.for-1stwho-training:n-infodemic management

Please don't hesitate to reach out if you haveany further questions.

us
Get Outlook for 105
From: Irene Jay Liu <irencjay@google.com>
Sent: Thursday, October 8, 2020 6:55:45 AM
‘To: Wilhelm, Elisabeth (COC/DDPHSIS/CGH/GID) <nlaS@cdc.gov>
Cc: Joie Goh <joiegoh@themasterplan.com.sg>; rin Three] BE ; Chelsea sim
<chelseasim@themasterplan.com sg>
Subject: Re: Thank you Elisabeth! - TMS 2020

HiElsabeth,
“Thanks so much for giving such a dynamic keynote! | know it sparked a lot of interest among participants.
I received a lot of requests to be able to replay your presentation from participants, so thank you for
allowingusto share to attendees!
Would you mind resharing the lnk to the unicorn program? Il send a follow up email and include it in
the fink.
Also, | don't knowifyou've had a chance to meet my colleague Alexios Mantzarlis, but he's working on
programs to counter immunization misinfo so 'd ove to introduce you, if you're interested!
Thanks,
Irene

On Thu, Oct 8, 2020 at 11:49 AM Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID) <laS@cde.gov> wrote:

Oh that makes me want to laugh hysterically.

You're talking to the new vaccine confidence strategist for USG. Send good thoughts toward me, | shall
need them. 0

Have agreat day, Joie and colleagues!

Sincerely,

Elisabeth Wilhelm
Health Communications Specialist

| Deployed to COC Vaccine Task Force in Vaccine Confidence Team as Vaccine Confidence Strategist

Day Job: Demand for Immunization Team, Global Immunization Division, COC

wm ®6)
E: asecdcgov

From: Joie Goh <joiegoh@themasterplan.com.sg>

Sent: Wednesday, October 7, 2020 11:48 PM
To: Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID) <nlaS@cdc.gov>
Cc: Irene Jay Liu <irenejay@google.com>; trin Three XE) J: Chelsea Sim
<chelseasim@themasterplancomsg>
Subject: Re: Thank you Elisabeth! - TMS 2020

Gotit

hope you goto catch some Z22's these few days!

io Gon
Resistant Project Manager The Masterplan|IB]
45 Jalan Pemimpin, FooWah Industral Suing, 407-08, S577157

On Thu, Oct 8, 2020 at 11:44 AM Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID) <nlas@cdc.gov> wrote:

I'm good without it, thank you for asking. 0

Sincerely,

Elisabeth Wiel
HealthCommunications Secialst

| Deployed to COC Vaccine Task Force in Vaccine Confidence Team as Vaccine Confidence Srategist
Day Job: Demand for Immunization Team, Global Immunization Division, COC

wm o6
&: plas@cdc gov

From: Joie Goh <joiegoh

@themasterplan.comsg>
Sent: Wednesday, October 7,2020 11:40 PM
‘To: Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID) <nlas@cdc.gov>
Ces rene Jay Liu<ireneiay@googlecom; trin Three ©X6) ; Chelsea sim
<chelseasim@themasterplan comsg>
Subject: Re: Thank you Elisabeth! - TMS 2020

Hey Elisabeth,

Gott! Thanks for letting us know.

Would you want us to edit and send you your individual video?

Let me know!
Joie Goh
Assistant Project Manager| The MasterPlan |: BYE)
45 Jalan Pemimpin, Foo Wah IndustrialBuilding, 407-008, SS77197

On Thu, Oct 8, 2020 at 11:23 AM Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID) <nlas@cdc.gov> wrote:

Hilo,

Thanks for reaching out and thanks for keeping ll te plates spinning in theai or this very thoughtfully
constructed event.
1 ot permission to present due it beinga closed conference so 'm afraid | won't be able to have made it
public. Closed loop works fine though. 0

Thanks for the kind thought of token of appreciation but Il be unable to accept it as a US government
employee.

1hope that the rest of the conference went swimmingly and that you ll caught up on sleep!

Please dort hesitate to reach out if youhaveany further questions.

Sincerely,

Elisabeth Wilhelm
Health Communications Specialist

| Deployed to COC Vaccine Task Force in Vaccine Confidence Team as Vaccine Confidence Strategist

Day Job: Demand for Immunization Team, Global Immunization Division, COC

woe
&: nlas@cdcgov

From: Joe Goh <joiegoh

@themasterplan.comsg>
Sent: Wednesday, October 7, 2020 1:59 AM
To: Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID) <nlas@cdc.gov>
Ces rene Jay Liu <ireneiay@googlecom tin Three © Chelsea sim
<chelseasim@themasterplan.com.sg>
Subject: Thank you Elisabeth! - TMS 2020

Hello Elisabeth!

Thank you again for being a part of the Trusted Media Summit. Your presentation definitely added value
to our event this year!

We'vea few logistical questions for you:

1. We are wondering whether you'd be ok with us takingyourTM talk and making it available to
participants to view as a replay? There are a few options and we'd like to hear what you are
comfortable with (wecan do all or noneofthe following):
«We make it available only to registered participants via a closedYT channel or some other
format.
«We edit thevideo and then make it available on aYTchannel that is open to a more public
forum
«We edit your individual video and give it to you to post on your own platforms.
2.We'd like to send you alittle token of appreciation for participating in TMS 2020.
« Could you send us your complete mailing address for this?

Hope to hear from you soon!

Thank you
Joie Goh
Assistant Project Manager| The MasterPlan|m[_(BX6)
45 Jalan Pemimpin, Foo Wah Industrial Building, #07-008, S577197
WANTED: INFODEMIC MANAGER UNICORNS

TRAINNE
$ 4.5
dian+
/ALVATON Ly
mer AME ies 7 [comupnrcaron
WG \ -sou sctewee
ECE T T Ko, \ pine
[4 phe
v Yaocen's
ADAPTABLE OMTBAEAFRESPONSE
8
= = vi
Call for applicants for 1st WHO DEADLINE: =
training in infodemic management 0cT 18

Recruiting the first global cohortof Infodemic [1] aR [=

Managers to support health authorities in Eg
addressing the COVID-19 infodemic and i Fp=rn el
strengthen community resilience against Fi
misinformation. i Lise [5
8) World Health
[EF: =
Ll ts pea SCAN AND APPLY!
WANTED: INFODEMIC MANAGER UNICORNS

$
JEANNE. Co
-
Ctr
+ MANAGEMENT «7 (commynicanoN,
T. fd. f MG | - sourscene
gre gy NTZoho
Ae p=
vi Vv A unpgesiamome
PuBUCHEATH +
ADAPTABLE ), OUTBREA RESPONSE
ZA S .
= 20 Ii 7
Call for applicants for 1st WHO DEADLINE: =
training in infodemic management 0CT 18

Recruiting the first global cohort of Infodemic [=] EEE [=]

Managers to support health authorities in Tok wyEA
addressing the COVID-19 infodemic and : EHR
strengthen community resilience against SEE TS
misinformation. EL
[Olg - Ab

755 World Health .

Hosted by @) tera SCAN AND APPLY!
From: Wilhelm, Elisabeth (COC/DDPHSIS/CGH/GID)
sent Thu, 11 Jun 2020 20:14:09 40000
To: Heios Mantarls
Sublet A —
We're hoping o gether involved, as hr mame has come up several times. Things ae mcwing!
From: Alexios Mantzarlis <alexios@google.com>
Sent Thursday June 1, 2020 359
To: Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID) <nlas@cdc.gov>
Subject: Re: Touchingbase and help signal boost job opp?

Very exciting! sounds good. Is Wardle involved?

On Thu, un 11, 2020 a 3:53 PM Wilhelm lsabeth (COC/ODPHSIS/CGH/GID) <n@cd gov wrote
ies,
—— | ——
vo
Se things Have eer ong fost, But spare you nesing os cveroad your calendar, Hl cut tthe
Chose WHO hosting an ifodemiogyconference at the en of th month. Things are moving
extremely fast but | thought you'd be interested in hearing more. We are establishing the scientific
discipline of infodemiology, and targeting the general publicforpartofthe conference and the rest for
he eaing 50 global pert working on misinformation including Al computing, ethic, apidemiciogy
ue, design, media, governance and behavioral science We'l eed to get th push back against he
informatio that threatens people's heath, now and whan a COVID-19 vaccine 5 avalabe.
As 500m as 1 get offal nf, Fl send 0 youl Should drop in nest dayo ws Th conference starts
Sine 29, viral
you have any questions or ar interested ina more robust ole, et’ talk about. Schedule something
tens
——
us
roms Aleios Mantzals alesis google.com»
sent Thursday June 11, 2020 3.42
To: Wilhelm, Elisabeth (CDC/DDPHSIS/CGH/GID) <nlaS@cdc.gov>
Subject: Re: Touching base and help signal boost job opp?

Heys,
 terribly sorry but i'shorrificallycomplicated periodforcals giver{__(GX6) _pbligations too. Could
You do 4p next thursday Jun 187 Excited to learn more!
On Wed, Jun 10, 2020 at 1:45 PM Wilhelm, Elisabeth (COC/DDPHSIS/CGH/GID) <alas@cdi.gov> wrote:
Dear Alexios,
That time has come! Ave you free to speak for 15 minutes later on today? | already have [B)pouncing
offthe walls after spoke with him
Happy to work about your schedule.
us
From:Wilhelm, Elisabeth (COC/DDPHSIS/CGH/GID) <las cde.gov»
Sent: Saturday, June 6, 2020 1.08 PM
To: Alexios Mantaaris<alxios@googlecom>
Subject: Re: Touching base and help signalboostjob opp?
Oh suspect will absolutely be in touch with you again soon. )
Wishing you awonderful weekend!
Get Outlook for 105
From: Alexios Mantzarls<alexios @google com>
Sent: Saturday, une 6, 2020 12:21:33 PM
To: Wilhelm, Efsabeth (COC/DDPHSIS/CGH/GID) <olas@cde. gov
Subject: Re: Touchingbase and help signal boost ob opp?
Hey! I'm concentrating primarily on fact-checking (Iaunching products, partnerships and sharing data
50shoutif you end up interested in this type of thing.
1 have also been somewhat across a Question Hub thing that Google s working with the COC on, |
believe
know Harry! We're definitely of the same mili - his org. was a signatory of the IFCN code that |
oversaw.
Please do keep me posted on anything infodemiology-related. Right now Im spinning down the COVID
specific to focus primarily on election but the two are inevitably related.
Take good care,
On ii Jun 5, 2020 at 8:39 PM Wilhelm, Elisabeth (COC/DDPHSIS/CGH/GID) <nla5@ce.gov> wrote:
Hi Aleios,
Likewise! What's keeping you busy nowadays?| heard Google is on the teleworkforever track?
Meanwhile, I'm spending about60%of my time now on infodemicresponse at WHO, and that is the
work hope this new comms person will help support.
I meta guy in Indonesia, where | have recently been doing alot of prep work for social inoculation
implementation research with Unicef and his team, who reminded me a ot of you! His name is Harry
Sufehmi who runs Mafindo, the country's leading hoax busting org and who is tight with Google
colleagues locally. They did incredible work to get the country’s official COVID-19 resource website up
and running (and survive a lot of hacking attempts). Millions of visits in days ater launch, but only step
one ofa long road to fil the info gap and push back against misinformation.
The infodemnic unit at WHO is heating up will be runninga conference in three weeks that will et the
groundwork on the new scientific discipline of infodemiology. | thought you'd like hearing that.)
Let me know if you'd ike any additional info in case you have colleagues who may be interested in
attending!
Wishing you a restful weekend ahead,
us
Get Qutlook foriO
From: Alexios Mantaarii <alexios@google.com>
Sent: Friday, June 5, 2020 7:59:01 PM
To: Wilhelm, Elisabeth (COC/DDPHSIS/CGH/GID) <nlaS@cdc gov
Subject: Re: Touchingbase and help signal boost job opp?
great to hear from youl and | will do, pity i's only for UScitizensbut | guess you all have some good
apples 100.)
take care
On Fri, Jun 5, 2020 at 10:38 AM Wilhelm, Elisabeth (COC/DDPHSIS/CGH/GID) <nlas@cdc.gov> wrote:
Dear Alexios,

Thope you're settling in nicely into this gig and that you and your family are doing well. 0

Could you help signal boost thisjob announcement to your contacts (US citizens) who may be a
00d fit for our team in the Global Immunization Division at US CDC? We're acrackerjack
international social and behavioral science team focused on improving demand for
immunizations, especially in low and middle income countries through innovative
implementation research. And our latest focus i the intersectionofthe infodemic and its impact
on vaccine acceptance, including a future COVID-19 vaccine.

figured you might know a few folks who'd be great.

Thank you!

See link below to the health communications specialist 1 year temp position on our Demand for
Immunization team with a focus on increasing Infodemic/Social inoculation efforts so a premium
on digital analytic skill, etc. would be great. Closingdate is June 8.

Health Communications Specialist: htps://www.usajobs gov/Getlob/ViewDetails/569098400

“This position requires US citizenship.

Kind regards,

Elisabeth Wilhelm
Health Communications Specilis
nlas@eds cov| )6)

Supporting WHO infodemic response

Global Immunization Division (GID)
Centers for Disease Control and Prevention, Atlanta

Alexios Mantzarlis
News& Information Credibly Load, News
Lab
‘alesios@google
com

Alexios Mantzarlis
News& Information Credibity Lead, Nows
Lab
‘alesios@aoolecom

Alexios Mantzarlis
News& Information Crodiily Load, News
Lab
slesos@google com

Alexios Mantzarlis
News& Information Credibity Lead, News
La
‘alesos@oooglecom